Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
1
CURRICULUM VITAE July, 2018
Professor C. B. Bunker
MA (Cantab.), MD (Cantab.), FRCP (Lond.)
Consultant Physician, Dermatology
University College and Chelsea & Westminster Hospitals, London
Honorary Professor
University College and Imperial College, London
Honorary Consultant in Dermatology
Royal Hospital Chelsea and St Luke’s Hospital for the Clergy, London
ADDRESSES:
NHS
University College Hospital,
235 Euston Road, London
NW1 2BU
Academic [email protected]
Private Practice
King Edward VII Hospital
Beaumont Sreet, London W1G 6AA, UK
+44 (0)20 7794 5943
Home
3 Rudall Crescent, London
NW3 1RR, UK
+44 (0)20 7794 5943
FOR AN EXPEDITIOUS RESPONSE, PLEASE SELECT EMAIL ADDRESS JUDICIOUSLY
CIVIL STATUS: British. Married. 2 daughters. dob: 22nd November, 1956
PROFESSIONAL General Medical Council 2699954 Revalidated 2016
STATUS: Medical Defence Union 161597J
ORCID ID 0000-0002-6693-7483
2
NAME: Christopher Barry BUNKER
EDUCATION: Wycliffe College, Stonehouse, Glos. 1970-74
St. Catharine’s College, Cambridge 1975-78
Westminster Medical School, London 1978-81
QUALIFICATIONS: BA (Cantab.) 2(i) Nat. Sci. Tripos (Path. Part II) 1978
LRCP (Lond.), MRCS (Lond.), MB, BS (Lond.) 1981
MRCP (UK) 1985
Specialist accreditation in Dermatology 1991
MD (Cantab.) 1992
FRCP (Lond.) 1996
MAJOR HONOURS, First Scholarship to Wycliffe College 1970
AWARDS & Kitchener Scholarship (Lord Kitchener National Memorial Fund) 1975-81
POSITIONS: Sir Jules Thorn Research Fellowship 1988-90
Sir Walter Langdon Brown Prize (joint winner), MD, Cantab. 1992-93
John Thornton Ingram Lecture, Royal College of Physicians 2001 & 2015
Personal Chair, Imperial College, London 2005
Personal Chair, University College, London 2010
President, St John’s Hospital Dermatological Society 2006-07
President, West London Medico-Chirurgical Society 2007-08
American Dermatological Association (International Honorary Member) 2008
President, Chelsea Clinical Society 2010-11
Dowling Orator, The Dowling Club 2010
Neil Smith Lecturer, St John’s Hospital Dermatological Society 2011
European Dermatology Forum, Member 2013
Poulogy Prize (Inaugural winner - Archives of Dermatology, USA) 2010
Clinical Excellence Awards: National Silver 2006-2017
President, British Association of Dermatologists 2012-14
Council, Royal College of Physicians, London 2012-14
Who’s Who 2015-
Plenary Lecturer, European Academy of Dermatovenereology (EADV) 2016
President, Dermatology Section, Royal Society of Medicine 2015-16
Pierre Deville Memorial Lecturer, Royal Society of Medicine 2016
President, The Dowling Club 2016-17
IMPACT METRICS: h-index 37; i10-index 145; citations 5,95; Research Gate 45.93; top 97.5% 2018
CURRENT UK Board Member, European Academy of Dermatovenereology (EADV) 2014-2020
POSITIONS: Honorary Secretary and Trustee, British Skin Foundation (BSF) 2015-
Trustee, START & Dermatrust
Medical Adviser & Oversight Group, All Party Parliamentary Group on Skin 2002-
External Professional Assessor, Health Service Ombudsman 2010-2012; 2014-
Board Member, British Society for Skin Care in Immunosuppressed Individuals (BSSCII) 2011-
Board Member, British Society for Male Genital Dermatology (BSMGD) 2000-
Expert Resource Group; STDs and HIV, American Academy of Dermatology 2010- Chair, Data Monitoring Committee, SPOT trial 2014-
Editorial Board, Clinics in Dermatology 2015-
3
Editorial Board, Dermatology in Practice 2016-
4
MOST IMPORTANT PUBLICATIONS-PAPERS:
1. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Deficiency of calcitonin gene-
related peptide in Raynaud’s phenomenon. Lancet 1990;336:1530-33.
2. Bunker CB, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in
treatment of severe peripheral vascular insufficiency in Raynaud’s phenomenon. Lancet 1993;
342:80-82.
3. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to histamine, compound 48/80
and calcitonin gene-related peptide in patients with Raynaud’s phenomenon. J Invest Dermatol
1991;96:314-317.
4. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce FL & Dowd PM. Basophil mediator
release in atopic dermatitis. J Invest Dermatol 1993;100:305-309.
5. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Depletion of cutaneous
peptidergic innervation in HIV-associated xerosis. J Invest Dermatol 1999;112:284-9.
6. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a
meta analysis of serological studies. J Invest Dermatol 1999;113:693-5.
7. Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM.
Most women with acne have polycystic ovaries. Br J Dermatol 1989;121:675-680.
8. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R & Bunker CB
HLA-Cw*0602 and HIV associated psoriasis. Br J Dermatol 1998;139:527-533.
9. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F & Bunker CB. HLA-C and
guttate psoriasis. Br J Dermatol 2000;143:1177-1182.
10. Fearfield LA, Larkin JMG, Rowe A, A’Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore
ME & Bunker CB. Expression of p16, CD95, CD95L and HPA in relapsing and non-relapsing
very thin melanoma. Br J Dermatol 2007;156:440-7.
11. Chapman A, Williams G, Soni N, Bunker CB. G-CSF in toxic epidermal necrolysis (TEN). Br J
Dermatol 2010;162:860-5.
12. Edmonds EVJ, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad H & Bunker CB. Gene
expression profiling in male genital lichen sclerosus (MGLSc). Int J Exp Pathol 2011;92:320-
325.
13. Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N & Bunker CB. Clinical parameters in
male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol
2012;26:730-7.
14. Singh S, Kaye S, Francis N, Peston D, McClure & Bunker CB. Human endogenous retrovirus K
(HERV-K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skin.
Pig Cell & Mel Res 2013;26:426-8.
5
15. Bunker CB, Patel, N & Shim TN. Urinary voiding symptomatology (micro-incontinence) in male
genital lichen sclerosus (MGLSc). Acta Derm Venereol 2013;93:216–256.
16. Rashidghamat E, Bunker CB, Bower M & Banerjee P. Kaposi Sarcoma in HIV-negative men who
have sex with men. Br J Dermatol 2014;171:1267-8.
17. Kravvas G, Shim TN, Doiron PR, Freeman A, Jameson C, Minhas S, Muneer A, Bunker CB. The
diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients.
JEADV 2018;32:91-95.
18. Shim TN, Doiron PR, Francis N, Minhas S, Muneer A, Hawkins D, Dinneen, M & Bunker CB
Penile lymphoedema: approach to investigation and management. Clin Exp Dermatol 2018 (in
press).
MOST IMPORTANT PUBLICATIONS-REVIEW ARTICLES:
1. Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.
2. Bunker CB. CGRP, ET-1 and Raynaud’s phenomenon. Current Medical Literature:
Rheumatology 1993;12: 87-89.
3. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol 2001;26:469-79.
4. Porter WM & Bunker CB. The dysfunctional foreskin. Int J STD & AIDS 2001;12:216-20.
5. Singh S & Bunker CB. Male genital dermatoses in old age. Age Ageing 2008;37:500-504
6. Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. The role of human endogenous
retroviruses in melanoma. Br J Dermatol 2009;161:1225-1231.
7. Meys R Gotch FM & Bunker CB. Human papillomavirus in the HAART era of HIV: an immune
reconstitution associated disease (IRAD)? Br J Dermatol 2010;162:6-11.
8. Morar N, Willis-Owen SA, Maurer T & Bunker CB. HIV associated psoriasis: pathogenesis,
clinical features and management. Lancet Inf Dis 2010;10:470-478.
9. Bunker CB & Shim TN. Male genital lichen sclerosus. Indian J Dermatol 2015;60:111-7.
10. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009-
2015;http://www.pointofcare.bmj.com. Point of Care (US version) http://online.epocrates.com.
Best Practice (rest-of-world version) http://bestpractice.bmj.com/best-practice/welcome.html
11. Edwards S, Bunker C, Ziller F, van der Meijden WI. 2013 European guideline for the
management of balanoposthitis. Int J STD AIDS 2014;25:615-626.
6
MOST IMPORTANT PUBLICATIONS-GUIDELINES:
1. Abela C, Hartmann CE, De Leo A, de Sica Chapman A, Shah H, Jawad M, Bunker CB, Williams
GJ, Leon-Villapalos J. Toxic epidermal necrolysis (TEN): The Chelsea and Westminster Hospital
wound management algorithm. J Plast Reconstr Aesthet Surg 2014;67:1026-32.
2 Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB,
Ardern-Jones MR, Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G,
Shah M, Brown D, Williams P, Mohd Mustapa MF & Smith CH. UK guidelines for the
management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2016;174:
1194-227 & J Plast Reconstr Aesthet Surg 2016;69:736-41
3. Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, Mohd Mustapa MF,
& Exton LS. British Association of Dermatologists guidelines for the management of lichen
sclerosus 2018. Br J Dermatol 2018 Jan 4. doi: 10.1111/bjd.16241. [Epub ahead of print]
GUIDELINES DEVELOPED DURING BAD THERAPETICS AND AUDIT COMMITTEE MEMBERSHIP: 1. Roberts DT, Taylor WD & Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402.
2. Sterling JC, Handfield-Jones, S & Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol
2001;144:4-11.
3. Higgins EM, Fuller LC & Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000:143:53-
58.
4. Cox N, Eedy D & Morton C. Guidelines for the management of Bowen’s disease. Br . Dermatol 1999;141: 633-641.
5. Roberts DLL, Anstey AV, Barlow RJ& Cox NH (BAD) and Newton-Bishop JA, Corrie PG, Evans J, Gore ME, Hall
PN & Kirkham N (MSG). UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7.
6. Motley R, Kersey P & Lawrence C. Multiprofessional guidelines for the management of the patient with primary
cutaneous squamous cell carcinoma. Br J Plas Surg 2003:56:85-91. 7. Grattan C, Powell S & Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J
Dermatol 2001;144: 708-714.
8. Wojnarowska F, Kirtschig G, Highet AS, Venning VA & Khumalo W. Guidelines for the management of bullous
pemphigoid. Br J Dermatol 2002;147:214.
9. Bourke J, Coulson I, & English J. Guidelines for care of contact dermatitis. Br J Dermatol 2001;145:877-885.
10. Neill SM, Tatnall FM & Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol.2002;147:640.
MOST IMPORTANT PUBLICATIONS-LETTERS:
1. Bunker CB & Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet 1987; i:1266.
2. Bunker CB, Foreman JC, & Dowd PM. Calcitonin gene-related peptide and Raynaud’s
phenomenon. Lancet 1990;335:239.
3. Bunker CB, Whittaker S, Luzatto L, Gore ME, Rustin MHA, Smith NP & Levene GM. Indolent
cutaneous prodrome of fatal HTLV-1 infection. Lancet 1990;335:426.
4. Rowe A, Farrell A, Kazmi SH, & Bunker CB. Expression of inducible nitric oxide synthase in
dermal microvasculature in psoriasis. Lancet 1994;344:1371.
7
5. Dowd PM, Bunker CB, Bull HA, Foreman JC, Terenghi G, Springall DR, & Polak JM.
Raynaud’s phenomenon, calcitonin gene-related peptide, endothelin and cutaneous vasculature.
Lancet 1990;336:1014.
6. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a
meta-analysis of published serologic studies. J Invest Dermatol 1999;113:693-5.
7. Burge S, Bunker C & Eedy D. Modernising Medical Careers. Young Doctors. The Times 2007
(Mar 21).
8. Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO & Bunker CB. Revisiting the
past: utilising archival tissue for the detection and quantification of gene expression. Br J
Dermatol 2009;160:885-6.
9. Bunker CB, Edmonds E, Hawkins D, Francis N & Dinneen M. Re: Pugliese et al. Lichen
sclerosus: review of the literature and current recommendations for management. J Urol
2009;181:1802-3.
10. Bunker CB. Urine in the causation of male genital lichen sclerosus. Re: Kulkarni S et al. Lichen
sclerosus of the male genitalia and urethra: surgical options and results in a multicenter
international experience with 215 patients. Eur Urol 2009;55:945–956.
11. Bunker CB. Comments on the BAD guidelines for the management of lichen sclerosus Br J
Dermatol 2011;164:894-5.
12. Doiron P & Bunker CB. Response to "Expanding the benefits of HPV vaccination to boys and
men”. Lancet 2016;388:659.
MOST IMPORTANT PUBLICATIONS-BOOKS:
1. Bunker CB & Dowd PM. Skin Disease. In: Medicine. Edited by Axford J. Blackwell Scientific
Publications, Oxford, 1996.
2. Bunker CB & Dowd PM. Raynaud’s phenomenon. In: Cutaneous Medicine and Surgery.
Edited by Arndt et al.. Saunders, New York, 1996.
3. Bunker CB. Dermatological Problems in HIV Infection and AIDS. In: Medical Management of
HIV and AIDS. Edited by Millar A. Springer-Verlag. Berlin, 1996; 162-189.
4. Bunker CB & Bridgett CK. Depression and the Skin. In: Depression and Physical Illness.
Edited by Robertson MM. & Katona CLE. John Wiley & Sons, London,1997.
5. Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care
Handbook. Edited by Gazzard B. Mediscript, London, 1999.
6. Bunker CB. Dermatology. In: Medicine at a Glance. Edited by Davey P. Blackwell Scientific
Publications, Oxford, 2002
8
7. Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care
Handbook. Edited by Gazzard B. Mediscript, London, 2002.
8. Fearfield L, Stephenson A, Bunker CB, Thomas M & Gore M. Skin cancer and melanoma. In:
Cancer in Primary Care. Eds Gore M. & Russell D. Martin Dunitz, London & New York,
2003.
9. Bunker CB. Male Genital Dermatology. Saunders, London, 2004.
10. Agnew K, Gilchrest B & Bunker CB. Fast Facts-Skin Cancer. Health Press, London UK, 2005
11. Bunker CB & Gotch F. HIV and AIDS. In: Textbook of Dermatology (Rook). 7th Edition.
Oxford, Blackwells. 2004.
12. Bunker CB & Neill SA. The Umbilicus, Perianal and Genital Regions. In: Textbook of
Dermatology (Rook). 7th Edition. Oxford, Blackwells. 2004.
13. Bunker CB. Skin Disease. In: Medicine 2e (Edited by Axford J, O’Callaghan J.) Blackwell
Scientific Publications. Oxford, 2004.
14. Bunker CB & Staughton RCD. Genital inflammatory papules and nodules. In: Genital
Dermatology. Edited by Edwards L. Saunders, Philadelphia, 2004.
15. Bunker CB. Dermatology. In: Medicine at a Glance 2e. Edited by Davey P. Blackwell
Scientific Publications, Oxford, 2005.
16. Bunker CB. Chapter 51. Non-venereal penile dermatoses. In: Kumar B, Gupta S Eds.
Sexually Transmitted Infections. Elsevier, New Delhi, 2005; pp 539-564.
17. Bunker CB. Male Genital Dermatology. Fitzpatrick’s Dermatology in General Medicine, 7th
edition. Wiley 2007.
18. Bunker CB & Gotch F. HIV and AIDS. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths,
(eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;35:1-
47.
19. Bunker CB & Neill S.A. The genital, perianal and umbilical regions. In: T.Burns, S. Breathnach,
N.Cox and C. Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell,
New York. 2010;71:1-102.
20. Bunker CB. Dermatology. In: Medicine at a Glance 3e. Edited by Davey P. Wiley-Blackwell,
Oxford, 2010.
21. Edwards S & Bunker CB. Other conditions affecting the male genitalia. In: ABC of Sexually
Transmitted Infections. Ed. Rogstad KE. Sixth Edition. Wiley-Blackwell 2011, pp 35-41.
22. Bunker CB. Non-venereal penile dermatoses. In: Gupta S. & Kumar B. Eds. Sexually
Transmitted Infections. 2nd edition. Elsevier, New Delhi, 2012; pp 703-727.
9
23. Calonje E, Neill S, Bunker C, Francis N, Chaux A & Cubilla AC. Diseases of the anogenital
skin. In: McKee’s Pathology of the Skin. Eds Calonje E, Brenn T, Lazar A& McKee P. 4th
Edition. Elsevier Saunders. London. 2012 Chapter 12. 438-519; pp 452-456.
24. Bunker CB. Diseases and disorders of the male genitalia. In: Goldsmith LA. Katz SI, Gilchrest
BA, Paller AS, Leffell DJ & Wolff K. Eds. Fitzpatrick’s Dermatology in General Medicine. 8th
edition. McGraw Hill 2012, pp 852-877.
GUEST EDITORSHIP Clinical Medicine CME Dermatology (Royal College of Physicians):
1. Fogo A, du Vivier A. The cutaneous manifestations of haematological malignancy. Clin Med
2009;9:366-70. Erratum in: Clin Med 2009;9:495.
2. Groves RW. Pemphigus. Clin Med. 2009;9:371-5.
3. Topham E. Cutaneous manifestations of cancer and chemotherapy. Clin Med 2009;9:375-9.
4. Dhoat S, Rustin M. The skin in general medicine. Clin Med 2009;9:379-84.
5. Roberts N. Infantile haemangioma: harmless 'strawberry' or life-threatening vascular anomaly?
Clin Med 2009;9:385-9.
MAJOR GRANTS:
1. Dr CB Bunker: Sir Jules Thorn Research Fellowship. Salary and costs. 1988-1990
2. Dr Eleanor Mallon: Research Fellowship. Salary and costs. 1998-1989
Joint Research Committee (Chelsea & Westminster Hospital).
3. Dr Louise Fearfield: Research Fellowship. Salary and costs. 1998-2000
Joint Research Committee (Chelsea & Westminster Hospital.)
4. Medical Research Council Grant No: G0000328 Grant ID: ID56834. 2001-2003
“Does venous surgery improve healing and minimise recurrence of venous ulcers?”
USABLE Trial (ICRCTN 97621126).
Investigators: Davies A, Greenhalgh R, Powell J, Russell I, Cullen N,
Thompson S, Bradbury A, Buxton M, Bunker CB, Stansby G, Torgerson D.
MRC alpha B rated from the Health Service Public Health Research Board.
5. Dr Emma Edmonds: Clinical Research Fellowship. Salary and costs. 2004-2006
START* and Joint Research Committee (Chelsea & Westminster Hospital).
6. Dr Sarita Singh: Clinical Research Fellowship. Salary and costs. 2006-2008
START* and Spyros Retsas Melanoma Research Fund.
7. Dr Rhonda Meys: Clinical Research Fellowship. Salary and costs 2007-2008
Joint Research Committee (Chelsea & Westminster Hospital) and START*.
8. Dr Sacha Goolamali: Clinical Research Fellowship, £70,000 salary 2009-2011
British Skin Foundation Grant
10
9. Dr Tang Shim: Sir John Fisher Trust. £75,000 salary and START costs 2011-2013
10. Dr Phil Doiron: Chelsea & Westminster Healthcare Charity. £150,000 salary and costs 2014-16
Clinical Research Fellowship
11. The Linbury Trust (Sainsbury family trust). £600,000. (in abeyance) 2014
Gerontodermatology
12. Dr Richard Watchorn: European Association of Dermatovenereology. €30,000 (costs) 2016
*START: Skin Treatment and Research Trust.
OTHER AWARDS and HONOURS:
French Scholarship (Royal College of Physicians/French Government), Sevres, Paris 1989
Dowling Club Bioglan Travelling Fellowship 1989
Lederle Acne Fellowship 1988
Silver Award, American Academy of Dermatology (Historical Poster) 1990
Gold Award, American Academy of Dermatology (Historical Poster) 1991
Bronze Award, American Academy of Dermatology (Historical Poster) 1992
Overseas Scholarship, World Congress of Dermatology 1992
Bristol Cup, British Association of Dermatologists (Research Poster) 1998
Visiting Professor, New York University, NY, USA 2000
Visiting Professor, Post Graduate Medical Institute, Chandigarh, India 2004
Visiting Professor, Boston University, MA, USA 2007
‘Highly Commended’, Medicine at a Glance. BMA Book Awards 2007
NHS Champions Nomination, Kings Fund 2008
Visiting Professor, Maadi Military Hospital, Cairo, Egypt 2009-2010
Nominee, (1/23), London Deanery, Best Clinical Trainer 2011
Excellence in Education, Outstanding Clinical Educators
Royal College of Physicians Regional Lecturer (Taunton) 2010
Honorary Member, Baltic Association of Dermatovenereologists 2014
Discretionary Points: 2 (1996); 1 (1997); 2 (1998); 1 (2000); 1 (2001)
Merit Awards: “B” (2001, 2005)
Clinical Excellence Awards: Local Bronze (2004); National Silver 2006-20
MEDICOLEGAL REPORTS:
Reports prepared for solicitors and counsel especially in melanoma, 1992-
pyoderma gangrenosum and penis cancer, often as a single joint expert.
Several reports for the Healthcare Commission 2007-2009
(Associate Complaints Advisor)
Several reports for the Health Service Ombudsman 2007-
11
(External Professional Assessor)
MISCELLANEOUS REPORTS:
Independent Review Panel: multidisciplinary care of a patient at another hospital 1999
(details confidential)
For the Health Service Ombudsman: patient complaint about 2007
clinical research ethics and governance at another institution (details confidential)
For Deputy Registrar: patient complaint about clinical research ethics and governance 2008
at another institution (details confidential)
For a Primary Care Trust and Cancer Network: 2009
Independent Review of Skin Cancer Services (details confidential)
12
GENERAL MEDICAL TRAINING:
House Physician and House Surgeon Posts, Westminster Hospital, London 1981-1982
Senior House Officer Posts, Derby, Oxford and The Middlesex Hospitals, London 1982-1985
Registrar, Psychiatry, The Middlesex Hospital, London 1985
Lecturer, Medicine (locum: Hon. Registrar)
University College & Middlesex School of Medicine, London 1985-1986
DERMATOLOGY TRAINING:
Senior House Officer, The Middlesex Hospital, London 1985
Registrar, The Middlesex and University College Hospitals, London 1986-1988
Honorary Clinical Assistant, St. John’s Hospital for Diseases of the Skin, London 1986-1987
Research Fellow (Hon. Senior Registrar), University College, London 1988-1990
Senior Registrar, University College Hospitals, London 1989-1992
MANAGEMENT EXPERIENCE:
King’s Fund College residential course for Senior Registrars (E729) 1991
Lead Clinician/Speciality Director, Dermatology, Chelsea & Westminster Hospital 1992-2001
Riverside Health Authority and Chelsea & Westminster Hospital Healthcare Trust
Project Board (HR 2000, Accounts and Personnel Database) 1992-1993
Project Group (HISS implementation) 1993-1995
Secretary, Medical Committee, Chelsea & Westminster Hospital 1995-2000
Chairman, Medical Committee, Chelsea & Westminster Hospital 2003-2007
ACADEMIC EXPERIENCE-TEACHING:
Undergraduate teaching and admin., Westminster, Nottingham, Oxford, UCMSM 1981-1991
Undergraduate teaching and admin., CXWMS, ICSM 1992-
BSc (Immunology, Biochemistry), UCMSM 1986-1994
MSc (STDs), ICSM 1999
MRCP course Parts I and II, UCMSM (BPMF, 1988) invigilator 1985
teacher 1985-91
organiser 1986-90
AFOM (RCP) invigilator 1985-7
~190 Postgraduate lectures (listed separately: p. 72) 1986-2009
20 Undergraduate and Postgraduate textbooks and chapters written 1986-2009
Learning, Teaching and Assessment Course, Oxford 2007
ACADEMIC EXPERIENCE-EXAMINING
500 MCQs (UCMSM MRCP): Two books published 1986-1992
OSSE and OSCE, CXWMX and ICSM 1997-
External Examiner, Diploma in Dermatology, 1996-2002
13
St. John’s Institute of Dermatology, St. Thomas’ Hospital, London,
MD (London), Dr J. Ramsbotham, Genetics of Psoriasis 1997
Examiner, Diploma in HIV Medicine, Society of Apothecaries, London 2002-2012
Dermatology KBA Question Setting Group RCP (Jun) 2005
Dermatology KBA Question Setting Group RCP (Nov) 2005
MCQs for Medicine, 2nd Edition 2005
PhD (Manchester), Dr Helen Young (VEGF in Psoriasis) 2006
Dermatology SCE (Specialist Certificate Examination) Board (Jan) 2009
MD (London), Dr Emmanuela Campalani (Psoriasis Pharmacogenetics) 2009
MD (London), Dr Jane Setterfield (Mucous Membrane Pemphigoid) 2009
MD (London), Dr Catriona Maybury (Co-morbidities in Sever Psoriasis) 1st yr review 2013
PhD (Nottingham), Dr Ser Ling Chua (Pruritic Papular Ereuption in HIV) 2015
ACADEMIC EXPERIENCE-RESEARCH:
Part II Pathology ( Cantab.) supervised by Dr M. Mitchison) 1977 Tissue culture Biochemist (supraregional PRU, Westminster Hospital) supervised by Dr P. Riches 1978 Radioimmunoassay (IgE), polyacrylamide gel electrophoresis (CSF)
Clinical Research-Raynaud’s phenomenon, systemic sclerosis and acne 1985-1991 Laser Doppler velocimetry, video capillary microscopy, ovarian ultrasound, electron microscopy,
pulmonary function, psychometry, immunohistochemistry, biostatistics
Sir Jules Thorn Research Fellow-CGRP and Raynaud’s phenomenon 1988-1990 intradermal pharmacology, ELISA, DNA and RNA extraction, cloning and sub-cloning,
DNA restriction enzyme analysis, Sanger nucleic acid sequencing, Southern blotting,
polymerase chain reaction nucleic acid amplification, in situ hybridisation,
human endothelial cell culture, radioimmunoassay (CGRP, PG) immunohistochemistry, biostatistics
Clinical and Laboratory Research 1992-
vascular pharmacology, inflammation, psoriasis, lichen sclerosus, HIV, melanoma immunohistochemistry, molecular biology, electron microscopy, intradermal pharmacology,
nuclear magnetic reasonance spectroscopy, virology, immunogenetics
epidemiology, biostatistics
Research Supervision 1991-
BMS II (UCMSM) Psoriasis (mutageneticity of treatment) Mr M. Jefford 1991
BSc (Imperial College) Zoon’s balanitis Ms K. Bhate 2005
MD (Frieberg) Neuropeptides in HIV xerosis Dr P. Rosenberger 1997-1998
MD (Hamburg) HLA-C in psoriasis Dr J. Schilling 1998-2000
MD (London) Immunogenetics of psoriasis Dr E. Mallon 1997-1999
DM (Oxon) Prognosis of thin melanoma Dr L. Fearfield 1998-2004
MD (London) Male genital lichen sclerosus Dr E. Edmonds 2004-2007 (not submitted)
MD (Imperial College) Retroviruses in melanoma Dr S. Singh 2006-2009
MD (Imperial College) HPV in HIV IRD Dr R. Meys 2007-2010
MD (Imperial College) Non-melanoma skin cancer in HIV Dr S. Goolamali 2009-
MD (Imperial College) Male genital lichen sclerosus Dr T. Shim 2011-2016
MD (UCD) Male genital lichen sclerosus Dr R. Watchorn 2016-
14
Dr Mallon won the Norman Plummer Memorial Prize (Charing Cross Hospital, ICSM) 1999
Dr Singh was a runner-up for the Everett C. Fox prize 2011
(Residents and Fellows Symposium, American Academy of Dermatology, New Orleans)
Dr Singh and Dr Meys were joint runners up for the BAD Clive Archer THESI prize 2014
Dr Shim won a Scholarship to the World Congress on Cancers of the Skin (Edinburgh) 2014
One of his posters was selected for plenary presentation
Dr Shim was Runner Up in inaugural Royal Society of Medicine AbbVie 2015
Dermatology Trainee Research Prize awards
Dr Watchorn was a awarded and NIHR/BAD Travel Bursary to the IID, Orlando 2018
Dr Watchorn was Runner Up in Royal Society of Medicine AbbVie
Dermatology Trainee Research Prize awards
Seven sandwich students, University of East London (with Dr A. Rowe) 1994-2000
ACADEMIC EXPERIENCE-ADMINISTRATION
Medical Student Selection, UCSM 1989-91
Medical Student Selection, CXWMS, ICSM 1992-
Clinical Tutor, Imperial College 2005-2010
Research Director and Trustee, START (Skin Treatment and Research Trust) 1992-
Laboratories headed by headed by Dr A. Rowe PhD (molecular biochemist) until 2003
British Association of University Teachers of Dermatology (now defunct) 1993-2001
Westminster Medical School Research Trust – Trustee 1994-
Westminster Medical School Oncology Trust – Trustee (now defunct) 1999-2009
Research Committee /Way Forward Group, Chelsea & Westminster Hospital 1998-
Board Member/Executive Committee Member, Skin Pharmacology Society 1993-1995
School Council/Executive Board/Advisory Standing Sub-Committee/Academic Board
Charing Cross & Westminster Medical School 1995-1997
Vice-Principal’s Advisory Group, Imperial College School of Medicine 1997-1999
Convenor, Dermatology Curriculum Review, CXWSM and ICSM 1995-1997
College Tutor, Royal College of Physicians, Chelsea & Westminster Hospital 1995-2000
Good Clinical Practice and the EU Directive, ICH, (2001/20/EC), London 2005
I coordinated the successful RCP Visit and Review of ~50 Training Posts in Medicine and
Paediatrics at the CWH in April 1995.
GRANT REVIEWS:
Trustees of the Welcome Foundation. (Grant Review) 1993
Joint Research Committee, Chelsea and Westminster Hospital 1995-2010
Royal College of Surgeons of England, Research Fellowship Scheme Assessor 1999-2003
Reviewed application for BUPA Foundation Grant 2002
Royal College of Surgeons of England, Research Fellowship Scheme Assessor 2002-2003
Royal College of Surgeons of England, Referee, Professors and Lecturers 2004
15
Royal College of Surgeons of England, Research Fellowship Scheme Assessor 2004-2005
Royal College of Surgeons/Healing Foundation Research Fellowship Interviews 2005
Royal College of Surgeons, Hunterian Professorship Selection 2006
Royal College of Surgeons, Election of Professors & Lectureships 2007
British Skin Foundation, Grants Advisory Committee 2008-2010
Royal College of Surgeons Research Fellowship Scheme 2009
Royal College of Surgeons Research Fellowship Scheme 2010
Rosetrees Trust, Small Grant Application 2010
Royal College of Surgeons Research Fellowship Scheme 2011
Royal College of Surgeons Research Fellowship Scheme 2012
Royal College of Surgeons, Hunterian Lectureship Selection 2014
Lupus, UK 2016
Abertawe Bro Morgannwg University Health Board 2016
UCLH Pleomorphic Dermal Sarcoma, Single peer review of research protocol 2017
16
EDITORIAL ACTIVITIES:
Associate/Co-Editor, Clinical & Experimental Dermatology 2003-2005
Editorial Board, British Journal of Dermatology 2012-2010
Editorial Board, Clinics in Dermatology 2015-
Editorial Advisory Board, Indian Journal of Dermatology Venereology and Leprosy 2009-2010
Editorial Advisory Board, International Journal of STD and AIDS 2010-
Advisory Editorial Board, Clinical & Experimental Dermatology 1995-2005
Helper, Lancet 1994, 1997, 2016
Reviewer,
American Journal of Clinical Dermatology, Archives of Dermatology; JAMA
Dermatology, British Journal of Dermatology, Skin Pharmacology, Clinical and
Experimental Dermatology, Journal of Experimental Pathology, Journal of Rheumatology,
Acta Dermato-Venereologica, Journal of Dermatological Treatment, Journal of
Immunopharmacology, Genitourinary Medicine and now Sexually Transmitted Infection,
Journal of Affective Disorders, Prescriber, Care of the Critically Ill, Journal of the
European Association of Dermatovenereology, Bone Marrow Transplantation, Journal of
Medical Case Reports, HIV Medicine, British Journal of Medical and Surgical Urology,
Histopathology, European Journal of Dermatology, Practical Neurology, Nature Urology
Reviews
Reviewer, Sexually Transmitted Infections CD ROM for Wellcome Trust 2003
Reviewer, Society of Authors and Royal Society of Medicine 2002, 2006, 2007
Medical Book Awards
Reviewer, NHS Clinical Knowledge Series-HIV Infection and AIDS www.cks.nhs.uk 2010
Executive Committee, Society of Authors Medical Writers Group 2005 –2007
ACADEMIC AMBITIONS;
I was successful in creating a University Chair in Dermatology at ICSM on the CWH campus (2001) but
this lapsed with the resignation of the appointee. The establishment of a University Department is still a
major ambition and that was one of the reasons for my move to UCLH and UCL in 2010. In 2014 I
secured ~£K650 from the Linbury Trust (Sainsbury Family Trusts) to establish and academic
department of Gerontodermatology at UCL; unfortunately a suitable appointment was not achieved.
I was awarded a Personal Chair at Imperial College in 2005 and at University College in 2010.
I continue to press for academic developments in Dermatology at UCL and ICL and in the UK.
(i) to provide research opportunities for Dermatology trainees,
17
ii) to augment British dermatological research output, currently disproportionate to populace
morbidity and
iii) to improve the curricular prominence of Dermatology, currently disproportionate to populace
morbidity.
My personal research ambitions are to develop my interests in:
i) Genital dermatology (lichen sclerosus, penile intraepithelial neoplasia, penis cancer)
ii) Aetiopathogenesis, management and prognosis of thin melanoma
iii) HIV related skin disease, including skin and genital cancer
iv) Gerontodermatology
v) Toxic epidermal necrolysysis
18
OTHER CONTRIBUTIONS TO TEACHING, TRAINING, CME/CPD:
College Tutor, Royal College of Physicians 1995-2000
North Thames Specialist Training Committee, Dermatology (Vice-chair) 1996-2005
Proposal for 5 year curriculum HIV (for British Association of Dermatologists) 1998
SAC/JCHMT (Derm), British Association of Dermatologists Representative 2000-
Chairman (2005-2007)
SAC/JCHMT (GUM), British Association of Dermatologists Representative 2002-
British Association of Dermatologists (Therapeutics & Audit Subcommittee) 1997-2002
British Association of University Teachers of Dermatology (now defunct) 1994-2004
Royal Society of Medicine-Member of Council (Dermatology) 1977-2000
THESIS (The Skin Investigation Society) 1993-
Examiner, Diploma in HIV Medicine, Worshipful Society of Apothecaries, 2002-
In person, 2006, 2008, 2009
Imperial College London Examining
OSCE’s 2006
MBBS Finals Medicine 2006
MBBS PACES 2008
OSCE’s 2008
Kuwait Board of Dermatology Visiting Examiner, Part I Examinations 2008
International Investigative Dermatology, Edinburgh 2013
Local Organising Committee
XV World Congress on Cancers of the Skin, Edinburgh 2012-14
Local Organising Committee Member
Reviewer: International Classification of Diseases (ICD) 11th Revision/Review (beta version) 2014
Disorders of Male Genitalia
19
PREVIOUS POSTS:
Biochemist, Protein Reference Unit, Westminster Medical School, London 1978
Prof. J. Hobbs and Dr (later Prof.) P. Riches
House Physician, Westminster Hospital, London 1982
Drs F. Gibberd, R. Guiloff, R. Zeegen, A. Keat and Prof. D. Brewerton
House Surgeon, Westminster Hospital, London 1982
Messrs. D. Evans, B. Andrews, P. Aichroth, and K. Robinson
Senior House Officer, General and Renal Medicine, Derby City Hospital 1982-1983
Dr G. Cohen
Senior House Officer, Neurology, Derbyshire Royal Infirmary 1983
Drs R. Godwin-Austin, D. Jefferson and A. Whitely
Senior House Officer, Oncology, Churchill Hospital, Oxford 1983
Drs C. Paine, G. Wiernik, A. Laing and K. Durrant
Senior House Officer, Osler Chest Unit, Churchill Hospital, Oxford 1983-1984
Dr D. Lane
Senior House Officer, Endocrinology and Clinical Pharmacology, 1984
Radcliffe Infirmary, Oxford
Drs T. Hockaday, R. Turner, C. Burke, J. Mann and Prof. Grahame-Smith
Senior House Officer, Department of Dermatology, 1984-1985
The Middlesex Hospital, London
Drs G. Levene and Dr (later Prof.) P. Dowd
Registrar, Department of Psychiatry, 1985
The Middlesex, University College and St. Lukes Woodside Hospitals, London
Drs A. Beard and E. Chesser
Lecturer in Medicine, Honorary Registrar (locum) 1985-1986
Department of Medicine, University College and Middlesex School of Medicine
Dr N. Mcl. Johnson and Prof. S. Semple
Registrar (locum), Department of Dermatology, 1986
University College and Middlesex School of Medicine,
Drs T. Robinson, G. Levene, J. Gilkes and Dr (later Prof.) P. Dowd
Registrar, Department of Dermatology, 1986-1988
University College and Middlesex School of Medicine
Drs T. Robinson, G. Levene, J. Gilkes and Dr (later Prof.) P. Dowd
Senior Registrar (locum), Department of Dermatology, 1986-1987
University College and Middlesex School of Medicine
20
Drs T. Robinson, G. Levene, J. Gilkes and Dr (later Prof.) P. Dowd
Honorary Clinical Assistant, St. John’s Hospital for Diseases of the Skin 1986-1987
Dr (later Prof.) P. Dowd and Prof. M. Greaves
Sir Jules Thorn Research Fellow, Honorary Senior Registrar 1988-1990
Departments of Dermatology, Pharmacology and Molecular Biology,
University College and Middlesex School of Medicine
Dr (later Prof.) P. Dowd, Dr (later Prof.) J. Foreman, Prof J. Polak,
Prof R. Craig, Dr (later Prof.) P. Brickell
Senior Registrar, Department of Dermatology, 1989-1992
University College and Middlesex School of Medicine
Drs T. Robinson, G. Levene, J. Gilkes and Dr (later Prof.) P. Dowd
Consultant Physician, Department of Dermatology, Westminster Hospital 1992-1993
Consultant Physician, Department of Dermatology, Charing Cross Hospital 1992-2003
Consultant Physician, Department of Dermatology, Royal Marsden Hospital 1997-2010
PREVIOUS POSITIONS:
At School and University
Head of School House, Wycliffe College 1974
St. Catharine’s College May Ball Committee 1978
Summer Festival Committee, Westminster Medical School 1979
Publicity, Flowers Action Committee, Westminster Medical School 1980
Treasurer, Westminster Hospital Doctors Mess 1981-1982
As a Trainee
Secretary, UCMSM Wine Club 1988-1990
Local Organiser, Skin Pharmacology Society Meeting, Pitlochry, Scotland 1991
As a Consultant
Chairman, Westminster Wake Committee 1993
Lead Clinician, Department of Dermatology, Riverside HA 1992-2002
Project Board (Computerised Accounts and Personnel), RHA 1992-1993
Consultant, Procter & Gamble 1992-2005
(product development and post-marketing surveillance)
Project Group (HISS implementation), Chelsea & Westminster Hospital 1993-1995
Chelsea & Westminster Hospital Postgraduate Education Committeee 1993-1999
Board Member/Executive Committee Member, Skin Pharmacology Society 1993-1995
Trustee, Westminster Medical School Research Trust 1994-2010
Secretary, Medical Committee, Chelsea & Westminster Hospital 1994-2000
21
Editorial Advisory Board, Clinical & Experimental Dermatology 1995-2003
School Council/Executive Board/Advisory Standing Sub-Committee/
Academic Board-Charing Cross & Westminster Medical School 1995-1997
College Tutor, Royal College of Physicians, Chelsea & Westminster Hospital 1995-1999
Joint Research Committee, Chelsea & Westminster Hospital 1995-2010
North Thames Specialty Training Committee, Dermatology (Vice-Chair 2000-2004) 1996-2004
Royal Society of Medicine-Member of Council (Dermatology Section) 1997-2000
Therapeutics & Audit Subcommittee, British Association of Dermatologists 1997-2002
Archives Committee, Chelsea & Westminster Hospital, 1997-2005
Vice-Principal’s Advisory Group, Imperial College School of Medicine 1997-1999
Charing Cross and Westminster Medical School/Imperial College School of Medicine
“Past, Present and into the Future”, Cobham Event Committee Member 1998
Charing Cross and Westminster Medical School Alumnus Committee 1999-2007
Member, Specialty Advisory Committee (Dermatology), RCP 2000-2009
Consultant, British Advertising Clearance Centre 2001-2006
Adviser, London Regional Specialised Commisioning Group, Dermatology 2000-2001
Adviser, National Specialised Services Definition Set-Phase 2, Dermatology 2001-2002
Medical Committee, St. Luke’s Hospital for the Clergy (Clinical Lead, Dermatology) 2001-2008
Medical Advisory Panel, Independent Television Commission 2001-2005
Private Practice Committee, British Association of Dermatologists 2001-2004
Hon. Secretary, Westminster Hospital School and Staff Dining Club 2002-2010
Chairman, Skin Cancer Multidisciplinary Team, Charing Cross Hospital 2002-2003
Chairman, Skin Cancer Multidisciplinary Team, Chelsea &Westminster Hospital 2002-2010
Member, Skin Care Campaign Future Dermatology Services Working Party 2003-2004
Co-Editor, Clinical & Experimental Dermatology 2003-2004
Chairman, Medical Staff Committee, Chelsea & Westminster Hospital 2003-2007
Clinical Tutor, Imperial College (Medical Student Supervisor) 2005-2010
Scientific Committee, European Academy of Dermatovenereology, London 2005
Chairman, Specialty Advisory Committee (Dermatology), RCP 2005-2007
Member Joint Specialty Committee (Dermatology), Royal College of Physicians 2005-2007
Executive Committee, The Medical Writers Group, The Society of Authors 2005-2007
Member Specialty Advisory Committee, (GUM), JRCPTB, RCP 2005-2009
Chairman, Medical Advisory Board, The Mole Clinic/Scansol UK 2006-2007
West London Skin Tumour Working Group 2006-2010
Council Member, St John’s Hospital Dermatological Society 2006-2011
President, St John’s Hospital Dermatological Society 2006-2007
Organiser, inaugural Lucy Bull Memorial Melanoma Lecture 2007
Dermatology Adviser, England & Wales Cricket Baord 2007
European Union of Medical Specialists, Dermatology Representative 2007-2009
Associate Complaints Advisor, Healthcare Commission 2007-2009
Chairman, Specialist Skin Cancer Multi Disciplinary Team, CWH 2008-2010
Advisory Committee for Clinical Excellence Awards, North West Thames 2008-2010
Advisory Committee for Clinical Excellence Awards, North East Thames 2010-
Grants Committee, British Skin Foundation 2008-2010
Royal Society of Medicine-Member of Council (Library Rep.Dermatology Section) 2009-2011
Clinical Resource Group, Dermatology, National Commissioning Board 2011-2013
Chair, Steering Committee, LIMIT-1 (Lentigo maligna & imiquimod treatment) 2010-2013
Advisory Group, Tackling HIV Testing, MedFASH 2008-
Council, Dermatology Section, Royal Society of Medicine 2008-
22
Advisory Committee for Clinical Excellence Awards (NE & NW Thames) 2007-15
POSTGRADUATE COURSES:
Dowling Club Educational Weekend, Hull 1986
Entomology and Dermatology, RAMC, London 1986
Dowling Club Educational Weekend, Norwich 1986
Practical Procedures in Dermatology, Oxford 1986
Communications in Medicine, Windsor 1986
Biology of the Skin, Cambridge 1986
New Drug Treatments for Skin Diseases, Institute of Dermatology, London 1987
Histopathology of the Skin, Glasgow 1988
Dowling Club Educational Weekend, Oxford 1988
Dowling Club Educational Weekend, Liverpool 1988
Recent Advances in the Biological Sciences Applied to Dermatology, Cambridge 1988
Datastar On-line Literature Searching, London 1988
American Academy of Dermatology, Washington 1988 (Advanced Immunology, Dermatopharmacology, Directions in Dermatology, Ageing Skin,
Dermatitis Herpetiformis and Linear IgA Disease, Resident’s Symposium (Faculty Member)
Cell Membrane Receptors in Skin Diseases, Internal Medicine and Dermatology, Pharmacology of Drugs
Around the Corner, Update on Genodermatoses, Clinical Immunology, Contact Dermatitis and Contact Urticaria)
French for the Medical Profession, Royal College of Physicians./Institut Francais 1988-1989
French for The Medical Profession, Centre Internationale Etudes Pedagogique, Paris 1989 (sponsored place awarded by the French government and the Royal College of Physicians)
American Academy of Dermatology, San Francisco 1989 (Advanced Immunology, Life Threatening Dermatoses, Residents Symposium (Faculty Member)
Gross and Microscopic Dermatology (Faculty Member)
Dowling Club Educational Weekend, Sheffield 1990
In Situ Hybridisation, Royal Postgraduate Medical School, London 1990
Society for Investigative Dermatology, Washington 1990 (Special Methods Workshop: DNA Probes; the Polymerase Chain Reaction)
Dowling Club Educational Weekend, Leicester 1990
American Academy of Dermatology, Atlanta 1990 (Photobiology, Skin Disease in Black Races, Lasers in Dermatology)
Dowling Club Educational Weekend, London 1991
Management Training for Senior Registrars, King’s Fund College, London 1991
Dowling Club Educational Weekend, Durham 1991
American Academy of Dermatology, Dallas 1991 (Langerhans Cells, Dermatopharmacology (Faculty Member), Malignant Melanoma,
Contact Dermatitis, Psoriasis)
American Academy of Dermatology, San Francisco 1992 (Dermatopharmacology (Faculty Member)
American Academy of Dermatology, Washington 1993 (Dermatopharmacology (Faculty Member)
American Academy of Dermatology, New Orleans 1995 (Dermatopharmacology (Faculty Member), Advanced Immunology, Lasers, Atopic Dermatitis)
British Postgraduate Medical Federation, Appraisal and Assessment, London 1995
13th Annual Course in Advances in Dermatology, London 1996
College Tutor’s Seminar, Royal College of Physicians, London 1997
College Tutor’s Seminar, Royal College of Physicians, London 1998
Examining for: Objective Structured Skills Examination - OSSE 1998
23
Imperial College School of Medicine, Chelsea & Westminster Hospital, London
British Society for Dermatological Surgery Intermediate Workshop, Manchester 1998
Special Conference for College Tutors - Clinical Governance, 1999 Royal College of Physicians, London
Appraisal and Assessment, 1999 Chelsea & Westminster Hospital, Training Resource Centre, London Equal Opportunities/Non-discriminatory selecting and interviewing 1999 Chelsea & Westminster Hospital, Training Resource Centre, London American Academy of Dermatology, New Orleans 1999
Clinical Governance (Prof A. Newman Taylor, Dr N. Beresford) 1999 Chelsea & Westminster Hospital, London Television Teaching Course, ICSM, Chelsea & Westminster Hospital, London 2000
Postgraduate Course/ESDR/Stockholm
2001 Molecular tools in medical research, Gene therapy, UV and apoptosis, HPV and skin cancer,
Proteoglycan biology
Appraisal for Senior Medical Staff: Seminar. MiAD.uk 2002 Chelsea & Westminster Hospital OSCE Training Course for Examiners ICSM 2002
SAC/RSA/JCHMT Induction Day, Royal College of Physicians, London 2003
Direct Entry in the Specialist Register/JCHMT, Royal College of Physicians, London 2003
London Deanery Equal Opportunities Training, Beechcroft Wansboroughs, London 2004
Assessment Methods for SpR Training, Royal College of Physicians, London 2004
Competency Based Assessment Methods, Royal College of Physicians, London 2004
Dermatology Scientific Day, Update in Genetic Skin Diseases: the UK story, London 2005
Bringing Biotechnology to Dermatology, Royal College of Physicians 2005
Good Clinical Practice (Clinical Research) and the EU Directive (2001/20/EC) 2005
Research & Development office, Chelsea & Westminster Hospital
Article 14 Evaluators Training, JCHMT, Royal College of Physicians, London 2006
Adult & Paediatric Basic Life Support Update, Chelsea & Westminster Hospital 2006
Competency Assessments Feedback, Delegate and Speaker, BAD 2006
Creating a Robust Assessment Strategy for Undergraduate Medicine, Prof Val Wass 2006
Learning, Teaching and Assessment Course (Dermatology), Oxford 2007
Effective Supervision of Research Students, Institute of Cancer Research 2007
Interviewers’ Discussion Forum, Imperial College School of Medicine. 2007
American Academy of Dermatology, San Antonio 2008 (Hot Topics in Dermatology, Skin disease in the Oncology patient, Modern dermatological therapy,
Resident’s & Fellows Symposium, Drug Actions, Issues impacting your practice, Cutaneous cancer syndromes,
Consultative Dermatology for the hospitalised patient, Managing melanoma in the modern millennium)
Adult Basic Life Support & Advanced Life Support, Chelsea & Westminster Hospital 2008
UK Guidelines for HIV Testing (BASHH/BHIVA/BIS), Royal College of Physicians 2008
American Academy of Dermatology, San Antonio 2008 Medical Dermatology
Information Governance: Online Training Course E-learning Application 2008
Chelsea & Westminster Hospital
Specialty Certificate Examination Dermatology Examining Board 2009 Royal College of Physicians (two days)
Mandatory Training for Consultants, Royal Marsden Hospital 2009 Infection control, Medicine Management, Fire, Manual handling, Risk Management (Learning from SUIs), Safeguarding children, Consent, MCA, Safeguarding Adults, Communication Skills
Clinical Supervision for Experienced Supervisors 2009 Chelsea and Westminster Hospital
24
Advanced Communication Skills 2009 Royal Marsden Hospital Mandatory Training for Consultants 2010 Royal Marsden Hospital Infection Control, CPR
UCLH Induction Programme 2010 Corporate communications, Occupational Health and Safety, Clinical effectiveness,
Information governance, Safeguarding children and vulnerable adults, Infection control,
Fraud awareness, Equality and Diversity, Fire safety, Pneumatic tube system, Care of the back,
Medical Devices, Pharmacy and Medicines management, Anticoagulation,
Aseptic non-touch technique, Safe Transfusion practice, Malnutrition Universal Screening Tool,
Adult Resuscitation (Basic Life Support)
American Academy of Dermatology, New Orleans 2011 Residents and Fellows Symposium
Examiner Training (Assessment, OSCEs, BO5), Society of Apothecaries 2011
American Academy of Dermatology, San Diego 2012 Dermatology Diagnosis and the Visual Arts, Dermatology Speaker Development,
Tropical Dermatology, Telomeres, Leadership, Botox, Cosmetics, AIDS and STDs,
Strategies for Care for Uninsured and Underinsured, Clinical Issues in Medical Dermatology
Educational Supervision Course, UCLH/London Deanery 2013
Central London Research Network Dermatology Specialty Group Open Meeting 2013 Chelsea & Westminster Hospital
American Academy of Dermatology, Miami Beach 2013 TENS/SJS, Late-Breaking Research, World Congress 2015 Preview, Photodermatology,
Advaced Medical Dermatology
Non-melanoma Skin Cancer Update, BAD/RCP, London 2014
American Academy of Dermatology, Denver 2014 Warts, GVHD, Anger Management: ‘Hot Buttons’, Statistics, Skin of Color,
Hyroxychloroquine, Medical Dermatology Australasian College of Dermatologists, Melbourne 2014 Registrar Training Day, Genital Dermatology Symposium, Sentinel Node Biopsy
Dealing with Difficult People, ACM Training, London 2015
Good Clinical Practice, NIHR Research Governance, CWH, London 2015
An Introduction to Research Student Supervision, UCL, London 2017
Advanced Dermoscopy Course, St. John’s Academy, London 2017
CLINICAL AND SCIENTIFIC MEETINGS:
British Association of Dermatologists, Sheffield 1986
British Society for Investigative Dermatology, York 1986
Psoriasis, Cambridge 1986
A Biological Approach to the Wound Healing Process, RCP, London 1987
Laser Doppler User’s Group, Kings College Hospital, London 1987
Dermatopharmacology, RSM, London 1987
British Association of Dermatologists, London 1988
Centre Internationale Recherche Dermatologique Symposium, Cannes 1988
British Society for Investigative Dermatology, Manchester 1988
American Academy of Dermatology, Washington D. C. 1988
Laser Doppler User’s Group, St. Bartholomew’s Hospital, London 1989
Society for Investigative Dermatology, Japanese Society of Investigative Dermatology
& European Society for Dermatological Research, Washington D. C. 1989
25
European Society for Histamine Research, Breda, Holland 1989
British Association of Dermatologists, Cambridge 1989
Skin Pharmacology Society, New York 1989
Forum on Computers in Medicine, RSM, London 1989
Bayliss and Starling Society, Nottingham 1989
European Academy of Dermatology and Venereology, Florence 1989
American Academy of Dermatology, San Francisco 1989
British Microcirculation Society, London 1990
Society for Investigative Dermatology, Washington 1990
European Society for Histamine Research, Kuopio, Finland 1990
British Association of Dermatologists, Warwick 1990
British Society for Investigative Dermatology, Newcastle 1990
British Society for Rheumatology, London 1990
Skin Pharmacology Society, Hiroshima 1990
American Academy of Dermatology, Atlanta 1990
European Society for Dermatological Research, Copenhagen 1991
British Association of Dermatologists, London 1991
Skin Pharmacology Society (Local Secretary and Treasurer), Pitlochry, Scotland 1991
British Society for Investigative Dermatology, Leicester 1991
American Academy of Dermatology, Dallas 1991
Society for Investigative Dermatology, Baltimore 1992
World Congress of Dermatology (Overseas Scholarship), New York 1992
European Conference on the Microcirculation, London 1992
British Association of Dermatologists, Bournemouth 1992
British Society for Investigative Dermatology, Sheffield 1992
Skin Pharmacology Society, Cleveland, Ohio 1992
American Academy of Dermatology, San Francisco 1992
Society for Investigative Dermatology, Washington D.C. 1993
Skin Pharmacology Society (Session Moderator), Hong Kong 1993
American Academy of Dermatology, Atlanta 1993
Society for Investigative Dermatology, Baltimore 1994
British Association of Dermatologists, London 1994
British Society for Investigative Dermatology, Bath 1994
Skin Pharmacology Society, London 1994
American Academy of Dermatology, New Orleans 1995
British Society for Investigative Dermatology, Oxford 1995
Society for Investigative Dermatology, Chicago 1995
Skin Pharmacology Society, Vienna 1995
British Society for Investigative Dermatology, Glasgow 1996
Society for Investigative Dermatology, Washington D. C. 1996
Psoriasis-From Gene to Clinic, London 1996
British Society for Investigative Dermatology, Bristol 1997
Inflammatory & Thrombotic problems in Vascular Surgery. 1997 19th International Charing Cross Symposium, London Society for Investigative Dermatology, Washington D. C. 1997
European Academy of Dermatology and Venereology, Dublin 1997
British Society for Investigative Dermatology, Liverpool 1998
British Association of Dermatologists, Brighton 1998
Current Issues in Skin Therapeutics, London 1998 Society of Pharmaceutical Medicine and British Association of Dermatologists
26
UK Melanoma Study Group Meeting, Royal Marsden Hospital, London 1999
Joint Meeting, Sections of Coloproctology and Dermatology, RSM, London 1999
American Academy of Dermatology, New Orleans 1999
Society for Investigative Dermatology, Chicago 1999
Joint Meeting of Sections of Rheumatology and Dermatology, RSM, London 1999
UK Melanoma Study Group Meeting, Cambridge 2000
American Academy of Dermatology, San Francisco 2000
British Association of Dermatologists, London 2000
European Society for Dermatological Research, Berlin 2000
The Effective Management of Malignant Melanoma, RCP, London 2000
5th International Conference on Melanoma, Venice 2001
Society for Investigative Dermatology, Washington D. C. 2001
European Society for Dermatological Research, Stockholm 2001
European Academy of Dermatology & Venereology, Munich 2001
UK Melanoma Study Group, Royal Marsden Hospital, London 2002
Topical Immunomodulators (treatment of Atopic Dermatitis meeting), London 2002
UK Melanoma Study Group, Royal Marsden Hospital, London 2003
European Academy of Dermatology & Venereology, Barcelona 2003
Indian Association of Dermatology, Venereology and Leprosy, Mumbai 2004
British Association of Dermatologists, Belfast 2004
European Academy of Dermatology & Venereology, Florence 2004
Society for Investigative Dermatology, St Louis 2005
British Association of Dermatologists, Glasgow 2005
European Academy of Dermatology & Venereology, London 2005
American Academy of Dermatology, San Francisco 2006
British Association of Dermatologists, Manchester 2006
Melanoma Study Group Meeting, Southampton 2006
European Academy of Dermatology & Venereology, Rhodes 2006
Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chennai 2007
American Academy of Dermatology, Washington, D.C. 2007
Society for Investigative Dermatology, Los Angeles 2007
European Academy of Dermatology & Venereology, Vienna 2007
Scottish Dermatology Association, Dunfermline 2007
British Association of Dermatologists, Birmingham 2007
European Society for Dermatological Research, Zurich 2007
Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chandigarh 2008
American Academy of Dermatology, San Antonio 2008
International Investigative Dermatology Meeting, Kyoto 2008
Key Advances in the Effective Management of Malignant Melanoma, London 2008
Masterclass in Advanced Cancer Medicine-Skin Cancers, London 2008
Psoriasis – From Gene to Clinic, 5th International Congress, London 2008
American Academy of Dermatology, San Francisco 2009
World Congress on Cancer of the Skin, Tel Aviv 2009
Society for Investigative Dermatology, Montreal 2009
International Society of Dermatology, Prague 2009
Key Advances in the Effective Management of Malignant Melanoma, London 2009
Masterclass in Advanced Cancer Medicine-Malignant Melanoma, London 2010
American Academy of Dermatology, Miami Beach 2010
Society for Investigative Dermatology, Atlanta 2010
27
Dowling Club, Lincoln 2010
European Academy of Dermatology & Venereology, Gothenburg 2010
Sharm Derma 2010, Sharm El Sheikh 2010
European Society for Sexual Medicine, Malaga 2010
Royal College of Physicians (SW) Regional Meeting, Taunton 2010
American Dermatological Association, New York 2010
British Association of Dermatologists Annual UK Consultants Course, London 2010
American Academy of Dermatology, New Orleans 2011
Primary Care Dermatology Society of Ireland, Galway 2011
UCLH Penile Cancer Day 2011
VII All-Russian Congress “Men’s Health”, Rostov-on-Don 2011
British Association of Dermatologists, London 2011
Dowling Club, Oxford 2011
European Academy of Dermatology & Venereology, Lisbon 2011
Eastern Mediterranean Seminar on General Medicine, Limassol 2011
Asicon, National Conference of AIDS Society of India, Lucknow 2011
Medical Dermatology Meeting, BSMD/Endocrinology, RCP, London 2012
Indian Association of Dermatology, Venereology and Leprosy, DERMACON, Jaipur 2012
Dowling Club, India 2012
Ulster Dermatological Society, Craigavon 2012
European Association of Urology, Paris 2012
British Association of Dermatologists Strategy Day, London 2011
American Academy of Dermatology, San Diego 2012
Dowling Club, Stratford-upon-Avon 2012
Society for Investigative Dermatology, Raleigh 2012
International League of Dermatological Societies, 1st Summit. Berlin 2012
European Academy of Dermatology & Venereology, Verona 2012
International Medical Meeting, Riga 2012
Clinical Dermatology Update Meeting, SAS Doctors, Manchester 2012
American Dermatological Association, Washington 2012
British Association of Dermatologists Strategy Day, London 2013
Medical Dermatology Meeting, BSMD/Neurology, RCP, London 2013
European Dermatology Forum, Lucerne 2013
Dowling Club International Visit, Addis Ababa 2013
American Academy of Dermatology, San Diego 2013
Midlands Dermatological Society, Leicester 2013
International Investigative Dermatology, Edinburgh 2013
British Association of Dermatologists, Liverpool 2013
Dowling Club, Brecon, Wales 2013
European Academy of Dermatology & Venereology, Istanbul 2013
Clinical Dermatology Update Meeting, SAS Doctors, Manchester 2013
Baltic Association of Dermatovenereologists, Kaunas 2013
Primary Care Dermatology Society, Edinburgh 2013
XI International Congress of Dermatology and 42nd Dermacon, New Delhi 2013
British Association of Dermatologists Strategy Day, London 2014
European Dermatology Forum, Bern 2014
Primary Care Dermatology Society, Kenilworth 2014
American Academy of Dermatology, Denver 2014
British Society for the Study of Vulval Disease, Glasgow 2014
28
Australasian College of Dermatologists, Melbourne 2014
Australasian Society for Dermatological Research, Melbourne 2014
Baltic Association of Dermatovenereologists, Riga 2014
Dowling Club, Moscow 2014
British Association of Dematologists, Glasgow 2014
World Congress on Cancer of the Skin, Edinburgh 2014
European Academy of Dermatology & Venereology, Amsterdam 2014
Melanoma Focus, London 2014
UK TREND, London 2014
Medical Dermatology Meeting, (RCP, BAD, BSMD, BSSCII), London 2015
European Dermatology Forum, Bern 2015
Dermatology and Oral Medicine, UCL, London 2015
European Academy of Dermatology & Venereology, Valencia 2015
History of Dermatology Society, San Francisco 2015
American Academy of Dermatology, San Francisco 2015
European Association of Urology, Madrid 2015
Dubai Derma, Dubai World Dermatology & Laser Conference & Exhibition, Dubai 2015
Teach In. Dermatology for the General Physician, RCP 2015
Male Genital Disease, Anogenital & Oral Genital Dermatology Course, London 2015
Dowling Club & British Hair and Nail Society, Brighton 2015
British Association of Dermatologists, Manchester 2015
European Academy of Dermatology and Venereology, Copenhagen 2015
Euroderm Excellence, Nice 2015
Medical Dermatology Meeting (BAD, BSMD, RCP), London
Dansk Dermatologisk Selskab, Munkebjerg, Veijle 2016
Primary Care Dermatology Society of Ireland, Killarney 2016
European Academy of Dermatology and Venereology, Athens 2016
British Association of Dermatologists, Birmingham 2016
European Academy of Dermatology and Venereology, Vienna 2016
International Conference of Dermatology 2016
& Society of Dermatologists, Venereologists & Leprologists of Nepal,
SODVELON, Kathmandu
Euroderm Excellence, Nice 2016
Medical Dermatology Meeting (BAD, BSMD, RCP), London 2017
European Dermatology Forum, Montreux 2017
British Association of Dermatologists, Liverpool 2017
South West of England & Wales Dermatological Society & Dowling Club, Bristol 2017
Dowling Club Business Skills, Interview Training and Clinical Meeting, Derby 2017
Sri Lanka College of Dermatologists /Dowling Club Meeting, Colombo, Galle & Kandy 2017
European Academy of Dermatology & Venereology, Geneva 2017
European Academy of Dermatology & Venereology, Budva, Montenegro 2018
Dowling Club, Valletta, Malta 2018
British Association of Dermatologists, Edinburgh 2018
Not listed are attendances at weekly St John’s Hospital Saturday clinical meetings (1984-88), the
monthly Westminster Hospital/Chelsea & Westminster Hospital Combined Clinics (1992-), the
monthly St Johns’ Hospital Dermatological Society Thursday meetings (1984-), the monthly
29
Dermatology Section of the Royal Society of Medicine meetings (1984-) and the quarterly North
London clinical meetings (2010-)
POST GRADUATE TRAINING MEETINGS
College Tutors’ Seminar 1995
Royal College of Physicians, London
College Tutors/Regional Advisors Meeting: NW Thames 1995
Royal College of Physicians, London
College Tutors’ Seminar 1996
Royal College of Physicians, London
College Tutors’ Seminar 1997
Royal College of Physicians, London
College Tutors’ Seminar 1998
Royal College of Physicians, London
NW Thames Meeting of College and Associate College Tutors 1998
Royal College of Physicians, London
SAC/RSA Induction Day RCP 2003
Launch, PMETB, London 2005
SAC Chairs Meeting, PMETB, London 2005
SAC Chairs Meeting, Royal College of Physicians, London (Jun) 2005
Meetings of SAC Chairs and Directors of Training, PMETB, London (Nov) 2005
SAC Chairs Meeting, Royal College of Physicians, London (Dec) 2005
JCHMT SAC Chairs Meeting, Royal College of Physicians, London (Mar) 2006
SAC Chairs Meeting, Royal College of Physicians, London (April) 2006
SAC Chairs Meeting, Royal College of Physicians, London (Sept) 2006
Dermatology Curriculum, PMETB, London 2006
JRCPTB Inaugural Meeting, Royal College of Physicians, London 2007
Dermatology Assessment Programme, PMETB, London 2007
ROLES AT MEETINGS:
Local Secretary and Treasurer, Skin Pharmacology Society 1991 Pitlochry, Scotland
European Melanoma Day 2000 The Lister Hospital, London
Chair, Immuno-Dermatology & Immune Response Modifiers 2001
3M, Chelsea & Westminster Hospital
Instigator, Organiser, Chair and Lecturer, Dermatology for Plastic Surgeons 2001 Chelsea and Westminster Hospital, London
Chair, Plenary Scientific Session 2005 British Association of Dermatologists, Glasgow
30
Scientific Committee Member, London EADV 2005 2003-2005
European Academy of Dermatology & Venereology, London
Chair, Symposium S16 – Penile Dermatoses 2005 European Academy of Dermatology & Venereology, London
Co-Chair, FCO5 - Cosmetic Dermatology and Related Topics (15 papers) 2005 European Academy of Dermatology & Venereology, London
Chair, Symposium S44 – Genital Dermatoses 2006 European Academy of Dermatology & Venereology, Rhodes
Chair, Optimising Treatment Outcomes in Psoriasis 2006 RCP Live, Royal College of Physicians, London
Co-Chair Symposium S45 – Sexual Health, ‘Male dyspareunia’. 2007 European Academy of Dermatology & Venereology, Vienna
Chair and Organiser, ‘Festschrift’ for Professor Pauline M Dowd 2007
Royal Society of Medicine
Chair and Organiser, ‘Festschrift’ for Dr Richard Staughton 2007
Chelsea and Westminster Hospital
Symposium Planning Committee; Chair, Clinical Services and Evaluation Session 2008
Key Advances in the Effective Management of Malignant Melanoma UK Key Advances in Clinical Practice Series, 2nd National Update, London
Organiser and Chair, Genital Dermatology 2008 HIV/GUM Course, Chelsea and Westminster Hospital, London
Expert Panel Member, Masterclass in Advanced Cancer Medicine-Skin Cancers 2008 Association of Cancer Physicians and British Oncological Association, London
Sessional Chair, Key Advances in the Effective Management of Malignant Melanoma 2009
London
Expert Panel Member, Masterclass in Advanced Cancer Medicine-Skin Cancers 2009 Association of Cancer Physicians and British Oncological Association, London
Orator, Dowling Club, 2010
Lincoln
Co-Chair, SO5 Sexually Transmitted Infections 2010 European Academy of Dermatology & Venereology, Gothenburg
Co-Chair, Session XVIII (Medical Dermatology) 2010 Sharm Derma, Sharm El Sheikh, Egypt
College Lecturer, Royal College of Physicians (SW) Regional Meeting, Taunton 2010
31
Co-Chair, Session 12. Sexual Disorders as a Social Problem of Gender Relations 2011
VII All-Russian Congress “Men’s Health”, Rostov-on-Don
Co- Chair, Session TY07, Genital and Oral Lesions-Whats your Diagnosis? 2011
(with Drs Setterfield, Lewis and Pelisse)
Chair, SessionXXIV HIV & Malignancies 2011
ASICON 2011: 4th National Conference of AIDS Society of India
SGPG, Lucknow
Chair, Ask the Expert session II 2012
DERMACON 2012, Jaipur
Expert Panellist, Strategies for the Care for Uninsured and Underinsured 2012
FO75 American Academy of Dermatology, San Diego
Co-Chair, WS01 Diseases of the Anogenital Mucosa 2012
European Academy of Dermatology & Venereology, Verona
Chair, Male Genital Dermatoses 2012
Ano-Genital and Mucosal Dermatology Course, St Thomas’ Hospital
Expert Panel, Interactive Case Discussion 2102
British Society for Skin Care in Immunocompromised Individuals,
British Association of Dermatologists, Birmingham
Co-Chair, Professors & Registrars Forum 2012
British Association of Dermatologists, Birmingham
Co-Chair, Plenary Session 2012
International Medical Meeting, Riga
Chair, BAD Strategy Day 2013
British Association of Dermatologists, London
Welcome Address, Medical Dermatology Meeting 2013
British Society for Medical Dermatology/Neurology, RCP, London 2013
Local Organising Committee 2013
International Investigative Dermatology, Edinburgh
Chair, Public Lecture, Dr Michael Mosley, The Pleasures of Self-Experimenting 2013
International Investigative Dermatology, Edinburgh
President and Organising Committee Member 2013
British Association of Dermatologists, Liverpool
Chair, Scientific Session 2013
British Association of Dermatologists, Liverpool
32
Chair, Understanding Pharma 2013
British Association of Dermatologists, Liverpool
Chair, Professors & Registrars Forum 2013
British Association of Dermatologists, Liverpool
Co-Chair, Symposium SY29, Penile Dermatoses in Later Life 2013
European Academy of Dermatology & Venereology, Istanbul
Co-Chair, Rare Case Reports 2013
Baltic Association of Dermatovenereologists, Kaunas
Chair, Workshop 8, Genital Dermatology 2013
International Congress of Dermatology and Dermacon, New Delhi
Co-Chair, Plenary 7, Sexually Transmitted Diseases 2013
International Congress of Dermatology and Dermacon, New Delhi
Non-melanoma Skin Cancer Update, BAD/RCP, London 2014
Introduction (Crisis in Dermatology)
Co-Chair, Plenary Invited Lecturers Session 2014
Baltic Association of Dermatovenereologists, Riga
Chair, Clinical and Research Agenda, British Association of Dermatologists 2014
UK TREND Launch, London
President and Organising Committee Member 2014
British Association of Dermatologists, Glasgow
Chair, Plenary Session 2014
British Association of Dermatologists, Glasgow
Local Organising Committee Member 2012-14
XV World Congress on Cancers of the Skin, Edinburgh
Chair, WS38 Anogenital diseases: Digging deep for answers 2014
European Academy of Dermatology & Venereology, Amsterdam
Programme planning and Abstract Reviewer 2015
Medicine 2015: Delivering the Future Hospital
Royal College of Physicians, Harrogate
Abstract Reviewer 2015
European Academy of Dermatology & Venereology, Valencia
Chair, Review and Update: STIs and HIV: RU28
European Academy of Dermatology & Venereology, Valencia 2015
33
Faculty, FO35, Hot Topics in AIDS and STIs 2015
American Academy of Dermatology, San Francisco
Faculty, Inaugural European School of Urology Course: Penile Diseases 2015
European Association of Urology, Madrid
Chair and Organiser 2015
Teach In, Dermatology for the General Physician
Royal College of Physicians, London
Chair and Co-Organiser 2015
Male Genital Disease
5th Annual Anogenital and Oral Genital Dermatology Course
St John's Institute of Dermatology, Royal College of Physicians, London
Chair and Organiser 2015
AM113, Best of British
World Congress of Dermatology, Vancouver
Chair and Organiser 2015
SY70, Men's Issues
World Congress of Dermatology, Vancouver
Co-Chair 2015
British Society for Skin Care in Immunocompromised Individuals
British Association of Dermatologists, Manchester
Co-Chair 2015
D1T05.4, Review and Updates: HIV
European Academy of Dermatology & Venereology, Copenhagen
Chair and Organiser,
Gerontodermatology symposium 2015
Royal Society of Medicine
Chair and Organiser 2016
Male (GUM, Andrology, Urology, HIV) symposium
Chair and Co-Organiser 2016
Male Genital Disease
6th Annual Anogenital and Oral Genital Dermatology Course
St John's Institute of Dermatology, Royal College of Physicians, London
Co-Chair 2016
International Dermatology, British Association of Dermatologists, Birmingham
Judging Committee 2016
British Association of Dermatologists, Birmingham
34
Abstract Selection Committee 2016
British Society for Skin Care in Immunocompromised Individuals
British Association of Dermatologists, Birmingham
Co-Chair
Plenary Session A, European Academy of Dermatology and Venereology, Athens 2016
Organising Committee (Secretary of the BSF) 2016
British Skin Foundation ‘Skin Deep’ – 20th Anniversary Symposium
Royal College of Physicians, London
Co-Chair 2016
STI & HIV Session
2nd International Conference of Dermatology &
XIIIth Society of Dermatologists, Venereologists & Leprologists of Nepal
SODVELON, Kathmandu
Co-Chair 2016
GUM & STI session
Euroderm Excellence, Nice
Co-Organiser (President of the Dowling Club)
South West of England & Wales Dermatological Society & Dowling Club, Bristol 2017
Co-Organiser (President of the Dowling Club) 2017
Business Skills, Interview Training and Clinical Meeting, Derby
Co-Organiser (President of the Dowling Club) 2017
Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo
Chief Guest (President of the Dowling Club) 2017
Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo
Chair 2017
Acne and Coesmtic Symposium
Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo
Chair and Co-Organiser 2017
Male Genital Disease
7th Annual Anogenital and Oral Genital Dermatology Course
St John's Institute of Dermatology, Royal College of Physicians, London
Chair and Co-Organiser 2016
Male Genital Disease
7th Annual Anogenital and Oral Genital Dermatology Course
St John's Institute of Dermatology, Royal College of Physicians, London
Chair and Co-Organiser 2017
35
Male Genital Disease
7th Annual Anogenital and Oral Genital Dermatology Course
St John's Institute of Dermatology, Royal College of Physicians, London
Co-Chair 2017
Dermatology of the mucosae (D3T07.3)
European Academy of Dermatology & Venereology, Geneva
Panel 2018
Business Skills Interview Training, Dowling Club, London
36
MEMBERSHIP OF LEARNED SOCIETIES AND OTHER ORGANISATIONS:
British Medical Association 1980-
Royal College of Physicians of London 1985-
College Tutor 1995-2000
SAC/JCHMT (Derm), BAD Rep., UEMS Rep., (Chairman) 2000-2009
SAC/JCHMT (GUM) 2002-2009
Council 2012-2014
Royal College of Physicians of Edinburgh 2008-2009
Royal Society of Medicine 1986-
Member of Council-Dermatology (1997-2001; 2008-)
Library Representative
President 2015-2016
British Association of Dermatologists 1986-
Therapeutics & Audit Subcommittee 1997-2002
Private Practice Subcommittee 2001-2004
Executive (ex officio: SAC Chair; UEMS Rep) 2005-2009
President Elect 2011-2012
President 2012-2014
Skin Care Campaign Future Dermatology Services Working Party 2003-2004
American Academy of Dermatology (Non-resident Fellow) 1999-
American Dermatological Association (International Honorary Member) 2008-
European Dermatology Forum 2013-
British Association of University Teachers of Dermatology (defunct) 1994-2004
Society for Investigative Dermatology 1986-
Skin Pharmacology Society (defunct)-Committee and Executive Board (1993-6) 1988-1996
British Society for Investigative Dermatology 1987-
European Society for Dermatological Research 1990-
European Academy of Dermatovenereology 1998-
European Society for Histamine Research 1987-1992
British Society for the Skin Care of Immunocompromised Individuals 2011-
St. John’s Hospital Dermatological Society 1996-
President 2006-2007
Primary Care Dermatology Society (Honorary Member) 2005-
THESIS (The Skin Investigation Society) 1993-
UK Melanoma Study Group 1999-2010
Melanoma Focus 2014-
Baltic Association of Dermatovenereologists (Honorary Member) 2014-
Associate Parliamentary Group on Skin (Medical Adviser) 2002-
British Skin Foundation Top 100 Club 2012
Laser Doppler Users Group 1988-1994
National Health Service Consultants Association 2003-
Worshipful Society of Apothecaries of London (Livery, 1998) 1994-
Member, Chelsea & Westminster Hospital NHS Foundation Trust 2006-2010
Chelsea Clinical Society 1998-
Council 2006-2009
President 2010-2011
Medical Society of London 1995-
37
West London Medico-chirurgical Society 1994-
President 2006-2007
Dowling Club 1986-
Orator 2010
Society of Authors including the Medical Writers Group 2002-2010
Authors’ Licensing & Collecting Society 2006-
Kitchener Scholars Association 1981-
Committee 1992-2002
Garrick Club 2002-
United Oxford and Cambridge University Club 1982-2004
Crabtree Foundation (University College London) 1990-
Cambridge Society 1981-2008
Cambridge Union Society 1975-
Cambridge University Medical Graduates Club 1980-
Alibert Society 1989-
National Geographic Society 1998-2000
Marylebone Cricket Club (Associate Member 2002-2010) 2011-
Middlesex County Cricket Club 1995-2011
Hampstead Parochial Church Council 2000-2002
Hampstead Medical Society 2011-
38
PUBLICATIONS-ORIGINAL PAPERS, LETTERS, ARTICLES, BOOKS and CHAPTERS:
1. Bunker CB. Medical Education in London. The Times 1980 (Mar 1).
2. Bunker CB & Gilkes JJH. Geriatrics: Dermatology. Br J Hosp Med 1987;37:122-134. 3. Bunker CB & Dowd P. M. Alterations in scalp blood flow after the epicutaneous application of 3%
minoxidil and 0.1% hexyl nicotinate in androgenetic alopecia. Br J Dermatol 1987;117:668-669.
4. Bunker CB & Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet 1987;i:1266.
5. Sumners D & Bunker CB. Affective disorder and neoplasia: can malignancy present with hypomania?
Br J Clin Soc Psychiatry 1987;4:99-103
6. Bunker CB. Angiostrongyliasis. Sunday Telegraph 1987 (Jun 8).
7. Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.
8. Johnson NMcI & Bunker CB. More MRCP Part 1. Springer-Verlag. London 1988.
9. Bunker CB & Maurice P. Sweet’s syndrome associated with IgG paraproteinaemia. Clin Exp Dermatol
1988;13:135.
10. Bunker CB & Dowd PM. Giant cell arteritis and systemic lupus erythematosus. Br J Dermatol
1988;119:115-120.
11. Bunker CB, Lanigan SW, Rustin MHA & Dowd PM. The effects of topically applied hexyl
nicotinate on the cutaneous blood flow in patients with Raynaud’s phenomenon. Br J Dermatol 1988;119:
771-776.
12. Maurice PDL, Bunker CB, Giles F, Goldstone A & Holton J. Mycobacterium avium-intracellulare
infection associated with hairy cell leukaemia. Arch Dermatol 1988;124:1545-549.
13. Rustin MHA, Bunker CB & Dowd PM. Chronic leg ulceration with livedoid vasculitis and response
to oral ketanserin. Br J Dermatol 1989;120:101-105.
14. Bunker CB, Smith NP, Russell RCG & Dowd PM. Cock’s peculiar tumour. Clin Exp Dermatol
1989;14:237-239.
15. Rustin MHA, Bunker CB, Dowd PM & Robinson TWE. Erythema multiforme due to griseofulvin.
Br J Dermatol 1989;120:455-458.
16. Bunker CB. Topical erythromycin. Drugs of Today 1989;25:427-430.
17. Bunker CB, Sheron N, Maurice PDL, Kocjan G et al. Isotretinoin and eosinophilic pleural effusion.
Lancet 1989:1;435-436.
18. Rustin MHA, Bunker CB & Levene GM. Follicular mucinosis presenting as acute dermatitis and
response to dapsone. Clin Exp Dermatol 1989;14:382-384.
19. English JSC, Bunker CB, Ruthven K Dowd PM & Greaves MW. A double-blind comparison of the efficacy of
betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
Clin Exp Dermatol 1989;14:32-34.
20. Maurice PDL, Bunker CB & Dowd PM. Isotretinoin in the treatment of systemic sclerosis.
Br J Dermatol 1989;121:367-374.
21. Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM. Most women with
acne have polycystic ovaries. Br J Dermatol 1989;121:675-680.
22. Rustin MHA, Bunker CB, Gilkes JJH, Robinson TW & Dowd PM. Extensive linear epidermal naevi and polyostotic
fibrous dysplasia. Clin Exp Dermatol 1989;14:371-375.
23. Bunker CB, Maurice PDL & Dowd PM. Isotretinoin and curly hair. Clin Exp Dermatol 1990;15:
143-145.
24. Bunker CB, Rustin MHA & Dowd PM. Isotretinoin treatment of severe acne in post-transplant
patients taking cyclosporine. J Am Acad Dermatol 1990;22:693-694.
25. Bunker CB, Delhantey J & Dowd PM. Familial localised scleroderma and telangiectasia associated with
cytogenetic abnormalities. J Roy Soc Med 1990;83:531-532.
26. Bunker CB, Erskine K, Rustin MHA & Gilkes JJH. Severe polymorphic eruption of pregnancy
occurring in twin pregnancies. Clin Exp Dermatol 1990;15:228-231.
27. Bunker CB, Foreman JC & Dowd PM. Calcitonin gene-related peptide and Raynaud’s phenomenon.
Lancet 1990;335:239.
28. Bunker CB, Whittaker S, Luzatto L, Gore ME, Rustin MHA, Smith NP & Levene GM. Indolent
cutaneous prodrome of fatal HTLV-1 infection. Lancet 1990;335:426.
29. Dowd PM, Bunker CB, Bull HA, Foreman JC, Terenghi G, Springall DR & Polak JM.
Raynaud’s phenomenon, calcitonin gene-related peptide, endothelin and cutaneous vasculature.
Lancet 1990;336:1014.
39
30. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Deficiency of calcitonin
gene-related peptide in Raynaud’s phenomenon. Lancet 1990;336:1530-33.
31. Bunker CB, Cerio R, Bull HA, Evans J, Dowd P M & Foreman JC. The effect of capsaicin
application on mast cells in normal human skin. Agents and Actions 1991;33:195-196.
32. Bunker CB, Foreman JC & Dowd PM. Vascular responses to histamine at low temperatures in normal
digital skin and Raynaud’s phenomenon. Agents and Actions 1991;33:197-199.
33. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to histamine, compound 48/80 and
calcitonin gene-related peptide in patients with Raynaud’s phenomenon. J Invest Dermatol 1991;96:
314-317.
34. Bunker CB, Maurice PDL, Little S, Johnson NM & Dowd PM. Isotretinoin and lung function in systemic sclerosis.
Clin Exp Dermatol 1991;16:11-13.
35. Terenghi. G, Bunker CB, Liu Y, Springall DR, Cowen T, Dowd PM & Polak JM. Image
analysis quantification of peptide-immunoreactive nerves in skin of patients with Raynaud’s phenomenon and
systemic sclerosis. J Pathol 1991;164:245-252.
36. Bunker CB, Newton JA, Conway GS, Jacobs HS, Greaves MW, Dowd PM. The endocrinological differences
between women with acne who have polycystic ovaries and other presentations of polycystic ovaries. Clin Exp
Dermatol 1991;16:420-423
37. Bull HA, Bunker CB, Terenghi G, Springall DR, Zhao Y, Polak JM. & Dowd PM.
Endothelin-1 in human skin: immunolocalization, receptor binding and effects on cutaneous microvascular
endothelial cells. J Invest Dermatol 1991;97:618-623.
38. Heagerty AH & Bunker CB. Dermatological manifestations of HIV infection. Hospital Update 1992;
18:213-218.
39. Bunker CB & Dowd PM. Henry Radcliffe Crocker. Int J Dermatol 1992;31:446-450.
40. Markus HS, Bunker CB, Kouris K, Costa DC & Harrison MJ. rCBF abnormalities detected and
sequentially followed by SPECT in neuro-Behcet’s syndrome with normal CT and MRI imaging. J Neurol 1992;
239:363-6.
41. Hayes N, Bunker CB, Marshall I, Dowd PM & Foreman JC. The action of a calcitonin gene-related peptide
antagonist in human skin. Agents & Actions 1992;38:C212-214.
42. Bunker CB. (1992) The role of calcitonin gene-related peptide in the pathophysiology and treatment of
Raynaud’s phenomenon. MD Dissertation, University of Cambridge. 1992.
43. Bunker CB, Coulson ML, Hayes N, Dowd PM & Foreman JC. Further studies on the actions
of endothelin-1 on blood flow in human skin. Br J Dermatol 1992;127,85-90.
44. Bunker CB. SHO posts in Dermatology for vocational trainees. Horizons, June 1992:282-288.
45. Roberts N & Bunker CB. The gut and the skin. Br J Hosp Med 1993;50:31-39.
46. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce FL & Dowd PM. Basophil mediator release
in atopic dermatitis. J Invest Dermatol 1993;100:305-309.
47. Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM & Polak JM. Characterization of
endothelin-binding sites in human skin and their regulation in primary Raynaud’s phenomenon and systemic
sclerosis. J Invest Dermatol 1993;101:73-78.
48. Schifter S, Johannsen L, Bunker C, Brickell P, Bork E, Lindberg L & Faber J. Calcitonin gene-related
peptide (CGRP) in small cell lung carcinomas. Clin Endocrinol 1993;39:59-65.
49. Carney O, Ross E, Bunker CB, Ikkos G & Mindel A. A prospective study of the psychological impact
on patients with a first episode of genital herpes. Genitourin Med 1993;70:40-45.
50. Bunker CB, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in treatment of
severe peripheral vascular insufficiency in Raynaud’s phenomenon. Lancet 1993;342:80-82.
51. Roberts N & Bunker CB. Adverse drug reactions: identifying adverse drug reactions: skin (part 1)
Prescriber: October 19, 1993;57-62.
52. Bunker CB. CGRP, ET-1 and Raynaud’s phenomenon. Current Medical Literature: Rheumatology 1993;12:
87-89.
53. Wilkinson LS, Bunker CB, Edwards JC, Scurr JH & Smith PD. Leukocytes: their role in the
aetiopathogenesis of skin damage in venous disease. J Vasc Surg 1993;17:669-675.
54. Bunker CB & Brown E. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1993;129:
502.
55. Roberts N & Bunker CB. Adverse drug reactions: identifying severe skin reactions to drugs (Part 2).
Prescriber December 3, 1993;47-50.
56. Johnson N McI & Bunker CB. Further MRCP Part 1. Springer -Verlag, London 1994
57. Goldsmith PC, Molina FA, Bunker CB, Terenghi G, Leslie TA, Fowler CJ, Polak JM & Dowd
40
PM. Cutaneous nerve fibre depletion in vibration white finger. J R Soc Med 1994;87:377-381.
58. Review: Physical Signs in Dermatology; Colour Atlas and Text. Lawrence CM & Cox NH. Retinoids Today. July
1994;30.
59. Smith RA, Ross JS & Bunker CB. Localised trichorrhexis nodosa. Clin Exp Dermatol 1994;19:441-442.
60. Rowe A, Farrell A, Kazmi SH & Bunker CB. Expression of inducible nitric oxide synthase in dermal
microvasculature in psoriasis. Lancet 1994;344:1371.
61. Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker CB. Panniculitis with
pseudomonas septicaemia in AIDS. JEADV 1995;4:166-169.
62. Bunker CB. Sir Thomas Lewis. Dermatology in Practice 1994;57:2-3,
63. Bewley AP, Bracka A, Staughton RCD & Bunker CB. Extramammary Paget’s disease of the penis, Br J
Dermatol 1994;131: 445-46.
64. Bunker CB. Unusual penile dermatoses. Dermatology in Practice 1996;4: 18-19.
65. Bunker CB & Dowd PM. Raynaud’s phenomenon. In: Cutaneous Medicine and Surgery. Eds Arndt KA,
Robinson JK, LeBoit PE & Wintroub BU. WB Saunders. Philadelphia. ISBN 0-7216-4852-5:1996;537-542. 66. Bunker CB & Dowd PM. Skin Disease. In: Medicine. (Ed. Axford J.) Blackwell
Scientific Publications. Oxford; 1996.
67. Bunker CB. Dermatological Problems in HIV Infection and AIDS. In: Medical Management of HIV and AIDS.
Ed. Millar A. Springer-Verlag. Berlin Heidelberg New York ISBN 3-540-19958-6: 1996; 162-189.
68. Farrell A, Ross JS, Barton SE & Bunker CB. Multiple pilomatricomas and myotonic dystrophy in a patient with
AIDS. Clin Exp Dermatol 1995;20:423-424.
69. Goldsmith P, Bunker CB, Leslie T, Foreman JC & Dowd PM. The effect of topical steroid on the actions of
vasoconstrictor and vasodilator peptides in human skin. Skin Pharmacol 1996;9:289-297.
70. Farrell AM, Sabroe RA & Bunker CB. Urticarial vasculitis associated with polycythaemia rubra vera. Clin
Exp Dermatol 1996;21:302-304.
71. Farrell AM, Gooptu C, Woodrow D, Costello C, Bunker CB & Cream JJ. Cutaneous lymphocytic vasculitis in acute
myeloid leukaemia. Br J Dermatol 1996;135:471-474.
72. Bunker CB, Goldsmith PC, Leslie TA, Hayes N, Foreman JC & Dowd PM. Calcitonin gene-related peptide,
endothelin-1, the cutaneous microvasculature and Raynaud’s phenomenon. Br J Dermatol 1996;134:399-406. 73. Papadavid E, Yu RC, Bunker CB, Scoones D & Chu AC. Tumour progression in a patient with granulomatous
mycosis fungoides. Br J Dermatol 1996;134:740-43.
74. Sabroe RA, Staughton RCD & Bunker CB. Bronchospasm induced by isotretinoin. Br Med J. 1996;312:886
75. Bewley AP, Ross JS, Bunker CB & Staughton RCD. Successful treatment of a patient with octreotide-
resistant necrolytic migratory erythema. Br J Dermatol 1996;134:1101-104.
76. Farrell AM, Ross JS, Umasankar S & Bunker CB. Staphylococcal scalded skin syndrome in an HIV-1
seropositive man. Br J Dermatol 1996;134:962-65.
77. Farrell AM, Branfoot AC, Moss J, Papadaki L, Woodrow DF & Bunker CB. Scleredema diabeticorum
of Buschke confined to the thighs. Br J Dermatol 1996;134:1113-115.
78. Farrell AM, Woodrow D, Bryceson AD, Bunker CB & Cream JJ. Ectopic cutaneous schistosomiasis:
extragenital involvement with progressive upward spread. Br J Dermatol 1996;135:110-12.
79. Bunker CB. Malodorous wounds. Lancet 1996;348:1737.
80. Ramsay B, Terenghi G, Polak JM, Guiloff RJ & Bunker CB. Depleted cutaneous innervation in familial
amyloid. Clin Exp Dermatol 1996;21:449-450.
81. Review: Dermatology and the New Genetics. Moss C & Savin J. Br J Hosp Med 1996; 55:297.
82. Bunker CB & Bridgett CK. Depression and the Skin. In: Depression and physical illness.
Ed. Robertson and Katona. John Wiley & Sons Ltd. London 1997
83. Rowe A, Farrell AM & Bunker C. Constitutive endothelial and inducible nitric oxide synthase in
inflammatory dermatoses. Br J Dermatol 1997;136:18-23
84. Mallon E & Bunker CB. Slides in Dermatology: 1 MRCP. Br J Hosp Med. 1997;57:159-161
85. Mallon E & Bunker CB. Slides in Dermatology: 2 MRCP. Br J Hosp Med. 1997;57:262-264
86. Bunker CB & Peters J. Dermatology Day Care. Skin Care in Focus. 1997;1:8-9
87. Bunker CB. Raynaud’s phenomenon. In: Inflammatory & Thrombotic problems in Vascular Surgery. Eds.
Greenhalgh R. M & Powell J. T. Saunders. London. 1997; 201-214.
88. Mallon E, Ross JS, Hawkins DA, Dinneen M, Francis N & Bunker CB. Biopsy of male genital dermatoses.
Genitour Med 1997;73:421.
89. Review: Cutaneous Disorders of the Lower Extremity. Dockery GL & Crawford ME. Br J Dermatol 1997; 301.
90. Fearfield LA & Bunker CB. Pityriasis versicolor associated with oral lithium therapy. Clin Exp Dermatol
1997;22:57-59.
41
91. Fearfield LA, Gazzard B & Bunker CB. Aquagenic urticaria and human immunodeficiency virus infection:
treatment with stanozolol. Br J Dermatol. 1997;137:620-622.
92. Gooptu C, Woollons A, Ross J, Price M, Wojnarowska F, Morris PJ, Wall S & Bunker CB. Merkel cell
carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997;137:637-641.
93. Farrell AM, Black MM, Bracka A & Bunker CB. Pyoderma gangrenosum of the penis. Br J Dermatol 1998;138:
337-340.
94. Rowe A & Bunker C.B. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis.
Contact Dermatitis 1998;38:36-39.
95. Review: ABC of Dermatology (3rd edn). Buxton PK. Hospital Medicine 1998; 59:664.
96. Farrell AM, Ross JS, Thomas JM, Fisher C & Bunker CB. Acquired ichthyosis, alopecia and loss of hair
pigment associated with leiomyosarcoma. J Eur Acad Dermatol Venereol 1998;10:159-163.
97. Farrell AM, Ross JS, Bunker CB, Staughton RCD. Crusted scabies with scalp involvement in HIV-1 infection.
Br J Dermatol 1998;138:192-193.
98. Smith GL, Bunker CB, Dinneen MD. Fournier’s gangrene. Br J Urol 1998;81:347-355.
99. Mallon E & Bunker CB. Management of penile erosions and ulcers. Postgrad Mid East Doct 1998; 21:
163-168
100. Mallon E & Bunker CB. Management of common herpes skin infections. Prescriber 1998; July: 33-36.
101. Mallon E & Bunker CB. Management of cold sores, shingles and chickenpox. Prescriber 1998; July: 37-42 102. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R & Bunker CB. HLA-Cw*0602 and HIV
associated psoriasis. Br J Dermatol 1998;139:527-533.
103. Farrell AM, Latif F, Odularu O, Bhatt HR & Bunker CB. Screening of cobalamin metabolism in
methotrexate-treated psoriasis. Br J Dermatol 1998;138:1097-8.
104. Farrell AM & Bunker CB. Cutaneous eruption due to indoramin. Clin Exp Dermatol 1998;23:233.
105. Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD & Bunker CB. An outbreak
of methicillin-resistant staphylococcus aureus (MRSA) in a dermatology unit. Clin Exp Dermatol 1998;23:249-53.
106. Bunker CB & Staughton RCD. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard
B. Mediscript London, 1999.
107. Mallon E, Osborne G, Dinneen M, Lane RJM, Glaser M & Bunker CB. Dermatomyositis in association with
transitional cell carcinoma of the bladder. Clin Exp Dermatol 1999;24:94-96
108. Griffiths DJ, Cooke SP, Herve Rigby SP, Mallon E, Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P, Bunker CB,
duBois R, Weiss RA & Venables PJW. Detection of human retrovirus-5 in patients with arthritis and systemic
lupus erythematosus. Arthr Rheum 1999;42:448-54.
109. Farrell AM, Ross JS & Bunker CB. Eosinophilic fasciitis associated with autoimmune thyroid disease and
myelodysplasia treated with pulsed methylprednisolone and antihistamines. Br J Dermatol 1999;140:1185-1187.
110. Farrell AM, Moss G, Woodrow D & Bunker CB. Benign cutaneous Degos’ disease. Br J Dermatol 1998;139:708-
12.
111. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Depletion of cutaneous peptidergic
innervation in HIV-associated xerosis. J Invest Dermatol 1999;112:284-9.
112. Fearfield LA & Bunker CB. Familial naevus sebaceous of Jadassohn. Br J Dermatol 1998;139:1119-20.
113. Fearfield LA, Ross JR, Farrell AM, Costello C, Bunker CB & Staughton RCD. Pyoderma gangrenosum associated
with Takayasu’s arteritis responding to cyclosporin. Br J Dermatol 1999;14:339-343.
114. Fearfield LA, Rowe A, Francis N, Bunker CB & Staughton RCD. Itchy folliculitis and human
immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br
J Dermatol 1999;141:3-11.
115. Bunker CB. Review of Dermatology Journals. Sex Trans Inf 1999; 75:281-282.
116. Fox PA, Barton SE, Francis N, Youle M, Henderson DC, Pillay D, Johnson MA, Fearfield L, Gazzard BG & Bunker
CB. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV
Medicine 1999;1:10-18.
117. Bunker CB. Male genital dermatoses. Dermatology in Practice 1999; Oct:14-17.
118. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta analysis of
serological studies. J Invest Dermatol 1999;113:693-5.
119. Porter WM, Roberts NM &Bunker CB. Adverse drug reactions; appearance and causes of common skin rashes.
Prescriber 1999;10:91-94
120. Porter WM, Roberts NM & Bunker CB. Adverse drug reactions; identifying severe skin reactions to drug therapy.
Prescriber 1999;10:119-122
121. Farrell AM, McGregor JM, Staughton RCD & Bunker CB. Jessner’s lymphocytic infiltrate treated with auranofin.
Clin Exp Dermatol 1999;24:500.
42
122. Fearfield LA & Bunker CB. Cutaneous paraneoplastic syndromes-Part 1. E J Pall Care 1999;6:82-86.
123. Fearfield LA, Bunker CB. Cutaneous paraneoplastic syndromes – Part 2. Eur J Pall Care 1999; 6: 117-120
124. Mallon E, Hawkins DA, Dinneen M, Francis N, Newson R, Fearfield LA & Bunker CB. Circumcision and genital
dermatoses. Arch Dermatol 2000;136:350-354.
125. Porter W & Bunker CB. Treatment of pearly penile papules with cryotherapy. Br J Dermatol; 2000;142:847-8.
126. Mallon E & Bunker CB. HIV associated psoriasis. Aids Patient Care STDS. 2000;14:239-46.
127. Fearfield LA, Smith JR, Bunker CB & Staughton RCD. Association of multiple familial cutaneous leiomyoma with a
uterine symplastic leiomyoma. Clin Exp Dermatol 2000;25:44-47.
128. Fearfield LA, Nelson M, Francis N & Bunker CB. Cutaneous squamous cell carcinoma with zosteriform
metastases in a human immunodeficiency virus-infected patient. Br J Dermatol 2000;142:573-4.
129. Fearfield L, Bunker CB. Radiotherapy and erythema nodosum. Br J Dermatol. 2000;142:177-199
130. Morris-Jones R, Fearfield L, Nelson M, Haskins DA, Dinneen M, Clark P, Bower M and Bunker CB. Acute stridor
and phimosis secondary to Kaposi’s sarcoma. Retinoids 2000;16:41-42.
131. Jain J, Nanchahal J & Bunker C. Pyoderma gangrenosum occurring in a lower limb fascio-cutaneous flap - a lesson
to learn. B J Plas Surg. 2000;53:437-440.
132. Sidwell R, Doe P, Sinnett D, Francis N & Bunker CB. Lymphocytoma cutis and chronic sepsis. Br J Dermatol
2000;143:909-910.
133. Mallon E, Bunce, Savoie H, Rowe A, Newson R, Gotch F & Bunker C.B. HLA-C and guttate psoriasis. Br J Dermatol 2000;143:1177-1182.
134. Porter WM, O’Gorman-Lalor O, Lane RJ, Francis N & Bunker CB. Barraquer-Simons lipodystrophy, Raynaud’s
phenomenon and cutaneous vasculitis. Clin Exp Dermatol 2000;25:277-80.
135. Osborne GE, Chinn RJ, Francis ND, Bunker CB. Magnetic resonance imaging in the investigation of penile
lymphangioma circumscriptum. Br J Dermatol 2000;143:467-8.
136. Porter WM, Hawkins DA, Dinneen M & Bunker CB. Zoon’s balanitis and carcinoma of the penis.
Int J STD AIDS 2000;11:484-5.
137. Osborne GE, Francis ND, Bunker CB. Synchronous onset of penile lichen sclerosus and vitiligo.
Br J Dermatol 2000;143:218-9.
138. Fearfield LA, Farrell AM, Agnew K, Ross J, Roberts N & Bunker CB. Topical lauromacrogols and cutaneous
neuronal function. J Dermatol Treat 2000;11:69-72.
139. Review: Text Atlas of the Pathology of the Foot. Caputo R, Veraldi S & Annoni F. Clin Exp Dermatol 2000;25:454.
140. Fearfield LA & Bunker CB. Bone marrow involvement in cutaneous mastocytosis. Br J Dermatol 2001;144:561-6.
141. Porter WM, Du P Menage H, Philip G & Bunker CB. Porokeratosis of the penis. Br J Dermatol 2001;144:643-4.
142. Porter WM, Bewley A, Dinneen M, Walker CC, Fallowfield M, Francis N & Bunker CB. Nodular lichen simplex
of the scrotum treated by surgical excision. Br J Dermatol 2001;144:915-916.
143. Porter WM & Bunker CB. The dysfunctional foreskin. Int J STD & AIDS 2001;12:216-20.
145. Sidwell RU, Francis N & Bunker CB. Hormonal influence on reticular erythematous mucinosis. Br J Dermatol
2001;144:633-4.
146. Porter WM, Sidwell RU, Catovsky D & Bunker CB. Cutaneous presentation of chronic lymphatic leukaemia and
response to UVB phototherapy. Br J Dermatol 2001;144:1092-1094.
147. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol 2001;26:469-79
148. Bunker CB. Scientific evidence and expert clinical opinion for investigation and management of Stage I malignant
melanoma. In: Key Advances in the Effective Management of Malignant Melanoma. UK Key Advances In Clinical
Practice series (2001) Ed. Mackie R, Murray D, Rosin D, Hancock B & Miles A. Aesculapius Medical Press. London
149. Morris-Jones R, Mallon E, Francis N, Staughton RCD, Bunker CB & Nelson M. Reticular erythematous mucinosis
associated with human immunodeficiency virus infection. Retinoids 2001;17:5-57
150. Porter WM, Dawe SA & Bunker CB. Dermatitis herpetiformis and cutaneous T-cell lymphoma. Clin Exp Dermatol
2001;26:305-6.
151. Porter WM, Dinneen M & Bunker C. Chronic penile lymphoedema: A report of 6 cases. Arch Dermatol 2001;
137:1108-10. 152. Bunker C. Skin conditions of the male genitalia. Medicine 2001;29:7: 9-13.
153. Porter WM, Dinneen M, Hawkins DA & Bunker CB. Erosive penile lichen planus responding to circumcision
JEADV 2001;15;266-68.
154. Grabczynska SA, Toh CT, Francis N, Costello C & Bunker CB. Rosai-Dorfman disease complicated by autoimmune
haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. Br J Dermatol.
2001;145:323-6.
155. Fearfield LA, Rowe A, Francis N, Fisher C, Gore ME & Bunker CB. Clinicopathological features of relapsing very
thin melanoma. Clin Exp Dermatol 2001;26:686-695.
43
156. Bunker CB & Staughton RCD. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard B.
Mediscript, London, 2002.
157. Bunker CB. Dermatology. Medicine at a Glance. Ed. Davey P. Blackwells, Oxford 2002.
158. Davison SC, Bunker CB & Basarab T. Etanercept for severe psoriasis and psoriatic arthritis: observations on
combination therapy. Br J Dermatol 2002;147: 808-840.
159. Qazi NA, Morlese JF, Walsh JC, Bunker CB, Francis N, Nelson M. Severe cutaneous ulceration secondary to
cytomegalovirus inclusion disease during successful immune reconstitution with HAART. Case Report. The AIDS
Reader, 2002;12:452-457.
160. Sidwell RU, Ibrahim MAA & Bunker CB. A case of common variable immunodeficiency presenting with
furunculosis. Br J Dermatol 2002;147:364-367.
161. Porter, WM, Francis N, Hawkins D, Dinneen M & Bunker CB. Penile intraepithelial neoplasia: clinical spectrum and
treatment of 35 cases. Br J Dermatol 2002;147:1159-1165. 162. Edmonds EVJ, Francis N & Bunker CB. A case of Fox-Fordyce disease. Retinoids 2003;19:15-16.
163. Fearfield L, Stephenson A, Bunker C, Thomas M & Gore M. Skin cancer and melanoma. In: Cancer in Primary Care.
Edited by Gore M and Russell D. Martin Dunitz 2003, London & New York.
164. Dawe S, Phillips R, Porter W, Cream J & Bunker CB. Sweet’s syndrome as a complication of radiotherapy for
squamous carcinoma of the pharynx. Br J Dermatol 2003;149:884.
165. Agnew KL & Bunker CB. Multiple squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and
ultraviolet radiation exposure with were suppressed by acitretin. JEADV, 2003;17: 97-116.
166. Sidwell RU, Francis N, Grahame R, Pope FM & Bunker CB. Connective tissue naevus (collagenoma) in a patient
with benign joint hypermobility syndrome (Ehlers-Danlos syndrome type III). Clin Exp Dermatol 2003;28:323-325.
167. Osuji N, Fearfield L, Matutes E, Wotherspoon AC, Bunker C & Catovsky D. Granulomatous slack skin disease –
disease features and response to Pentostatin. Br J Haematol 2003;123:297-304.
168. Sidwell RU, Swift S, Yan C-L, Porter W, Thompson EM, Clark JA & Bunker CB. Treatment of toxic epidermal
necrolysis with intravenous immunoglobulin. Int J Clin Pract 2003;57:643-645.
169. Sidwell RU, Seet J-E, Francis N & Bunker CB. Giant actinic porokeratosis of the scalp. Br J Dermatol 2003;149:654.
170. Bunker CB. Male genital skin disease. Saunders (London) 2004.
171. Bunker CB. Skin Disease. In: Medicine 2e. (Ed. Axford J.) Blackwell Scientific Publications. Oxford 2004
172. Bunker CB & Gotch F. HIV and AIDS. In: Textbook of Dermatology: Rook/Wilkinson/Ebling. 7th Edition. Oxford,
Blackwells. 2004.
173. Bunker CB & Neill SA. The Umbilicus, Perianal and Genital Regions. In: Textbook of Dermatology:
Rook/Wilkinson/Ebling. 7th Edition. Oxford, Blackwells. 2004.
174. Heaton NR, Edmonds EV, Francis ND, Bunker CB, Bowling JC, Morar N. Fatal toxic epidermal necrolysis due to
lansoprazole.Clin Exp Dermatol. 2004;29:612-3.
175. Bunker CB. Second Cite A review of recent journal highlights. Clin Exp Dermatol 2004;29:213-4.
176. Davison SC, Francis N, McLean K & Bunker CB. Epidermodysplasia verruciformis-like eruption associated with
HIV. Clin Exp Dermatol 2004;29:311-2.
177. Agnew KL, Ruchlemer R, Catovsky D, Matutes E & Bunker CB. Cutaneous findings in chronic lymphocytic
leukaemia. Br J Dermatol 2004;150:1129-35.
178. Bunker CB, Staughton RCD. Genital inflammatory papules and nodules: In Edwards. Genital Dermatology. Atlas.
Lippincott Williams & Wilkins. Philadelphia. 2004.
179. Edmonds EV, Riaz SN, Francis N, Bunker CB. Nodular prurigo responding to topical tacrolimus. Br J Dermatol
2004;150:1216-7
180. Bunker CB. Systemic steroids in the treatment of alopecia areata. Br J Dermatol 2004;151:246-7.
181. Bunker CB, Neill S & Staughton RCD. Topical tacrolimus, genital lichen sclerosus and risk of squamous cell
carcinoma. Arch Dermatol 2004;140:1169.
182. Phan PT, Francis N, Madden N & Bunker CB. Kissing naevus of the penis. Clin Exp Dermatol 2004;29:471-2.
183. Guest M, Parmar JH, Bunker C, Rowe A & Davies AH. Confirmation of peripheral neuropathy in patients with
venous ulceration through immunohistochemistry. Int J Angiol 2004;13:176-181.
184. Bunker CB. Non-venereal penile dermatoses. In: Kumar B, Gupta S. Eds. Sexually Transmitted Infections. New
Delhi, Elsevier, 2005; pp 539-564
185. Bunker CB. Diagnosis and management of penis pre-cancer: combined clinics and topical chemotherapy. In: The
effective management of urological malignancies. Eds Anderson J, Oliver RTD, Miles A. Aesculapius Medical Press.
London 2005.
186. Bunker CB. Dermatology. In: Medicine at a Glance 2e Edited by Davey P. Blackwell Scientific Publications,
Oxford, 2005.
44
187. Agnew KL, Blunt D, Francis ND & Bunker CB. Magnetic resonance imaging in eosinophilic fasciitis. Clin Exp
Dermatol 2005;30:435-6.
188. Sidwell RU, Francis N & Bunker CB. Keloid development within adolescent striae distensae. Clin Exp Dermatol
2005;30:94-5.
189. Bunker CB. Skin conditions of the male genitalia. Medicine 2005;33:10:68-71.
190. Agnew K, Gilchrest B & Bunker CB. Fast Facts-Skin Cancer. Health Press, London UK, 2005.
191. Jones J, Brenner C, Chinn R & Bunker CB. Radiological associations with dermatological disease. Br J Radiol
2005;78:662-71. 175.
192. Leary A, Bunker CB, Gore M. Melanoma. GP New Contract Clinical Review. March 2005.
http://www.gponline.com/newContract/clinical_review_full.cfm?ID=12033
193. Bowling JCR, Saha M, Bunker CB. Herpetic whitlow: a forgotten diagnosis. Clin Exp Dermatol 2005;30:609-10.
194. Bowling JCR, Powles A, Searle A, Nasiri N, Bunker CB. Spontaneous regression of extramammary Paget’s disease
after excision of primary apocrine carcinoma in an immunosuppressed patient. Br J Dermatol 2005;153:676-7.
195. Sidwell RU, Green JS, Agnew K, Francis ND, Roberts NM, Yates VM, Madden N & Bunker CB. Subcutaneous
granuloma annulare of the penis in two adolescents. J Pediatr Surg 2005;40:1329-31.
196. Bunker C. B. Specialist Private Practice in Dermatology: Ethical Aspects. British Association of Dermatologists
2005. 197. Bowling JC, Francis N & Bunker CB. Solitary anogenital xanthogranuloma. Clin Exp Dermatol 2005;30:716-17.
198. Lally A, Hollowood K, Bunker CB & Turner R. Penile pyoderma gangrenosum treated with topical tacrolimus. Arch
Dermatol 2005;141:1175-76.
199. Sidwell RU, Francis N and Bunker CB. Diffuse trichostasis spinulosa in chronic renal failure. Clin Exp Dermatol
2006;31:86-88.
200. Topham EJ, Francis N, Bunker CB. Medulloblastoma metastasing to the skin. Br J Dermatol 2006;154:554-5.
201. Bunker CB. Management of penile dermatoses. Expert Review of Dermatology 2006;1:241-260.
202. Sidwell RU, Johnson N. McI, Francis N & Bunker CB. Cutaneous sarcoidal granulomas developing after Artecoll
facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. Clin Exp Dermatol 2006;31:208-11.
203. Malhomme de la Roche HJ & Bunker CB. Digitate dermatosis responding to bicalutamide therapy. Clin Exp
Dermatol. 2006;31:590.
204. Saha M, Barlow R & Bunker CB. Angiokeratoma circumscriptum of the penis. Br J Dermatol. 2006;154:775-6.
205. Saha M, Azadian BS, Ion L & Bunker CB. Mycobacterium chelonae infection complicating cosmetic facial surgery.
Br J Dermatol 2006;155:1097-8.
206. Patalay R & Bunker C. Penile Problems. Practitioner 2006;250:63-6.
207. Fearfield LA, Larkin JMG, Rowe A, A’Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore ME, Bunker CB.
Expression of p16, CD95, CD95L and HPA in relapsing and non-relapsing very thin melanoma. Br J Dermatol 2007;
156:440-7.
208. Burge S, Bunker C & Eedy D. Modernising Medical Careers. The Times 2007 (Mar 21).
209. Bunker C. B. Specialist Private Practice in Dermatology: Ethical Aspects. British Association of Dermatologists
2007.
210. Dungarawalla M, Field-Smith A, Jameson C, Riley U, Chapman A, Bunker CB, Dearden CE, Matutes E. Cutaneous
Mycobacterium chelonae infection in chronic lymphocytic leukaemia. Br J Haematol 2007;92 (3 Suppl):ECR03.
211. Singh, S and Bunker CB. Common penile dermatoses in old age. The Age of Skin 2007;8 (Jan): 6-9.
212. Patalay R & Bunker CB. How to spot and treat male genital dermatoses. Br J Sex Med 2007;30: 213. Bunker CB. Male genital dermatology. Fitzpatrick’s Dermatology in General Medicine, 7th edition. Wiley 2007.
214. Webster RM, Sarwar, N, Bunker CB & Brock CS. A case series of HIV-positive patients with malignant melanoma.
J HIV Therapy 2007;12:75-8.
215. Bunker CB. Male genital lichen sclerosus and topical tacrolimus. Br J Dermatol 2007;157:1079-80.
216. Singh S & Bunker CB. Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream. Clin
Exp Dermatol 2007;32:594-5.
217. Bunker CB. Obituary: Jeffrey Joseph Cream. BMJ 2008;336:1255.
218. Bunker CB. Obituary: Jeff Cream. BAD Newsletter 2008 (Spring):30.
219. Schmulewitz L, Attard N, Fearfield L, Westaby D, Prasad P, Thomas HJW, Bunker CB. An unusual cutaneous-
polyposis syndrome stabilised with acitretin. Br J Dermatol 2008;l:159:228-30.
220. Gleeson C, Chan I, Griffiths W, Bunker CB. Eruptive seborrhoeic keratoses associated with erythrodermic pityriasis
rubra pilaris. JEADV 2008 May 13 [Epub ahead of print]. JEADV 2009;23:217-8.
221. Dewan P, Francis N, Lear J, Bunker CB. Angiolymphoid hyperplasia with eosinophilia affecting the penis. Br J
Dermatol 2008;159:755-7.
222. Singh S & Bunker CB. Male genital dermatoses in old age. Age Ageing 2008;37:500-504
45
223. Scott C, Staughton RCD, Bunker CB, & Asboe D. Acne vulgaris and acne rosacea as part of immune reconstitution
disease in HIV-1 infected patients starting antiretroviral therapy. Int J STD & AIDS 2008;19:493-495.
224. Saha M, Edmonds E, Martin J & Bunker CB. Penile lymphoedema in association with asymptomatic Crohn’s disease.
Clin Exp Dermatol 2009;34:88-90.
225. Bunker CB. Topical gentian violet in dermatology. J Am Acad Dermatol 2009;60:347-8.
226. Bunker CB, Edmonds E, Hawkins D, Francis N & Dinneen M. Re: Lichen sclerosus: review of the literature and
current recommendations for management. JM Pugliese et al. J Urol 2007;178:2268-2276. J Urol 2009;181:1802-3
227. Edmonds E, Mavin S, Francis N, Ho-Yen D, Bunker C. Borrelia burgdorferi is not associated with genital lichen
sclerosus in men. Br J Dermatol 2009;34:88-90.
228. Chan WC, Veraitch O, Radford W, Azadian B, Mortimer P, Shepherd J & Bunker CB. Chronic lymphoedema
complicated by septic arthritis of the hip. Br J Dermatol 2009;160:1130-2).
229. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009;http://www.pointofcare.bmj.com.
230. Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO, Bunker CB. Revisiting the past: utilising archival
tissue for the detection and quantification of gene expression. Br J Dermatol 2009;160:885-6.
231. Bunker CB. Skin conditions of the male genitalia. Medicine 2010;38,294-299.
232. Meys R Gotch FM & Bunker CB. Human papillomavirus in the HAART era of HIV: an immune reconstitution
associated disease (IRAD)? Br J Dermatol 2010;162:6-11.
233. Goolamali SI, Edmonds EV, Francis N, Bunker CB. Myotonic dystrophy and basal cell carcinomas: coincidence or
true association? Clin Exp Dermatol 2009;34:e370.
234. Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. The role of human endogenous retroviruses in melanoma. Br J
Dermatol 2009;161:1225-1231.
235. Chapman A, Williams G, Soni N, Bunker CB. G-CSF in toxic epidermal necrolysis (TEN). Br J Dermatol
2010;162:860-5.
236. Rajapakse Y, Bunker C, Ghattaura A, Jallali N, Henton J, James S, Harris P& Searle A. Case report: pyoderma
gangrenosum following deep inferior epigastric perforator (Diep) free flap breast reconstruction. J Plast Reconstr
Aesthet Surg 2010;63(4):e395-6
237. Bunker CB & Gotch F. HIV and AIDS. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths, (eds.) Rook’s Textbook
of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;35:1-47.
238. Bunker CB. & Neill SA. The genital, perianal and umbilical regions. In: T.Burns, S. Breathnach, N.Cox and C.
Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;71:1-102.
239. Parks T, Ali I, Mahtani KR, Esmail H, Chandrakumar A, Singh S, Leon-Villapalos J, Asher R, Bunker C, Heneghan
C, Venning V. Toxic epidermal necrolysis associated with an influenza-like illness and osteltamivir phosphate.
http://www.bmj.com/cgi/eletters/339/dec07_2/b5106 - 227773
http://www.bmj.com/rapid-response/2011/11/02/toxic-epidermal-necrolysis-associated-influenza-illness-and-
oseltamivir-ph
240. Bunker CB. Dermatology. In: Medicine at a Glance 3e. Edited by Davey P. Wiley-Blackwell, Oxford, 2010.
241. Patalay R, Fields P, Kazmi, Francis ND, Whittaker S, Bunker CB. A psoriasiform rash. (Clinicopathological case).
Clin Exp Dermatol 2010;35:209-210.
242. Dewan P, Bunker CB et al. Mycobacterium chelonae infection after craniofacial surgery. Clin Exp Dermatol 2010; 35(3):e30-1.
243. Bunker C. B. Specialist private practice in Dermatology: ethical aspects. British Association of Dermatologists 2010.
244. Morar N, Willis-Owen SA, Maurer T & Bunker CB. HIV associated psoriasis: pathogenesis, clinical features and
management. Lancet Inf Dis 2010;10:470-478.
245. de Koning MNC, ter Schegget J, Kamp M, Kleter B, Feltkamp MCW, Eekhof JAH, Bavinck JNB, Purdie KJ, Harwood CA,
Meys R, Bunker CB & Quint WGV. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for
identification of skin wart HPV. J Clin Microbiol 2010;48:1706-11.
246. Rao A & Bunker C. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the
treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol 2010;163:208.
247. Edwards S & Bunker CB. Other conditions affecting the male genitalia. In: ABC of Sexually Transmitted Infections.
Ed. Rogstad KE. Sixth Edition. Wiley-Blackwell 2011, pp 35-41.
248. Bunker CB. Review. A Colour Handbook: Dermatology. Rycroft RJG, Robertson SJ & Wakelin SH. Second edition.
Manson Publishing 2010. London. UK. Br J Hosp Med 2010;71:596.
249. Edmonds EVJ & Bunker CB. Nuclear magnetic resonance spectroscopy of urine in male genital lichen sclerosus. Br J
Dermatol 2010;163:1355-6.
250. Bunker CB. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar et al. Lichen sclerosus of the male genitalia and
urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol
2009;55:945–956. Eur Urol 2010;58:e55-6.
46
251. Meys R, Macedo C, Jones R, Day S, Weir J, Gotch FM & Bunker CB. Cutaneous HPV related immune reconstitution
associated disease in HIV: an under-recognised phenomenon. Br J Dermatol 2011;164:458-9. Erratum: Br J
Dermatol 2011;165:228
252. Perrett CM, Macedo C, Francis N, Ion L & Bunker CB. Atypical fibroxanthoma in an HIV-infected individual. J
Cutan Pathol 2011;38:357-9.
253. Gleeson C, Morar N, Staveley I & Bunker CB. Treatment of cutaneous sarcoid with topical gel PUVA. Br J
Dermatol 2011;164:892-4.
254. Dadzie O & Bunker CB. Dermatology. Medicine at a Glance: Core cases. Ed. Davey P. Wiley-Blackwell 2011.
255. Bunker CB. Comments on the BAD guidelines for the management of lichen sclerosus Br J Dermatol 2011;164:894-
5.
256. Edmonds EVJ, Oyama N, Chan I, Francis N, McGrath JA & Bunker CB. Extracellular cellular matrix protein 1
(ECM1) autoantibodies in male genital lichen sclerosus (MGLSc). Br J Dermatol 2011;165:218-9.
257. Edmonds EVJ, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad H & Bunker CB. Gene expression profiling
in male genital lichen sclerosus (MGLSc). Int J Exp Pathol 2011;92:320-325.
258. Rao A & Bunker CB. Male genital skin biopsy. Int J STD & AIDS 2011;22:418-9.
259. Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N & Bunker CB. Clinical parameters in male genital lichen
sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012;26:730-7; .JEADV 2011; Jun 27. doi:
10.1111/j.1468-3083.2011.04155.x. [Epub ahead of print]
260. Tewari A & Bunker CB. Sweet’s syndrome preceding carcinoid and myeloma by more than a decade. Cutis
2013;92:E1.
261. Robey RC, Mletzko S, Bower M, Meys R, Boffito M, Nelson M, Bunker CB & Gotch FM. Ex-Vivo Recognition of
Late-Lytic CD8 Epitopes Specific for Kaposi's Sarcoma-Associated Herpesvirus (KSHV) by HIV/KSHV-Coinfected
Individuals. Viral Immunol 2011;24:211-20.
262. Bunker CB. Review. A Colour Handbook: Acute Adult Dermatology. Creamer D, Barker J & Kerdel FA. Manson
Publishing 2011. London. UK. Br J Hosp Med 2011;72:357.
263. Bunker CB & Francis N. Pseudoeptheliomatous and keratotic micaceous balanitis: comment. Clin Exp Dermatol
2012;37:434-5.
264. Bunker CB. Keratoacanthoma, trauma and cryotherapy. Dermatol Surg 2011;37:1709.
265. Bunker CB. Diseases and disorders of the male genitalia. In: Goldsmith LA. Katz SI, Gilchrest BA, Paller AS,
Leffell DJ & Wolff K. Eds. Fitzpatrick’s Dermatology in General Medicine, 8th edition. McGraw Hill 2012, pp 852-
877.
266. Bunker CB. Non-venereal penile dermatoses. In: Gupta S. & Kumar B. Eds. Sexually Transmitted Infections. 2nd
Edition. Elsevier, New Delhi, 2012, pp 703-727.
267. Lowe SM, Katsidzira L, Meys R, Sterling JC, de Koning M, Quint W, Nathoo K, Munyati S, Ndhlovu CE, Bunker CB,
Corbett EL, Miller RF & Ferrand RA. Epidermodysplasia verruciformis: a common manifestation of HIV infection
among vertically-infected adolescents in Zimbabwe. Clin Infect Dis 2012;54:e119-23. Epub 2012 Apr 3
268. Bunker CB. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an
unreported complication. BJU Int 2012;109:E29-31.
269. Bunker CB. Occlusion, urine and genital lichen sclerosus. Indian J Dermatol Venereol Leprol 2012;78:367-8.
270. Calonje E, Neill S, Bunker C, Francis N, Chaux A & Cubilla AC. Diseases of the anogenital skin. In: McKee’s
Pathology of the Skin. Eds Calonje E, Brenn T, Lazar A & McKee P 4th Edition. Elsevier Saunders. London. 2012;
Chapter 12. 438-519 pp452-456).
271. Ayer J, Matthews S, Francis N, Walker NP, Dinneen M & Bunker CB. Successful treatment of Buschke-Lowenstein
tumour of the penis with carbon dioxide laser vaporisation. Acta Derm Venereol 2012;92:656-7.
272. Chandrakumar A & Bunker CB. Dermatology. In: Oxford Desk Reference: Acute Medicine. Eds Leach R, Bell, D &
Moore K. OUP. Oxford, 2016 Chapter 17. 651-687.
273. Bunker CB. Review. Skin Diseases in the Elderly: A Colour Handbook. Evans CC & High WA. Manson Publishing
2012. London. Br J Hosp Med 2012;73:237.
274. Bunker CB, Patel, N & Shim TN. Urinary voiding symptomatology (micro-incontinence) in male genital lichen
sclerosus (MGLSc). Acta Derm Venereol 2013;93:216–256.
275. Shim TN & Bunker CB. The aetiopathogenesis of male genital lichen sclerosus (MGLSc). Nepal J Derm Ven Leprol
2013;11: 1-6.
276. Chandrakumar A, Weir J, Bunker CB & Agnew K. An incidental scalp finding: agminate blue naevus. Clin Exp
Dermatol 2013;38:108-10.
277. Bunker CB & McLelland J. Re: Measure your team's performance, and publish the results. BMJ 2012;345; doi:
http://dx.doi.org/10.1136/bmj.e4590. BMJ 2012;345:e4590.
http://www.bmj.com/content/345/bmj.e4590/rr/594065
47
278. Bunker CB. Re: Personal View. The UK needs office Dermatologists. The UK needs office dermatologists. BMJ
2012;345doi: http://dx.doi.org/10.1136/bmj.e6006 BMJ 2012;345:e6006.
http://www.bmj.com/content/345/bmj.e6006?tab=responses
279. Bunker CB & Griffiths T. Re: Head to Head: Should all advertising of cosmetic surgery be banned? No. BMJ
2012;345doi:http://dx.doi.org/10.1136/bmj.e7508. BMJ 2012;345:e7508.
http://www.bmj.com/content/345/bmj.e7508/rr/615049
280. Bunker CB & Griffiths T. Cosmetic surgery advertising. Non-surgical invasive procedures such as dermal fillers
should also be regulated. BMJ 2012;345:e7996. http://dx.doi.org/10.1136/bmj.e7996
281. Shim TN & Bunker CB. Male genital lichen sclerosus and hepatitis C. Br J Dermatol 2012;167:1398-9.
282. Singh S, Kaye S, Francis N, Peston D, McClure & Bunker CB. Human endogenous retrovirus K (HERV-K) rec
mRNA is expressed in primary melanoma but not in benign naevi or normal skin. Pig Cell & Mel Res 2013;26:426-8.
283. Bunker CB. Support for article: Sentinel node biopsy for melanoma: unnecessary treatment? BMJ 2013;346doi:. BMJ
2013;346:e8645.
http://www.bmj.com/content/346/bmj.e8645/rr/625554
284. Bunker CB. Re: Regulating the NHS market in England. What about conflict of interest? BMJ 2013;346:f1608.
http://www.bmj.com/content/346/bmj.f1608?tab=responses
285. Bunker CB. Re: Act now against new NHS competition regulations. BMJ 2013;346:f1819
http://www.bmj.com/content/346/bmj.f1819/rr/637740
286. Bunker CB. Re: Malignant and premalignant lesions of the penis. BMJ 2013;346:f1149.
http://www.bmj.com/content/346/bmj.f1149/rr/637777
287. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009;http://www.pointofcare.bmj.com. Point
of Care (US version) http://online.epocrates.com. Best Practice (rest-of-world version)
http://bestpractice.bmj.com/best-practice/welcome.html
288 Levell NJ, Jones SK & Bunker CB. Dermatology. Consultant Physicians working with patients. Clinical Medicine
2013 81-89.
289. Bunker CB. Malignant and premalignant lesions of the penis: Penile cancer can be prevented or treated pre-emptively.
BMJ 2013;346:f2129. http://bmj.com/cgi/content/full/bmj.f2129
290. Dinneen EP, Bunker CB & Dinneen MD. Male circumcision-when is it justified? Trends in Urology & Mens Health
2013;4: 22-25.
291. Bunker CB. Skin conditions of the male genitalia. Medicine 2014;42:372-377.
292. Shim TN, Minhas S, Muneer A & Bunker CB. Atypical presentation of genital herpes simplex (HSV-2) in 2 patients
with chronic lymphocytic leukemia. Acta Derm Venereol 2014;94: 246–247
293. Bunker CB & Piquet V. HIV and AIDS. In: Griffiths C, Barker J, Bleiker T, Chalmers R Creamer D. eds. Rook's
Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. P.31.1-37
294 Bunker CB & Porter WM. Dermatoses of the male genitalia. In: Griffiths C, Barker J, Bleiker T, Chalmers R Creamer
D. Rook's Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. P. 111.1-41.
295. A segmental rash in a young male: A Quiz. Merika, EE, Bunker CB, Francis, N & Singh S. Acta Derm Venereol
2014;94: 253–254.
296. Bunker CB. Atopy, the barrier, urine and genital lichen sclerosus (LS). Br J Dermatol 2013;169:953.
297. Agnew K, Bunker CB & Aaron S. Fast Facts-Skin Cancer. Health Press, London UK, 2013.
298. Shah M & Bunker CB. Male Dermatoses. ABC of Sexual Health. Wiley 2013 (in press).
299. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,
Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd
Mustapa MF & Smith CH. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal
necrolysis. Br J Dermatol 2016;174: 1194-227.
300. Sidwell RU, Chan I, Francis N & Bunker CB. Trichophyton erinacei kerion barbae with direct osculatory transfer.
Clin Exp Dermatol 2014;39:38-40
301. Bunker CB. Dermatology. HIV for non-HIV specialists. MEDFASH 2e 2013 (in press).
302. Merika EE, Darling MI, Craig P, Paul M, Francis N, Lachmann H, Porter7 W & C.B. Bunker. Primary cutaneous
amyloidosis of the glans penis. Two case reports and a review of the literature. Br J Dermatol 2014;170:730-4.
303. Shim TN, Andrich DE, Mundy AR & Bunker CB. Lichen sclerosus associated with perineal urethrostomy. Br J
Dermatol 2014;170:222-3.
304. Wilmot M-C, Perrett CM, Calonje E, Weir J & Bunker CB. A crusted lesion on the penis. Clin Exp Dermatol
2014;39:238-9.
305. Bunker CB & Shim TN. Male genital oedema in Crohn's disease. J Am Acad Dermatol 2014;70:385.
306. Bunker CB. Commissioning-a wasteful process but we must get involved. NHSCA Editorial 2013 (Sept);18-19.
307. Rashidghamat E, Bunker CB, Bower M & Banerjee P. Kaposi Sarcoma in HIV-negative men who have sex with men.
48
Br J Dermatol 2014;171:1267-8.
308. Abela C, Hartmann CE, De Leo A, de Sica Chapman A, Shah H, Jawad M, Bunker CB, Williams GJ, Leon-Villapalos
J. Toxic epidermal necrolysis (TEN): The Chelsea and Westminster Hospital wound management algorithm. J Plast
Reconstr Aesthet Surg 2014;67:1026-32.
309. Edwards S, Bunker C, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis.
Int J STD AIDS 2014;25:615-626.
310. Eedy D & Bunker CB. Dermatology in the new NHS. Br J Healthcare Mgt 2014;20:312-14.
311. Bower M, Palfreeman A, Alfa-Wali M, Bunker C, Burns F, Churchill D, Collins S, Cwynarski K, Edwards S,
Fields P, Fife K, Gallop-Evans E, Kassam S, Kulasegaram R, Lacey C, Marcus R, Montoto S, Nelson M,
Newsom-Davis T, Orkin C, Shaw K, Tenant-Flowers M, Webb A, Westwell S & Williams M. British HIV
Association guidelines for HIV-associated malignancies 2014. HIV Med 2014;15 Suppl 2:1-92.
312. Dhoot S, Balachandran K, Tittle V, Bunker C, Nelson M, Kelleher P & Bower M. Immunological function in HIV-
seronegative men who have sex with men (MSM) with Kaposi's sarcoma (KS). HIV Med 2014;15:55-55. 313. Bunker CB & Shim TN. Male genital lichen sclerosus. Indian J Dermatol 2015;60:111-117.
314. Veitch D, Kravvas G, Hughes S & Bunker CB. A rare colocalisation of lichen planus and vitiligo. Case Reports in
Dermatological Medicine 2015; 2015: Article ID 840193. http://www.hindawi.com/journals/cridm/2015/840193/
315. Doiron P & Bunker CB. Important topics in male genital dermatology. Dermatology in Practice 2015;21:92-95.
316. Thomas LJ, Shim TN, Borysiewicz C, Dinneen M, Fawcett H, Roy A, Francis N & Bunker CB. Male genital lichen
sclerosus in recipients of bone marrow transplants. 2016;41:495-7.
317. Kravvas G, Veitch D, Fawcett H & Bunker CB. Porokeratosis of Mibelli: case report of an uncommon penile lesion.
Clin Exp Dermatol 2016;41:704-705.
318. Bunker CB. Private practice in Dermatology. Ethical aspects: a guide for members. British Association of
Dermatologists 2016.
319. Turnbull N, Shim T, Patel N, Mazzon & Bunker C. Primary melanoma of the penis in three patients with lichen
sclerosus. JAMA Dermatol 2016; JAMA Dermatol. 2016;152:226-7.
320. Shabbir M, Watkin N, Bunker CB & Muneer A. Premalignant lesions of the penis. In: A. Muneer et al. (eds.),
Textbook of Penile Cancer,. Springer-Verlag London, 2016 (in press).
321. Ziada M, Bunker CB & Muneer A. Premalignant penile lesions. J Clin Urol 2016 (in press).
http://uro.sagepub.com/cgi/reprint/9/4/216.pdf?ijkey=hOAvzyojdVQPiJY&keytype=finite
322. Meys R, Purdie KJ, de Koning MNC, Quint KD, Little AM, Baker F, Francis N, Asboe D, Hawkins D, Marsh SGE,
Harwood CA, Gotch FM & Bunker CB. HLA immunogenotype determines persistent HPV infection in anti-retroviral
treated HIV. J Infect Dis 2016;213:1717-24.
323. Noy ML, Hughes S & Bunker CB. Another face of demodicosis. Clin Exp Dermatol 2016;41:958-959.
324. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2016;http://www.pointofcare.bmj.com.
325. Bunker CB. EDF lichen sclerosus guidelines. JEADV 2016;31:e97-98
326. Doiron P & Bunker CB. Response to "Expanding the benefits of HPV vaccination to boys and men”. Lancet
2016;388:659.
327. Christodoulidou M, Bunker CB, Trevisan G, & Muneer A. BMJ Case Rep 2016 Aug 24;2016. pii: bcr2016216913.
doi: 10.1136/bcr-2016-216913.
328. Tull T, Noy M, Bunker CB, Francis ND, & Morar N. Sebopsoriasis in HIV positive patients: A case series of four
patients. Br J Dermatol 2016 (in press). Jul 22. doi: 10.1111/bjd.14874. [Epub ahead of print]
329. Shim TN, Ali I, Muneer A. & Bunker CB. Benign male genital dermatoses. Br Med J 2016
http://bmj.com/cgi/content/full/bmj.i4337?ijkey=LJqWPYX4jR74VXD&keytype=ref 330. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,
Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd
Mustapa MF & Smith CH. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal
necrolysis. J Plast Reconstr Aesthet Surg 2016;69:736-41.
331. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,
Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd
Mustapa MF & Smith CH. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal
necrolysis. Br J Dermatol 2016;174:1194-1227.
332. Doiron PR & Bunker CB. Obesity related male genital lichen sclerosus. JEADV 2017;31:876-879.
333. Kravvas G, Veitch D, Doiron PR, Freeman A, Muneer A, Dinneen M, Francis N & Bunker CB. Recurrent penile
squamous cell carcinoma in an elderly circumcised man. Clin Exp Dermatol 2017;42:360-362.
334. Bunker CB. Guidelines for the management of TEN and SJS. MIMS Dermatology 2017;13:6.
335. Doiron PR, Menage HP, Freeman A, Muneer A & Bunker CB. Peri-meatal PeIN and urethral SCC: a case report.
JEADV 2017 Mar 10. doi: 10.1111/jdv.14207. [Epub ahead of print] PMID: 28295605
49
336. Kravvas G, Shim TN, Doiron PR, Freeman A, Jameson C, Minhas S, Muneer A, Bunker CB. The diagnosis and
management of male genital lichen sclerosus: a retrospective review of 301 patients. JEADV 2018;32:91-95.
337. Schartau P, Carr J, Muneer A & Bunker CB. Male genital dermatoses: a practical guide for GPs. Innovait 2018 (in
press).
338. Shim TN, Doiron PR, Francis N, Minhas S, Muneer A, Hawkins D, Dinneen, M & Bunker. CB Penile lymphoedema:
approach to investigation and management. Clin Exp Dermatol 2018 (in press).
339. Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, Mohd Mustapa MF, & Exton LS. British
Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol 2018;178:839-
853.
340. Watchorn RE & Bunker CB. Genital diseases in the mature man. Clin Dermatol 2018 (in press).
341. Christodoulidou M, Parnham A, Khetrapal P, Freeman A, Jameson C, Mitra A, Malone P, Nigam R, Bunker CB &
Muneer A. Management of Penoscrotal Extramammary Pagets disease - A single centre UK experience. Urologic
Oncology: Seminars and Original Investigations 2018 (in press).
CITATIONS:
BJD Virtual Issue Number 4, August 2012 Top cited Melanoma articles
For the fourth Virtual Issue, the BJD has collated the top 10 most cited melanoma research articles since 2009. Over
the last three years the BJD has attracted the submission of high impact, good quality papers on this subject which
includes the revised UK guidelines for the management of cutaneous melanoma.
10. Singh S.; Kaye S.; Gore M. E.; et al. The role of human endogenous retroviruses in melanoma. British Journal of
Dermatology 2009;161;1225-1231.
SUBMITTED PAPERS AND OTHER CONTRIBUTIONS:
1. Phan P-A, Bunker CB. Dysgeusia due to doxycycline. Br J Dermatol
2. Farrell AM, Francis N, Bunker CB. Zoon’s balanitis and vulvitis: an immunohistochemichal study. Br J Dermatol
3. Borysiewycz C. & Bunker CB. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard B.
Mediscript, London, 2012 (in press
MANUSCRIPTS IN PREPARATION:
1. Bunker CB. Levene GML. Bowen’s disease of the penis treated with 5-fluorouracil.
2. Trendell-Smith N. Bunker CB. et al. Female pattern androgenic alopecia.
3. Bunker CB, Papadaki L, Leslie TA, Miller JA & Dowd PM. Scleredema of Buschke.
4. Mallon E, Francis N, Bunker CB. The spectrum of cutaneous CMV infection in HIV disease.
5. Farrell AM, Trendell-Smith NJ, Francis N, Bunker CB. Are idiopathic scrotal cysts idiopathic? An
immunohistochemichal study. Br J Dermatol
6. Jones J, Thompson P, Sohail M, Jenkins C & Bunker CB. Sclerosing lymphangitis of the penis
7. Phan P-A, Francis N, Warrell D, Bunker CB. Delayed persistent and recurrent cutaneous reactions to jellyfish sting
8. Saha M, Bunker CB. A case of dermatomyositis in a patient with primary biliary cirrhosis.
9. Bunker CB. Sorting out penile rashes. Trends in Urology, Gynaecology and Sexual Health.
PUBLICATIONS-ABSTRACTS AND PROCEEDINGS OF MEETINGS:
1. Bunker CB & Dowd PM. Topical minoxidil does not increase scalp blood flow in androgenic alopecia.
Br J Dermatol 1987;116:447.
2. Bunker CB, Lanigan S, Gilkes JJH. Report of a comparative study of the efficacy of Varidase Topical
versus benzoyl peroxide 20% in the cleansing of leg ulcers using reflex metrography. In: A biological
50
approach to the wound healing process: a clinical update (Rue Y. ed.) Andover: Medifax International
1987;23-27.
3. Newton JA, Bunker CB, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM. The prevalence of polycystic ovaries in patients with acne vulgaris. Br J Dermatol 1988;119 (suppl):34.
4. Bunker CB, Maurice PDL, Sharp JC et al. Scleroderma and polymyositis overlap syndrome associated
with IgG lambda paraproteinaemia and cutaneous amyloid deposition. Br J Dermatol 1988; 119 (suppl):
70-71.
5. Bunker CB & Dowd PM. Giant cell arteritis and systemic lupus erythematosus. Br J Dermatol 1988;
119 (suppl):71-72.
6. Rustin MHA, Bunker CB, Gilkes JJH et al. Extensive linear epidermal naevi and polyostotic fibrous
dysplasia. Br J Dermatol 1988; 119 (suppl):75-76.
7. Bunker CB, Newton JA, Kilborn J et al. Women with acne who have polycystic ovaries (PCO) have
endocrinological differences from other women with PCO. Br J Dermatol 1989;120:293.
8. Dowd PM, Lanigan S, Rustin MHA & Bunker CB. Topically applied hexyl nicotinate lotion
increases the cutaneous blood supply in patients with Raynaud’s phenomenon. Br J Dermatol 1988;120:
311-312.
9. Maurice PDL, Bunker CB & Dowd PM. Isotretinoin in the treatment of systemic sclerosis.
Pharmacology and the Skin Vol 3 Pharmacology of Retinoids in the Skin. Eds. Reichert U and Shroot B.
Karger. Basel. 1989;235-239.
10. Bunker CB, Maurice PDL, Little S et al. Isotretinoin given in the treatment of systemic sclerosis may
hasten the decline in pulmonary function. Thorax 1989;44:346-347P.
11. Bunker CB. Foreman J & Dowd PM. Digital cutaneous vascular responses to histamine, compound
48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon. J Invest Dermatol 1989;92:409.
12. Bull HA, Bunker CB & Dowd PM. Mechanisms of action of vasoactive neuropeptides on human
cutaneous endothelial cells. J Invest Dermatol 1989;92:409.
13. Bunker CB, Foreman J & Dowd PM. Digital cutaneous vascular responses to histamine, compound
48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon. Clin Res 1989;37:632A .
14. Bull HA, Bunker CB & Dowd PM. Mechanisms of action of vasoactive neuropeptides on human
cutaneous endothelial cells. Clin Res 1989;37:697A.
15. Bunker CB, Cooper F & Dowd PM. A double-blind placebo controlled trial of topical hexyl nicotinate in
primary Raynaud’s phenomenon. Br J Dermatol 1989;121 (Suppl.34):51-52.
16. Bunker CB, Foreman J, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in
the treatment of severe Raynaud’s phenomenon. Br J Dermatol 1989;121 (Suppl.34):43-44.
17. Bunker CB, Foreman JC, O’Shaughnessy D et al. Calcitonin gene-related peptide in Raynaud’s
phenomenon. Skin Pharmacol 1989;2:47.
18. Bull HA, Bunker CB & Dowd PM. Calcitonin gene-related peptide down-regulates cutaneous
endothelial responses to Substance P and histamine. Skin Pharmacol 1989;2:48.
19. Bunker CB, Foreman JC, O’Shaugnessy D et al. Calcitonin gene-related peptide in Raynaud’s
phenomenon. Regulatory Peptides 1989;26:51.
20. Bull HA, Bunker CB & Dowd PM. Cutaneous endothelial cell responses to substance P and histamine
are attenuated by calcitonin gene-related peptide. Regulatory Peptides 1989;26:62.
21. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to neuropeptides and histamine at
low temperatures in Raynaud’s phenomenon. J Invest Dermatol 1990;94:511.
22. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to neuropeptides and histamine at
low temperatures in Raynaud’s phenomenon. Clin Res 1990;
23. Bunker CB, Cerio R, Bull HA, Evans J, Foreman JC & Dowd PM. Mast cells after capsaicin
application in normal human skin. Br J Dermatol 1990;123 (Suppl 37):119.
24. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. Intravenous calcitonin gene-related peptide
in severe Raynaud’s phenomenon. Br J Rheumatol 1990;29 (Suppl 2):1.
25. Bunker CB, Foreman JC & Dowd PM. Neuropeptides and histamine induced vascular responses in
Raynaud’s phenomenon: the effect of low temperature. Skin Pharmacol 1990;3:188-189.
26. Bunker CB, Foreman JC & Dowd PM. Effect of topical steroid on the intradermal vascular responses
to neuropeptides, histamine and substance 48/80. Skin Pharmacol 1990;3:189.
27. Bunker CB, Foreman JC & Dowd PM. Topical steroid and the vascular responses to intradermal
neuropeptides, histamine and compound 48/80. Br J Dermatol 1990;123:814.
28. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Calcitonin gene-related peptide and
endothelin in digital skin in Raynaud’s phenomenon. Br J Dermatol 1990;123:814.
51
29. Brickell PM, Maschio A, Katz D, Bunker CB & Craig RK. Expression of milk protein genes in the
sebaceous glands of transgenic and normal mice during lactation. Br J Dermatol 1990;123:826.
30. Bunker CB & Robinson TWE. Erythrokeratoderma variabilis. Br J Dermatol 1991;125 (suppl 38):62.
31. Bunker CB & Gilkes JJH. Granulomatous cheilitis and Crohn’s disease. Br J Dermatol 1991; 125 (suppl 38):75.
32. Bunker CB, Rubin A, Cambridge G, Spiro S & Gilkes JJH. Wegener’s granulomatosis. Br J Dermatol
1991;125 (suppl 38):72.
33. Bunker CB, Miller JA, Kurtz A & Dowd PM. Scleredema of Buschke. Br J Dermatol 1991;125 (suppl 38):71.
34. Bunker CB, Katz D, Tobias J, Brook C & Levene GM. Histiocytosis X. Br J Dermatol 1991;125 (suppl 38):73.
35. Goldsmith PC, Bunker CB & Dowd PM. Irritant contact dermatitis due to water. Br J Dermatol 1991;
125 (suppl 38):48.
36. Bunker CB, Tomlinson MC, Johnson N.McI & Dowd PM. Isotretinoin and the lung. Br J Dermatol 1991;
125 (suppl 38):29.
37. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to endothelin in Raynaud’s
phenomenon. Skin Pharmacol 1991;125:481.
38. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce F & Dowd PM. Basophil histamine receptors (H3)
in atopic dermatitis. J Invest Dermatol 1991;96:627A.
39. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce F & Dowd PM. Basophil histamine receptors (H3)
in atopic dermatitis. Clin Res 1991;39:535A.
40. Bunker CB, Rustin MHA, Smith N & Levene GM. An indolent cutaneous prodrome of human T
lymphotropic virus type 1 (HTLV1) infection associated adult T cell leukaemia/lymphoma. In: Dermatology
in Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology,
Florence, Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 642
41. Bunker CB, Smith NP, Russell RCG & Dowd PM. peculiar tumour. In: Dermatology in
Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology,
Florence, Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 643.
42. Heagerty A, Bunker C, Rustin M & Dowd P. Treatment of Morphoea with Colchicine. In: Dermatololgy in
Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology, Florence,
Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 694.
43. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. Calcitonin gene-related peptide in the
treatment of Raynaud’s phenomenon. In: Dermatology in Europe 1989. Proceedings of the Ist Congress of
the European Academy of Dermatology and Venereology, Florence, Italy. 25-28 September 1989 (Ed.
Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 695.
44. Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak JM.
Endothelin in human skin-immunohistochemical, receptor binding and functional studies. Proceedings of 2nd
International Conference on Endothelin, Japan, Dec 1990;17:S455-457. Lippincott Raven (1991).
45. Bunker CB, Goldsmith PC, Leslie T, Bull HA, Foreman JC & Dowd PM. Cutaneous vascular
responses to endothelin in normal skin and in Raynaud’s phenomenon. Br J Dermatol 1991;125:481.
46. Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak J.M. (1991)
Endothelin-1 in human skin: immunolocalization, receptor binding and functional studies. J Cardiovas
Pharmac 1991;17 (suppl), S467-S470.
47. Bunker CB, Wilkinson LS, Bull HA, Goldsmsith PC, Cambridge G, Brickell PM, Coleridge-Smith PD, Edwards JCW,
Dowd PM. Tumour Necrosis Factor Alpha Expression in human skin. J Invest Dermatol 1991; 96: 1025A
48. Bull HA, Wilkinson LS, Bunker CB, Edwards JCW & Dowd PM. Regulation of expression of the CD34 antigen in
human dermal microvascular endothelial cells. J Invest Dermatol 1992;98:529.
49. Bunker CB, Hayes N, Foreman JC & Dowd PM. CGRP(8-37) is an antagonist of CGRP in human skin.
J Invest Dermatol 1992;98:563.
50. Bunker CB, Hayes N, Foreman JC & Dowd PM. CGRP(8-37) is an antagonist of CGRP in human skin.
Clin Res 1992;40:532A.
51. Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM. Cutaneous nerve fibre
depletion in vibration white finger. Br J Dermatol 1992;127:424.
52. Goldsmith PC, Bunker CB, Leslie TA, Bull HA, Foreman JC & Dowd PM. Inhibition of the endothelin-1
mediated flare in the skin following application of topical 0.05% clobetasol propionate. Br J Dermatol 1992;
127:425.
53. Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM. A study of
immunoreactive nerves in vibration white finger. Skin Pharmacol 1992;5:196-197.
54. Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC and Dowd PM. Capasaicin Modulates The Cutaneous
Vascular response to Endothelin-1. Skin Pharmacol 1992;5:196-197.
52
55. Goldsmith PC, Abadia-Molina F, Bunker CB, Leslie TA, Terenghi G, Polak JM, Dowd PM. Depletion of cutaneous
CGRP and PGP 9.5 in immunoreactive nerves in vibration white finger. Neuropeptides 1993;24;206
57. Markus H, Bunker CB, Kouris K, Costa D & Harrison M. Tc-99m-HMPHD SPECT in Behcets syndrome
with and without central nervous system involvement. J Neurol (in press)
58. Smith R, Asboe D, Ross J, Fisher M, Bunker CB & Gazzard BG. Infective panniculitis as a manifestation of
pseudomonas infection in a patient with acquired immune deficiency syndrome. The Medical Society for the
Study of Venereal Diseases, Zurich 1993.
59 Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC & Dowd PM. Cold challenge modulates
cutaneous responses to endothelin-1 after capsaicin treatment. Skin Pharmacol 1994;7:159.
60. Ross JS, Aqel NM & Bunker CB. Cutaneous manifestations of Kikuchi’s disease. Br J Dermatol 1993;
129 (Suppl 42):60.
61. Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker C.B. Panniculitis with
pseudomonas septicaemia in AIDS. Br J Dermatol 1993;129 (suppl 42):63.
62. Bewley AP, Bracka A, Staughton RCD & Bunker CB. Extramammary Paget’s disease of the scrotum:
treatment with topical 5-fluorouracil and plastic surgery. Br J Dermatol 1994;13:445-6.
63. Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB. Interleukin-4 in atopic dermatitis. Br J
Dermatol 1994;131:435-6.
64. Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB. In situ localisation of interleukin-4 mRNA
and proteins in atopic dermatitis. Skin Pharmacol 1995;8:269.
65. Rowe A, Farrell AM, Kazmi SH & Bunker CB. Localisation of inducible nitric oxide synthase in psoriatic dermal
microvasculature. Br J Dermatol 1995;132:637.
66. Rowe A, Farrell AM, Kazmi SH & Bunker CB. Expresssion of inducible nitric oxide synthase in atopic
dermatitis. J Invest Dermatol 1995;104:650.
67. Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD, Bunker CB.
Outbreak of MRSA in a Dermatology Unit. Br J Dermatol 1995;133:38.
68. Farrell AM, Bunker CB, Latif F, Odularu O & Bhatt HR. Screening of cobalamin (Cbi) metabolism in
methotrexate (MTx)-treated psoriatics. Skin Pharmacol 1996;9:147.
69. Paul W, Roberts N, Farrell A, Fearfield L, Page CP & Bunker CB. The effects of L-5 on the erythema
and extravasation due to histamine and bradykinin in human skin. Skin Pharmacol 1996;9:148.
70. Rowe A & Bunker CB. Localisation of iNOS mRNA in psoriatic lesions by in situ hybridisation. Br J
Dermatol 1996;135:841.
71. Miles R, Farrell AM, Staughton RCD, Bunker CB & Aspinall R. Changes in the peripheral T cell V
repertoire in psoriasis. Br J Dermatol 1996;134:569.
72. Rowe A, Choudhury AI, Farrell AM & Bunker CB. Localisation of IL-4 receptors in inflammatory skin
disease. Br J Dermatol 1996;134:588-9.
73. Rowe A, Choudhury AI, Roberts NM, Farrell AM & Bunker CB. Expression of interleukin-4 Receptors in T
lymphocytes and mast cells in inflammatory skin disease. J Invest Dermatol 1996:106:933.
74. Farrell AM & Bunker CB. Oral gold therapy in cutaneous lupus erythematosus (revisited) Br J Dermatol 1996;
135 (suppl 47):41.
75. Fearfield LA, Farrell AM, Roberts NM, Ross JS, Hayes N, Foreman J & Bunker CB. Do lauramacrogols
alter cutaneous neuronal function when used clinically in a bath oil? Br J Dermatol 1996;135 (suppl 47):38.
76. Farrell AM, Francis N & Bunker CB. Zoon’s balanitis: an immunohistochemical study. Br J Dermatol
1996;135 (suppl 47):57
77. Farrell AM, Trendell-Smith NJ, Francis N & Bunker CB. Are “idiopathic scrotal cysts” idiopathic? An
immunohistochemical approach. Br J Dermatol 1996;135 (suppl 47):57.
78. Gooptu C, Woolllons A, Ross J, Price M, Wojnarowska F, Morris P, Wall S & Bunker CB. Merkel cell carcinoma
arising after therapeutic immunosuppression. Br J Dermatol 1996;135 (suppl 47):61.
79. Simpson-Dent SL, Moss J, Woodrow DF & Bunker CB. The ultrastructural pharmacology of vascular permeability in
human skin. J Invest Dermatol 1997;108:663.
80. Mallon E, Young D, Gotch F & Bunker CB. HLA-C locus genotyping of psoriasis in HIV disease using sequence-
specific amplification primers. Br J Dermatol 1997;136:462.
81. Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD. Itchy folliculitis in HIV. Br J Dermatol
1997:137:20.
82. Fearfield, LA, Henry K, Costello C & Bunker CB. Bone Marrow involvement in cutaneous mastocytosis.
JEADV 1997;9:S176.
83. Bunker CB. HIV related skin diseases in man. Proceedings of Br Vet Derm. Study Group October 1997. p.5.
84. Mallon E, Bunce M, Savoie H, Gotch F, Easterbrook PJ & Bunker CB. HLA-CW*0602 and guttate psoriasis.
53
J Invest Dermatol 1998;110:618.
85. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Decreases in cutaneous peptidergic
innervation in HIV-associated xerosis. J Invest Dermatol 1998;110:667.
86. Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD. Eosinophil chemokines in HIV-
associated eosinophilic folliculitis. J Invest Dermatol 1998;110:659.
87. Simpson-Dent SL, Moss J, Woodrow DF & Bunker CB. The ultrastructural pharmacology of endothelin-1in human
cutaneous vasculature. J Invest Dermatol 1998;110: 664.
88. Mallon E, Bunce M, Savoie H, Wojnarowska F, Welsh K, Easterbrook PJ, Gotch F & Bunker CB. HLA-Cw*0602
and psoriasis. 5th European Congree on Psoriasis. 7th International psoriasis symposium. Milan. 1998, p.56.
89. Mallon E, Griffiths DJ, Bunker CB, Weiss RA & Venables PJW. Human Retrovirus-5 and psoriasis. 5th
European Congress on Psoriasis. 7th International psoriasis symposium. Milan. 1998, p. 64.
90. Fearfield LA, Agnew K & Bunker CB. A randomised, double-blind, crossover study of the antipruritic actions of
topical lauramacrogols. Br J Dermatol 1998;138:753.
91. Rowe A, Mallon E, Aladeshi A, Walsh J & Bunker CB. Cutaneous mast cell distribution is unchanged in HIV-
associated xerosis. Br J Dermatol 1998;138;743.
92. Mallon E, Hawkins DA, Dinneen M, Fearfield L, Francis N & Bunker CB. Circumcision and genital
dermatological morbidity. Br J Dermatol 1998;139 (Suppl 51):65.
93. Kooner, Sweeney O, Mallon E, Francis N, Bunker CB & Dinneen M. Zoon’s plasma cell balanitis-conservative
treatment is warranted. Br J Urol 1998; in press
94. Rowe A, Mallon E & Bunker CB. Expression of the mitotic suppressor p15INK4b is altered in psoriatic epidermis.
Br J Dermatol 1999;140:810.
95. Mallon E, Griffiths DJ, Venables PJW, Bunker CB & Weiss RA. Human retrovirus-5 is not involved in the
pathogenesis of psoriasis. J Invest Dermatol 1999;112;651.
96. Rowe A, Schilling JP, Mallon E & Bunker CB. Epidermal HLA class I variable chain expression is down-
regulated in chronic plaque and guttate psoriasis. J Invest Dermatol 1999;112;646.
97. Trendell-Smith NJ, Simpson-Dent S, Mallon E, Fearfield LA, Staughton RCD, Francis N & Bunker CB. Female
pattern androgenic alopecia - a histopathological study. Br J Dermatol 1999;141 (suppl 55):120-127.
98. Fearfield LA, Rowe A, Fisher C, Gore M & Bunker CB. Thin melanomas with unusual aggressive behaviour.
Br J Dermatol 1999;141 (suppl 55):43-88.
99. Porter WM, Dinneen M, Hawkins D, Francis N & Bunker CB. Disease spectrum in penile intraepithelial neoplasia.
Br J Dermatol 2000;143 (suppl 57):49-50. 100. Rowe A, Guest M, Allerston A, Davies AH & Bunker CB. Depletion of cutaneous innervation adjacent to venous
ulcers. J Invest Dermatol 2000;114:821. 101. Fearfield LA, Rowe A, Francis N, Fisher C, MacKie R, Gore ME & Bunker CB. CD95 and CD95 ligand expression
in very thin melanoma. J Invest Dermatol 2000;115:554. 102. Fearfield LA, Rowe A, Francis N, Fisher C, MacKie RM, Gore ME & Bunker CB. Clinicopathological features of
very thin melanoma with unusual aggressive behaviour and the expression of CD95 and CD95 ligand. Melanoma
Research 2001;11: (suppl ) S73-S74. 103. Hunt S, Porter WM, Hawkins D, Francis N, Dinneen M & Bunker CB. Chronic penile lymphoedema. Br J Dermatol
2001;145(suppl 59):62. 104. Agnew KL, Hunt SJ, Cream JJ, Staughton RCD & Bunker CB. The Fox Brothers: Founders of dermatology at
Westminster & Charing Cross Hospitals. Br J Dermatol 2001; 145(suppl 59):78. 105. Fearfield LA, Rowe A, Francis N, Fisher C, McCann B, MacKie RM, Gore ME & Bunker CB. Expression of p16 in
relapsing and non-relapsing very thin melanoma. J Invest Dermatol 2001;113:781
106. Rowe A, Guest M, Davies A & Bunker CB. Attenuation of GAP-43 and NF-200 innervation in chronic venous
ulceration. J Invest Dermatol 2001;117:441.
107. Mallon E, Bunce M, Rowe A, Newson R, Gotch F & Bunker C. HLA-Cw*0602 in the Pathogenesis of Psoriasis.
Proceedings of the World Congress of Dermatology 2002. Ann Dermatol Venereol 2002;129:1S607-1S842
108. Fearfield L, Rowe A, Francis N, Fisher C, McCann B, MacKie R, Gore M & Bunker C. Prognostic factors in very
thin melanoma. Proceedings of the 20th World Congress of Dermatology 2002. Ann Dermatol Venereol
2002;129:1S607-1S842.
109. Agnew K, Catovsky D, Costello C, Ruchlemer R & Bunker C. Cutaneous findings in thirty-seven patients with
chronic lymphocytic leukaemia. Proceedings of the World Congress of Dermatology 2002. Ann Dermatol Venereol
2002;129:1S607-1S842.
110. O’Donoghue NB, Bunker CB, Francis N & Fuller LC. Chronic erosive vegetative genital herpes simplex as an
immune reconstitution disease after initiation of HAART in two patients with HIV infection. Br J Dermatol
2002;147:52-3.
54
111. Hunt SJ, Francis N, Dinneen M, Hawkins D & Bunker CB. A retrospective study of 174 men with lichen sclerosus of
the penis. Br J Dermatol 2003;149(suppl):53-54.
112. Sykes K, Brenner C, Jones J, Bunker C & Chinn R. Skin disorders and their radiological manifestations. Educational
Exhibit 0268MS-e. www.rsna.org Radiological Society of North America Scientific Assembly Program 2003:726.
113. Bowling JCR, Bunker CB & Powles A. Spontaneous regression of extramammary Paget’s disease after excision of
underlying inguinal apocrine carcinoma. Br J Dermatol 2004;151 (suppl.68): 89.
114. Bunker C. The dysfunctional foreskin. JEADV 2004;18:70.
115. Phan P-A T, Francis N & Bunker CB. Kissing naevus of the penis: A historical and embryological review. J Am
Acad Dermatol 2004;50:P52.
116. Dyche J, Davison S, Breuer J, Leigh I, Lacey C, Bunker CB & Harwood, CA. Epidermodysplasia verruciformis
human papillomavirus types are frequently detected in skin lesions associated with HIV infection. J Am Acad
Dermatol 2004;50:P110.
117. Edmonds EV, Chan I, Pyama N, Neill SM, Black MM, McGrath JA and Bunker CB. Autoantibodies to extracellular
matrix protein 1 in male genital lichen sclerosus. J. Invest Dermatol 2005;124 (supplement) 4: A115.
118. Lally A, Hollowood K, Bunker CB & Turner R. Pyoderma gangrenosum of the penis treated with topical tacrolimus.
Br J Dermatol 2005; 153 (Suppl.1):17.
119. Goolamali, SI, Edmonds EVJ, Francis N, Nelson M, Bunker CB. Cutaneous lupus Erythematosus (LE) in HIV
Infection: minocycline induced or immune restoration disease (IRD)? P14.44 EADV 2005. Blackwell Publishing.
www.eadv.org.
120. Topham EJ, Bunker CB, Morar N. Radiotherapy induced vitiligo – an example of the Koebner phenomenon. P08.63
EADV 2005. Blackwell Publishing. www.eadv.org
121. Saha M, Barlow R and Bunker CB. A case of angiokeratoma circumscripta of the penis. P04.28. EADV 2005.
Blackwell Publishing. www.eadv.org.
122. Edmonds EVJ, Francis N, Hawkins D, Bunker CB. Herpes simplex virus type 2 immune reconstitution disease of the
scrotum successfully treated with topical imiquimod 5%. FC06.10 EADV 2005. Blackwell Publishing.
www.eadv.org.
123. Bunker CB. Male dyspareunia and the dysfunctional foreskin: 22nd IUSTI-Europe Conference on Sexually
Transmitted Infections. Int J STD & AIDS 2006;17 (Suppl 1):7-8.
124. Bunker CB, Cox J, Williams H & Edmonds EV. Urine metabolic profiling using high resolution nuclear magnetic
resonance (NMR) spectroscopy in male genital lichen sclerosus (MGLSc). J Invest Dermatol 2007;127:S39.
125. Edmonds EV, Buisson S, Barton G, Francis N & Bunker CB. Gene expression profiling in male genital lichen
sclerosus (MGLSc). J Invest Dermatol 2007;127:S85.
126. Edmonds EV, Francis N, Ho-Yen D, Bunker C. Borrelia Burgdorferi is not associated with male genital lichen
sclerosus in the UK. J Invest Dermatol 2007;127 (Suppl 2); S18.
127. Singh S, Kaye S, Francis ND, McClure MO, Bunker CB. Expression of human endogenous retrovirus K in
melanoma. J Invest Dermatol 2008; 128: S212.
128. Bunker CB, Singh S, Kaye S, Francis ND, McClure MO. Detection and quantification of gene expression in archival
formalin-fixed, paraffin-embeded skin tissue. J Invest Dermatol 2008; 128: S188.
129. Meys R, Asboe D, Gotch FM, Bunker CB. HPV associated mucocutaneous disease post HAART/IRD – patient
immunophenotype. J Invest Dermatol 2008;128:S190.
130. Meys R, Purdie KJ, de Koning MN, Quint WG, Cox A, Atkins M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,
Bunker CB. Beta human papillomavirus (beta-HPV) types are common in persistent warts in HAART treated HIV
positive individuals. J Invest Dermatol 2009;129:S30.
131. Meys R, Fowles F, Little A-M, Marsh SGE, Asboe D, Hawkins DA, Gotch FM, Bunker CB. Immunogenetics of HIV-
associated HPV Disease after HAART. SID Montreal, J Invest Dermatol 2009;129:S82.
132. Singh S, Kaye S, Francis ND, Peston, D, Gore ME, McClure MO, Bunker CB. Quantification of Human Endogenous
Retrovirus K (HERV-K) Expression in Primary Melanoma, Normal Skin and Benign Naevi. J Invest Dermatol 2009;
129:S137.
133. Singh S, Bunker CB, Kaye S, Tristem M, Gore ME, McClure MO. Expression of Human Endogenous Retrovirus K
(HERV-K) mRNA and Production of Putative Viral Particles by Melanoma Cell Lines. J Invest Dermatol 2009;
129:S136.
134. De Koning M, ter Schegget J, Kamp M, Kleter B, Feltkamp M, Eekhof J, Bavinck JNB, Purdie K, Harwood C, Meys
R, Bunker CB, Quint W. A novel broad-spectrum PCR-luminex assay for identification of ward HPV. 25th
International Papilloma Virus Conference, 2009, MALMÖ, SWEDEN
135. Meys R, Mantovani C, Asboe D, Hawkinns D, Gotch FM, Terenghi G, Bunker CB. The neurocutaneous environment
of warts in HIV infection. J Invest Dermatol 2009;129:S103
55
136. Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA, Quint WG, Gotch FM,
Harwood C, Bunker CB. The HPV profile of cutaneous warts in HIV infected patients. J Invest Dermatol 2010;130
(suppl 1):S125.
137. Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA, Quint WG, Gotch FM,
Harwood C, Bunker CB. The HPV profile of genital warts in HIV infected patients. J Invest Dermatol 2010;130
(suppl 1):S125.
138. Krishna SK, Meys R, Purdie KJ, de Koning MN, Bardhan A, Gotch FM, Quint WG, Harwood C, Bunker CB.
Carcinoma in-situ of the penis and β-HPV types. J Invest Dermatol 2010;130 (suppl 1):S27.
139. Meys R, Weir J, Gotch F, Bunker CB. Cutaneous HPV-related immune reconstitution associated disease (IRAD) in
HIV: an underrecognized phenomenon. J Am Acad Dermatol 2011;64:AB107.
140. Chandrakumar A & Bunker C. Central nervous system disorder of unknown aetiology as a cuse of neuropathic
pruritus. Br J Dermatol 2011;165 (Suppl.1):34.
141. Goolamali S!, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N, Morar N, Meys R, Harwood CA &
Bunker CB. HPV is associated with non-melanoma skin cancer in HIV. J Invest Dermato1 2012;132 Suppl 1:S41.
142. Shim TN, Patel N & Bunker CB. Urinary voiding symptomatology (microicontinence) in male genital lichen
sclerosus. Br J Dermatol 2012;167 (Suppl.1):45-6.
143. Meys R, Purdie K, de Koning M, Quint W, Harwood CA & Bunker CB. Immune reconstitution-associated disease in
the dermatological care of the human immunodeficiency virus-infected patient: an under-recognised phenomenon. Br
J Dermatol 2012;167 (Suppl.1):114.
144. Shim T, Muneer A & Bunker CB. Chronic erosive and verrucous herpes simplex of the penis in in chronic
lymphocytic leukaemia. Br J Dermatol 2012;167 (Suppl.1):115-116.
145. Goolamali S, Mladkova N, Purdie K, de Koning M, Quint W, Francis N, Morar N, Meys R, Harwood CA & Bunker
CB. Human papillomavirus is associated with nonmelanoma skin cancer in human immunodeficiency virus. Br J
Dermatol 2012;167 (Suppl.1):120.
146. Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint MGV, Francis N, Morar N, Meys R,
Harwood CA & Bunker CB. Human papillomavirus in non-melanoma skin cancer. J Invest Dermato1 2012;132
(Suppl 2):S61.
147. Shim T, de Koning M, Muneer A, Minhas S, Francis N, Jameson CF, Dinneen M, Purdie KJ, Goolamali SI, Harwood
CA & Bunker CB. HPV in male genital lichen sclerosus, penile carcinoma in situ and penile squamous carcinoma. J
Invest Dermatol 2013;133 (Suppl. 1):S195.
148. Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MN, Quint WQ, Francis N, Morar, N, Meys R, Harwood
CA & Bunker CB. HPV in non-melanoma skin cancer/precancer in HIV. J Invest Dermatol 2013;133 (Suppl.
1):S173.
149. Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson C, Francis N, Dinneen M & Bunker CB. Male
genital dermatoses in immunocompromised patients. Br J Dermatol 2013;169 (Suppl. 1):99.
150. Wilmot M-C, Perrett C, Calonje E & Bunker CB. A case of acantholytic dermatosis localized to the male genitalia.
Br J Dermatol 2013;169 (Suppl. 1):16.
151. Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson CF, Francis N, Dinneen M, Bunker CB. Male
genital dermatoses in HIV. Sex Transm Infec 2013;89 (Suppl 1):A1-A428.
152. Merika EE, Lim DTA, Asboe D, Pozniak A, Boffito M, Bunker CB & N Morar N. Skin cancer in ageing HIV positive
patients. HIV Med 2013;14 (Suppl. 2):28.
153. Bunker CB. Selected topics in male genital dermatology. Australasian J Dermatol 2014;55 (Suppl.1):1-2.
154. Bunker CB. Toxic epidermal necrolysis. Australasian J Dermatol 2014;55 (Suppl.1):1-2.
155. Bunker CB. The aetiopathogenesis of male genital lichen sclerosus. Australasian J Dermatol 2014;55 (Suppl.1):1-2.
156. Bunker CB. HIV dermatology. Australasian J Dermatol 2014;55 (Suppl.1):1-2.
157. Simpson J, Harris P, Stamp G, James S, Bunker C & Fearfield L. A case series of pyoderma gangrenosusm after deep
inferior epigastric perforator-flap breast reconstruction. Br J Dermatol 2014;171(Suppl.1):19-20.
158. Shim TN, Brown SJ, Campbell LE, Francis N, Dinneen M, Hawkins D, Muneer, A, Minhas S, Freeman A, McLean
WHI & Bunker CB. Male genital lichen sclerosus and filaggrin. Br J Dermatol 2014;171(Suppl.1):35.
159. Shim TN, Francis N, Peston D, Phan S, Minhas S, Nuneer A, Dinneen M, Freeman A & Bunker CB. Cables 1, male
genital lichen sclerosus and penile cancer. Br J Dermatol 2014;171(Suppl.1):47-8.
160. Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C, Muneer A, Minhas S,
De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB. Human leucocyte antigen and
human papilloma virus in male genital lichen sclerosus, penile precancer and penile cancer. Br J Dermatol
2014;171(Suppl.4):31.
161. Shim TN, de Koning MN, Gollamali SI Meys R, Francis N, Jameson C, Freeman A, Dinneen M, Minhas S, Muneer A,
Purdie KJ, Harwood CA & Bunker CB. Prevalence of human papillomavirus in male genital lichen sclerosus, penile
carcinoma in situ and penile carcinoma: correlation with p16INK4a status. Br J Dermatol 2014;171(Suppl.4):34-5.
56
162. Shim TN, Gollamali SI, Francis N, Dinneen M, Muneer A, Minhas S, Freeman A, Jameson C, Purdie KJ, Harwood
CA & Bunker CB. Immunosuppression, human papilloma virus and Merkel cell polyomavirus in male genital lichen
sclerosus, penile precancer and penile cancer. Br J Dermatol 2014;171(Suppl.4):35-6.
163. Goolamali SI, Shim T, Purdie K, Mladkova N, Francis N, Harwood CA & Bunker CB. Human papillomavirus (HPV),
Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. J Invest Dermatol 2014;134:S34.
164. Noy M, Bunker C, Fuller C, Shelley J, Weir J, & Fearfield L. Dermatological manifestations of syphilis. Br J
Dermatol 2015;173 (Suppl.1):149-50..
165. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch F, Harwood CA & Bunker CB.
Immunogenetics of non-melanoma skin cancer/pre-cancer in HIV. J Invest Dermatol 2015;135 (Suppl. 2): S34 (193).
166. Doiron P, Morar N & Bunker CB. Use of biological therapy in HIV: a review of the evidence. Br J Dermatol
2016;175 (Suppl.1):149.
167. Fitzgerald M, Bunker CB, Pozniak A & Morar N. Cutaneous tuberculosis and HIV coinfection: a case series. Br J
Dermatol 2016;175 (Suppl.1):153.
168. Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MNC, Quint WGV, Francis N, Morar N, Meys R,
Harwood CA & Bunker CB. Human papilloma virus (HPV) in non-melanoma skin cancer/pre-cancer in HIV. Br J
Dermatol 2016;175 (Suppl. S2) 35-69.
169. Goolamali SI, Shim TN, Purdie KJ, Mladkova N, Francis N, Harwood CA & Bunker CB. Human papilloma virus
(HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. Br J Dermatol 2016;175 (Suppl. S2)
35-69.
170. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE, Harwood CA & Bunker
CB. Immunogenetics of non-melanoma skin cancer /pre-cancer in HIV. Br J Dermatol 2016;175 (Suppl. S2) 35-69.
171. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE, Harwood CA & Bunker
CB. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. Br J
Dermatol 2016;175 (Suppl. S2) 35-69.
172. Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker. The balanopreputial
mycobiome in health and disease: male genital lichen sclerosus. Br J Dermatol 2018;178:e428-9.
173. Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker. The balanopreputial
microbiome in male genital lichen sclerosus. J Invest Dermatol 2018;138(5S):S172
174. Shah M, Watchorn RE & CB Bunker. Circumcision is not always curative in male genital lichen sclerosus. Br J
Dermatol 2018; (Suppl. S2).
CITATIONS UNCERTAIN:
1. Topham E, Cunningham D & Bunker CB. Isotretinoin in the treatment and prophylaxis of acneiform dermatosis due to
cetuximab. J Am Acad Dermatol 2006;
2. Rickaby WR, Maruthappu T, Perret C & Bunker CB. Case report of an unusual skin tumour mimicking basal cell
carcinoma. Journal of Pathology July 2011;224
ABSTRACTS SUBMITTED:
1. Asfour L, Bunker CB, Fearfield L. Familial melanoma: the role of the Dermatologist and the future of genetics. BAD
2016
UNPUBLISHED ABSTRACTS:
1. Bunker CB, Rustin MHA, Smith N & Levene GM. An indolent cutaneous prodrome of human T-lymphotropic virus
type 1(HTLV1) infection associated adult T-cell leukaemia/lymphoma (ATLL). EADV 1989.
2. Bunker CB, Smith NP, Russell RCG & Dowd PM. Cock’s peculiar tumour. EADV 1989.
3. Severe Raynaud’s phenomenon treated with calcitonin gene-related preptide. EADV 1989.
4. Worrall JG, Rook,G, Bunker CB & Dowd PM. Terminal N-acetylglucosamine expression I psoriatic epidermis.
ESDR 1992. 5. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. A randomised controlled study of intravenous
calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. Skin Pharmacol 1991.
57
6. Goldsmith PC, Bunker CB, Wilkinson LS et al. Tumour necrosis factor in the inflammatory response
of human skin. Skin Pharmacol 1991.
7. Foreman JC, Coulson ML, Hayes NA, Bunker CB & Dowd PM. The actions of endothelin-1 in
human skin: a pharmacological analysis. Skin Pharmacol 1991.
CONTRIBUTIONS TO OTHER MEDIA:
1. Polycystic ovaries and acne in women. British Medical Telivision 1990 (Feb)
2. BBC Radio 4 Medicine Today interview-Penis, 1994
3. BBC Radio 4 Medicine Today interview-HIV, 1994
4. Psoriasis and eczema video, 1995
58
PAPERS PRESENTED AT MEETINGS:
1. Varidase Topical versus benzoyl peroxide 20% in the cleansing of leg ulcers using reflex metrography. 1987
Bunker CB, Lanigan S & Gilkes JJH.
The Biology of the Wound Healing Process
The Royal College of Physicians, London
2. The prevalence of polycystic ovaries in patients with acne vulgaris 1988
Newton JA,. Bunker CB, Kilborn J et al.
British Association of Dermatologists, London
3. The effect of isotretinoin in patients with systemic sclerosis. 1988
Maurice PDL, Bunker CB & Dowd P.M.
Centre International de Recherches Dermatologique Symposium, Cannes
4. Women with acne who have polycystic ovaries (PCO) have
endocrinological differences from other women with PCO. 1988
Bunker CB, Newton JA, Kilborn J et al.
British Society of Investigative Dermatology, Manchester
5. The prevalence of polycystic ovaries in patients with acne vulgaris 1988
Bunker CB, Newton JA, Kilborn J et al.
Residents Symposium, American Academy of Dermatology, Washington D. C.
6. The effect of isotretinoin on patients with systemic sclerosis. 1988
Maurice PDL, Bunker CB & Dowd P.M.
American Academy of Dermatology, Washington D. C.
7. Digital cutaneous vascular responses to histamine, 1989
compound 48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon.
Bunker CB, Foreman J & Dowd PM.
Laser Doppler User’s Group, London
8. Digital vascular responses to histamine, compound 48/80 1989
and calcitonin gene-related peptide in patients with Raynaud’s phenomenon
Bunker CB, Dowd PM & Foreman JC.
European Society for Histamine Research, Breda, Holland
9. Calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. 1989
Bunker CB, Foreman J, Reavley C et al.
British Association of Dermatologists, Cambridge
10. Calcitonin gene-related peptide down-regulates cutaneous endothelial responses 1989
to Substance P and histamine.
Bull HA, Bunker CB & Dowd PM.
Skin Pharmacology Society, New York
11. An Hypercard based multiple choice question tutor for the Apple Macintosh 1989
Bunker CB.
Forum on Computers in Medicine, RSM, London
12. Treatment of morphoea with colchicine. 1989
Heagerty A, Bunker CB, Rustin MHA & Dowd PM.
European Academy of Dermatology and Venereology, Florence
13. Severe Raynaud’s phenomenon treated with calcitonin gene-related peptide. 1989
Bunker CB,. Foreman JC, O’Shaughnessy D et al.
59
European Academy of Dermatology and Venereology, Florence
14. The novel vasodilator calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon 1989
Bunker CB, Foreman JC, Reavley C & Dowd PM.
Residents Symposium, American Academy of Dermatology, San Francisco
15. Mast cells after capsaicin application in normal human skin. 1990
Bunker CB, Cerio R, Bull HA, Evans J, Foreman JC & Dowd PM
British Association of Dermatologists (Dermatopathology), Warwick
16. Neuropeptide and histamine induced vascular responses in Raynaud’s phenomenon: 1990
the effect of low temperature
Bunker CB, Foreman JC & Dowd PM.
Skin Pharmacology Society, Hiroshima
17. The effect of topical steroid on the intradermal vascular responses to neuropeptides, 1990
histamine and substance 48/80.
Bunker CB, Foreman JC & Dowd PM.
Skin Pharmacology Society, Hiroshima
18. Action of vasoactive peptides on microvascular endothelium. 1991
Bull HA, Bunker CB & Dowd PM.
British Microcirculation Society, Oxford
19. Receptor binding and mRNA expresssion of endothelin-1 by human cutaneous microvascular endothelium 1991
Bull HA, Terenghi G, Bunker CB, Properzi G, Facer P, Polak JM & Dowd PM.
European Society for Dermatological Research, Copenhagen
20. Tumour necrosis factor a expression in human skin. 1991
Bunker CB, Wilkinson LH, Bull HA, Goldsmith PC, Cambridge G, Brickell PM,
Coleridge-Smith PD, Edwards JCW & Dowd PM.
European Society for Dermatological Research, Copenhagen
21. Digital vascular responses to endothelin in Raynaud’s phenomenon 1991
Bunker CB, Foreman JC & Dowd PM.
Skin Pharmacology Society, Pitlochry, Scotland
22. A randomised controlled study of intravenous calcitonin 1991
gene-related peptide in the treatment of severe Raynaud’s phenomenon.
Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM.
Skin Pharmacology Society, Pitlochry, Scotland
23. Tumour necrosis factor in the inflammatory response of human skin 1991
Goldsmith PC, Bunker CB, Wilkinson LS et al.
Skin Pharmacology Society, Pitlochry, Scotland
24. The actions of endothelin-1 in human skin: A pharmacological analysis. 1991
Foreman JC, Coulson ML, Hayes NA, Bunker CB & Dowd PM.
Skin Pharmacology Society, Pitlochry, Scotland
25. Isotretinoin and the lung. 1991
Bunker CB, Tomlinson MC, Johnson N McI & Dowd PM.
British Association of Dermatologists, London
26. Cutaneous vascular responses to endothelin in normal skin and in Raynaud’s phenomenon. 1991
Bunker CB, Goldsmith PC, T, Bull HA, Foreman JC & Dowd PM.
British Society for Investigative Dermatology, Leicester
60
27. Most women with acne have polycystic ovaries. 1992
Bunker CB, Newton J, Conway G, Jacobs H, Greaves M, Dowd. PM.
World Congress of Dermatology, New York
28. The action of a calcitonin gene-related peptide antagonist in human skin. 1992
Hayes N, Bunker CB, Marshall I, Dowd PM & Foreman JC.
European Society for Histamine Research, Malaga, Spain
29. Cutaneous nerve fibre depletion in vibration white finger. 1992
Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J, Dowd PM.
British Society for Investigative Dermatology, Sheffield
30. Inhibition of the endothelin-1 mediated flare in the skin following 1992
application of topical 0.05% clobetasol propionate.
Goldsmith PC, Bunker CB, Leslie TA, Bull HA, Foreman JC, Dowd PM
British Society for Investigative Dermatology, Sheffield
31. A study of immunoreactive nerves in vibration white finger. 1992
Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM.
Skin Pharmacology Society, Cleveland, Ohio
32. Capsaicin modulates the cutaneous response to endothelin-1 1992
Leslie TA, Hayes N, Bunker CB, Levell NJ, Foreman JC & Dowd PM.
Skin Pharmacology Society, Cleveland, Ohio
33 Infective panniculitis as a manifestation of pseudomonas infection in a patient with 1993
acquired immune deficiency syndrome.
Smith R, Asboe D, Ross J, Fisher M, Bunker C & Gazzard B.
The Medical Society for the Study of Venereal Diseases, Zurich
34. Cutaneous manifestations of Kikuchi’s disease 1993
Ross JS, Aqel NM & Bunker CB.
British Association of Dermatologists, Oxford
36. Cold challenge modulates cutaneous responses to endothelin-1 after capsaicin treatment. 1993
Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC & Dowd PM.
Skin Pharmacology Society, Hong Kong
37. Dermatology and Audit-The Telestation Project. 1994
Roberts N & Bunker CB.
Forum on Computers in Medicine/British Medical Informatics Society, RSM, London
38. In situ localisation of interleukin-4 mRNA and proteins in atopic dermatitis. 1994
Rowe A, Sadri R, Farrell A, Roberts N, Ross J, & Bunker CB.
Skin Pharmacology Society, London
39. Localisation of inducible nitric oxide synthase in psoriatic dermal microvasculature 1995
Rowe A, Farrell AM, Kazmi SH & Bunker CB.
British Society for Investigative Dermatology, Oxford
40. Zoon’s Balanitis: an Immunohistochemical Study. 1996
Farrell AM, Francis N & Bunker CB.
British Association of Dermatologists
41. Are “Idiopathic Scrotal Cysts” Idiopathic? An Immunohistochemical Approach 1996
Farrell AM, Trendell-Smith NJ, Francis N & Bunker CB.
61
British Association of Dermatologists
42. Changes in the Peripheral T Cell VB Repertoire in Psoriasis. 1996
Miles R, Farrell AM, Staughton RCD, Bunker CB & Aspinall R.
British Society of Investigative Dermatology, Glasgow
43. HIV related skin diseases in man 1997
Bunker CB.
British Veterinary Dermatology Study Group, Stratford upon Avon
44. Zoon’s plasma cell balanitis-conservative treatment is warranted. 1998
Kooner, Sweeney O, Mallon E, Francis N, Bunker CB, Dinneen M.
British Urological Society
45. HLA-Cw*0602 and psoriasis 1998
Mallon E, Bunce M, Savoie H, Wojnarowska F, Welsh K, Easterbrook PJ, Gotch F & Bunker CB.
5th European Congress on Psoriasis/7th International Psoriasis Symposium, Milan
46. Human retrovirus-5 and psoriasis 1998
Mallon E, Griffiths DJ, Bunker CB, Weiss RA & Venables PJW.
5th European Congress on Psoriasis/7th International Psoriasis Symposium, Milan
47. Zoon’s (Plasma Cell) Balanitis - Conservative treatment is warranted. 1998
Kooner R, Sweeney O, Mallon E, Francis N, Bunker CB, Dinneen, M
British Association of Urological Surgeons, Harrogate
48. Clinicopathological features of very thin melanoma with unusual aggressive behaviour 2001
and the expression of CD95 and CD95 ligand.
Fearfield LA, Rowe A, Francis N, Fisher C, MacKie RM, Gore ME & Bunker CB
5th International Conference on Melanoma, Venice
49. Expression of Human Endogenous Retrovirus K in Melanoma 2008
Singh S, Kaye S, Francis ND, McClure M, Bunker CB.
Melanoma Study Group, Birmingham
50. Human Endogenous Retrovirus K Gene Expression in Cutaneous Malignant Melanoma. 2009
Singh S, Kaye S, Francis N, Gore M, McClure M & Bunker CB
Residents Forum, American Academy of Dermatology, San Francisco
(Withdrawn: Dr Singh unable to attend due to illness)
51. Human endogenous retrovirus K expression in melanoma 2009
Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure M & Bunker CB
12th world Congress on Cancers of the Skin, Tel Aviv, Israel.
52. A novel broad-spectrum PCR-luminex assay for identification of ward HPV 2009
De Koning M, ter Schegget J, Kamp M, Kleter B, Feltkamp M, Eekhof J, Bavinck JNB, Purdie K,
Harwood C, Meys R, Bunker CB, Quint W.
25th INTERNATIONAL PAPILLOMAVIRUS CONFERENCE MAY 8-14 2009, MALMÖ, SWEDEN
53. Immune reconstitution-associated disease in the dermatological care of the human immunodeficiency 2012
virus-infected patient: an under-recognised phenomenon
Meys R, Purdie K, de Koning M, Quint W, Harwood CA & Bunker CB.
British Society for Skin Care in Immunocompromised Individuals,
British Association of Dermatologists, Birmingham
54. Male Genital Dermatoses in the Immunocompromised 2012
Shim T & Bunker CB.
62
British Society for Male Genital Dermatology, British Association of Dermatologists, Birmingham
55. Male genital dermatoses in immunocompromised patients.
Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson C, Francis N, Dinneen M & Bunker CB. 2013
British Association of Dermatologists, Liverpool
56. Human leucocyte antigen and human papilloma virus in male genital lichen sclerosus, penile precancer 2014
and penile cancer.
Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C,
Muneer A, Minhas S, De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB..
World Congress on Cancer of the Skin, Edinburgh
57. Aetiopathogenesis of Male Genital Lichen Sclerosus (MGLSc), Penile Pre-cancer (PCIS) & 2015
Penile Cancer (PSCC)
Shim TN, Meys R, Goolamali SI, Francis N, Dinneen M, Freeman A, Jameson C,
Muneer A, Minhas S, Marsh S, de Koning MN, Gotch FM, Harwood CA.& Bunker CB.
RSM AbbVie Dermatology Trainee Research Prize finalist.
Royal Society of Medicine, London
58. Male genital oedema and Crohn’s disease. 2015
Bunker CB & Shim TN
World Congress of Dermatology, Vancouver
59. Aetiological factors in the pathogenesis of male genital lichen sclerosus, penile precancer and 2015
penile cancer
Shim TN & Bunker CB
World Congress of Dermatology, Vancouver
60. Cutaneous tuberculosis and HIV coinfection: a case series. 2016
Fitzgerald M, Bunker CB, Pozniak A & Morar N.
European Academey of Dermatovenereology, Athens
61. Use of biological therapy in HIV: a review of the evidence. 2016
Doiron P, Morar N & Bunker CB.
British Society for Skin Care in Immunocompromised Individuals,
British Association of Dermatologists, Birmingham
POSTERS PRESENTED AT MEETINGS:
1. Topical minoxidil does not increase scalp blood flow in androgenic alopecia. 1986
Bunker CB & Dowd PM.
British Society for Investigative Dermatology, York
2. Topically applied hexyl nicotinate lotion increases the cutaneous blood supply
in patients with Raynaud’s phenomenon. 1988
Dowd PM, Lanigan S, Rustin MHA & Bunker CB.
British Society of Investigative Dermatology, Manchester
3. Isotretinoin given in the treatment of systemic sclerosis may hasten the decline in pulmonary function. 1988
Bunker CB, Maurice PDL, Little S et al.
British Thoracic Society, London
4. Digital cutaneous vascular responses to histamine compound 48/80 and neuropeptides in normal subjects 1989
and Raynaud’s phenomenon.
Bunker CB, Foreman J & Dowd PM.
63
Society for Investigative Dermatology,Washington D. C.
5. Mechanisms of action of vasoactive neuropeptides on human cutaneous endothelial cells. 1989
Bull HA, Bunker CB &Dowd PM.
Society for Investigative Dermatology,Washington D. C.
6. A double-blind placebo controlled trial of topical hexyl nicotinate in primary Raynaud’s phenomenon. 1989
Bunker CB, Cooper F & Dowd PM.
British Association of Dermatologists, Cambridge
7. Calcitonin gene-related peptide in Raynaud’s phenomenon. 1989
Bunker CB, Foreman JC, O’Shaughnessy D et al.
Skin Pharmacology Society, New York
8. Calcitonin gene-related peptide in Raynaud’s phenomenon. 1989
Bunker CB, Foreman JC, O’Shaughnessy D et al.
Bayliss and Starling Society, Nottingham
9. Cutaneous endothelial cell responses to substance P and histamine 1989
are attenuated by calcitonin gene-related peptide.
Bull HA, Bunker CB & Dowd PM.
Bayliss and Starling Society, Nottingham
10. Dermatology in Bloomsbury-The first 200 years. 1989
Bunker CB, Rustin MHA, Heagerty A & Dowd PM.
American Academy of Dermatology, San Francisco
11. Cold-related disorders. 1989
Rustin MHA, Bunker CB & Dowd PM.
American Academy of Dermatology, San Francisco
12. Colchicine-a good therapy for morphoea. 1989
Heagerty AHM, Bunker CB, Rustin MHA & Dowd PM.
American Academy of Dermatology, San Francisco
13. The novel vasodilator calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. 1989
Bunker CB, Foreman JC, Reavley C & Dowd PM.
American Academy of Dermatology, San Francisco
14. Digital vascular responses to neuropeptides and histamine at low temperatures in Raynaud’s phenomenon. 1990
Bunker CB, Foreman JC & Dowd PM.
Society for Investigative Dermatology, Washington D. C.
15. The effects of capsaicin on mast cells in normal human skin. 1990
Bunker CB, Cerio R, Bull HA et al.
European Society for Histamine Research, Kuopio, Finland
16. Digital vascular responses to histamine and neuropeptides at low temperatures in Raynaud’s phenomenon. 1990
Bunker CB, Foreman JC & Dowd PM.
European Society for Histamine Research, Kuopio, Finland
17. Dermatology in Bloomsbury-The first 200 years. 1990
Bunker CB, Rustin MHA, Heagerty A & Dowd PM.
A glance through history. University College Hospital
18. Calcitonin gene-related peptide-immunoreactive nerves in Raynaud’s phenomenon and systemic sclerosis. 1990
Terenghi G, Bunker CB, Springall DR, Foreman JC, Dowd PM & Polak J. M.
64
Pathological Society of Great Britain and Ireland, Nottingham
19. Intravenous calcitonin gene-related peptide in severe Raynaud’s phenomenon. 1990
Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM.
British Society for Rheumatology, London
20. Henry Radcliffe Crocker (1845-1909) Physician to the skin department, UCH, London (1879-1909). 1990
(Silver Medal winner).
Bunker CB & Dowd PM.
American Academy of Dermatology, Atlanta
21. The cutaneous endothelial cell in health and disease. 1990
Bull HA, Bunker CB & Dowd PM.
American Academy of Dermatology, Atlanta
22. Endothelin in human skin-immunohistochemical, receptor binding and functional studies. 1990
Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak JM.
2nd International Conference on Endothelin, Tokyo
23. Basophil histamine receptors (H3) in atopic dermatitis. 1991
Bull HA, Courtney PE, Bunker CB, Rustin MHA, Pearce F & Dowd PM.
Society for Investigative Dermatology, Seattle
24. Henry Radcliffe Crocker (1845-1909) Physician to the skin department, UCH, London (1879-1909). 1991
Bunker CB & Dowd PM.
British Association of Dermatologists, London
25. Sir Thomas Lewis FRS and the Neurovasculature of the skin 1991
(Gold Medal winner)
Bunker CB & Dowd PM.
American Academy of Dermatology, Dallas
26. CGRP(8-37) is an antagonist of CGRP in human skin. 1992
Bunker CB, Hayes N, Foreman JC & Dowd PM.
Society for Investigative Dermatology, Baltimore
27. Sir Thomas Lewis FRS and the Neurovasculature of the skin 1992
Bunker CB & Dowd PM.
British Association of Dermatologists, Bournemouth
28 Sir Thomas Lewis FRS and the Neurovasculature of the skin 1992
Bunker CB & Dowd PM.
17th European Conference on the Microcirculation, London
29. Raynaud’s phenomenon 1862-1992 (Bronze Medal winner) 1992
Goldsmith P, Bunker CB & Dowd PM.
American Academy of Dermatology, San Francisco
30. Raynaud’s phenomenon 1862-1992 1993
Goldsmith P, Bunker CB & Dowd PM
British Association of Dermatologists, Oxford
31. Panniculitis with pseudomonas septicaemia in AIDS. 1993
Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker CB.
British Association of Dermatologists, Oxford
32. Interleukin-4 in atopic dermatitis. 1994
65
Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB.
British Society for Investigative Dermatology, Bath
33. Penile Dermatoses in Dermatological Hands. 1995
Ross JS, Ramsay B, Farrell AM & Bunker CB.
American Academy of Dermatology, New Orleans
34. Expresssion of inducible nitric oxide synthase in atopic dermatitis. 1995
Rowe A, Farrell AM, Kazmi SH & Bunker CB.
Society for Investigative Dermatology, Chicago
35. The effects of L-NAME on the erythema and extravasation due to histamine and bradykinin in human skin. 1995
Paul W, Roberts N, Farrell A, Fearfield L, Page CP & Bunker CB.
Skin Pharmacology Society, Vienna
36. Expression of Inducible Nitric Oxide Synthase in Atopic Dermatitis. 1995
Rowe A, Farrell AM, Kazmi SH & Bunker CB.
Society for Investigative Dermatology, Chicago
37. An outbreak of MRSA in a Dermatological Unit 1995
Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD & Bunker CB.
British Association of Dermatology, Glasgow
38. Localisation of IL-4 Receptors in Inflammatory Skin Disease 1996
Rowe A, Choudhury AI, Farrell AM & Bunker CB.
British Society of Investigative Dermatology, Glasgow
39. Expression of Interleukin-4 Receptors in T-Lymphocytes and Mast Cells in Inflammatory Skin Disorders. 1996
Rowe A, Roberts NM, Farrell A & Bunker CB.
Society of Investigative Dermatology, Washington D. C.
40. Oral Gold Therapy in Cutaneous Lupus Erythematosus (Revisited) 1996
Farrell AM & Bunker CB
British Association of Dermatologists, Bournemouth
41. Do Lauramacrogols Alter Cutaneous Neuronal Function when used Clinically in a Bath Oil? 1996
Fearfield LA, Farrell AM, Roberts NM, Ross JS, Hayes N, Foreman J & Bunker CB.
British Association of Dermatology, Bournemouth
42. Circumcision and Genital Disease 1997
Mallon E & Bunker CB.
American Academy of Dermatology, San Francisco
43. HLA-C locus genotyping of psoriasis in HIV disease using sequence specific amplification primers 1997
Mallon E, Young D, Gotch F & Bunker CB.
British Society for Investigative Dermatology, Bristol
44. The Ultrastructural Pharmacology of endothelin -1in human cutaneous vasculature. 1997
Simpson-Dent AL, Moss J, Woodrow DF & Bunker CB.
Society for Investigative Dermatology, Washington DC.
45. Itchy Folliculitis in HIV 1997
Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD.
British Association of Dermatologists, Harrogate
46. Bone Marrow involvement in cutaneous mastocytosis 1997
66
Fearfield LA, Henry K, Costello C & Bunker CB.
European Association of Dermatovenereology, Dublin
47. HLA-CW*0602 and guttate psoriasis 1998
Mallon E, Bunce M, Savoie H, Gotch F, Easterbrook PJ & Bunker CB.
International Investigative Dermatology, Cologne
48. Decreases in cutaneous peptidergic innervation in HIV-associated xerosis 1998
Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB.
International Investigative Dermatology, Cologne
49. Eosinophil chemokines in HIV-associated eosinophilic folliculitis. 1998
Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD
International Investigative Dermatology, Cologne
50. The Ultrastructural Pharmacology of vascuklar permeability in human skin. 1998
Simpson-Dent AL, Moss J, Woodrow DF & Bunker CB.
International Investigative Dermatology, Cologne
51. A randomised, double-blind, crossover study of the antipruritic actions of topical lauramacrogols 1998
Fearfield LA, Agnew K & Bunker CB.
British Society for Investigative Dermatology, Liverpool
52. Cutaneous mast cell distribution is unchanged in HIV-associated xerosis 1998
Rowe A, Mallon E, Aladeshi A, Walsh J & Bunker CB.
British Society for Investigative Dermatology, Liverpool
53. Circumcision and Genital Dermatological Morbidity (Bristol Cup Winner) 1998
Mallon E, Hawkins DA, Dinneen M, Fearfield L, Francis N & Bunker CB.
British Association of Dermatologists, Brighton
54. Expression of the mitotic suppressor p15INK4b is altered in psoriatic epidermis. 1999
Rowe A, Mallon E & Bunker CB.
British Society for Investigative Dermatology, Cardiff
55. Human retrovirus-5 is not involved in the pathogenesis of psoriasis 1999
Mallon E, Griffiths DJ, Venables PJW, Bunker CB, Weiss RA.
Society for Investigative Dermatology, Chicago
56. Epidermal HLA class I variable chain expression is down-regulated in chronic plaque and guttate psoriasis 1999
Rowe A, Schilling JP, Mallon E & Bunker CB
Society for Investigative Dermatology, Chicago
57. Female Pattern Androgenic Alopecia - a histopathological study 1999
Trendell-Smith NJ, Simpson-Dent S, Mallon E, Fearfield LA, Staughton RCD, Francis N & Bunker CB.
British Association of Dermatologists, Edinburgh
58. Thin melanomas with unusual aggressive behaviour 1999
Fearfield LA, Rowe A, Fisher C, Gore M & Bunker CB.
British Association of Dermatologists, Edinburgh
59. Decreased peptidergic innervation adjacent to venous ulcers. 2000
Rowe A, Guest M, Allerston A, Davies AH & Bunker CB.
British Society of Investigative Dermatology, Edinburgh
60. The Fox Brothers: Founders of dermatology at Westminster & Charing Cross Hospitals 2001
Agnew KL, Hunt SJ, Cream JJ, Staughton RCD, Bunker CB.
67
British Association of Dermatologists,
61. Attenuation of GAP-43 and NF-200 innervation in chronic venous ulceration. 2001
Rowe A, Guest M, Davies A & Bunker CB. J Invest Dermatol 2001;117:441.
Society for Investigative Dermatology, Washington DC
62. Expression of p16 in relapsing and non-relapsing very thin melanoma 2001
Fearfield LA, Rowe A, Francis N, Fisher C, McCann B, MacKie RM, Gore ME & Bunker CB.
Society for Investigative Dermatology, Washington DC
63. HLA-Cw*0602 in the Pathogenesis of Psoriasis 2002
Mallon E, Bunce M, Rowe A, Newson R, Gotch F, Bunker C.
World Congress of Dermatology, Paris
64. Prognostic factors in very thin melanoma 2002
Fearfield L, Rowe A, Francis N, Fisher C, McCann B, MacKie R, Gore M, Bunker C.
World Congress of Dermatology, Paris
65. Cutaneous findings in thirty-seven patients with chronic lymphocytic leukaemia 2002
Agnew K, Catovsky D, Costello, C, Ruchlemer R, Bunker CB.
World Congress of Dermatology, Paris
66. Chronic erosive vegetative genital herpes simplex as a immune reconstitution disease 2002
after initiation of HAART in two patients with HIV infection.
O’Donoghue NB, Bunker CB, Francis N and Fuller LC.
British Association of Dermatologists, Edinburgh
66. Anorexia, Alcohol, Eczema and Poliosis. 2003
Simpson-Dent SL, Sidwell R & Bunker CB.
American Academy of Dermatology, San Francisco
67. A Retrospective Study of 174 men with Lichen Sclerosus of the Penis 2003
Hunt SJ, Francis N, Dinneen M, Hawkins D, Bunker CB
British Association of Dermatologists, Brighton.
68. Skin Disorders and their radiological manifestations 2003
Sykes K, Brenner C, Jones J, Bunker C, Chinn R.
Radiological Society of North America, Chicago
70. Kissing Naevus of the Penis: A Historical and Embryological Review 2004
Phan PT, Francis N, Madden N, Bunker CB
American Academy of Dermatology, Washington DC
71. Epidermodysplasia verruciformis human papillomavirus types are frequently detected 2004
in skin lesions associated with HIV infection.
Dyche J, Harwood C, Bunker C
American Academy of Dermatology, Washington DC
72. Cutaneous lupus erythematosus (LE) in HIV Infection: 2005
minocycline induced or immune restoration disease (IRD)? (P14.44)
Goolamali, SI, Edmonds EVJ, Francis N, Nelson M & Bunker CB.
European Association of Dermatovenereology, London
73. Radiotherapy induced vitiligo – an example of the Koebner phenomenon. (P08.63) 2005
Topham EJ, Bunker CB, Morar N.
European Association of Dermatovenereology, London
68
74. A case of angiokeratoma circumscripta of the penis. (P04.28) 2005
Saha M, Barlow R & Bunker CB.
European Association of Dermatovenereology, London
75. Urine metabolic profiling using high resolution nuclear magnetic resonance (NMR) spectroscopy 2007
in male genital lichen sclerosus (MGLSc).
Bunker CB, Cox J, Williams H & Edmonds EV.
Society for Investigative Dermatology, Los Angeles
76. Gene expression profiling in male genital lichen sclerosus (MGLSc). 2007
Edmonds EV, Buisson S, Barton G, Francis N & Bunker CB.
Society for Investigative Dermatology, Los Angeles
77. Borrelia Burgdorferi is not associated with male genital lichen sclerosus in the UK. 2007
Edmonds EV, Francis N, Ho-Yen D, Bunker C.
European Society for Dermatological Research, Zurichdmonds
78. Wound management in toxic epidermal necrolysis (TEN). 2007
Abela C, De Leo A, Shah H, Fu B, Jawad M, De Sica Chapman A, Bunker CB, Williams G.
European Burns Association, Budapest
79. Localised bullous tinea corporis due to trichophyton rubrum. 2008
Singh S, Schmulewitz L, Bunker CB.
European Association of Dermatovenereology, Paris
80. Expression of human endogenous retrovirus K in melanoma. 2008
Singh S, Kaye S, Francis ND, McClure MO, Bunker CB.
International Investigative Dermatology Meeting, Kyoto
81. Detection and quantification of gene expression in archival formalin-fixed, paraffin-embeded skin tissue. 2008
Bunker CB, Singh S, Kaye S, Francis ND, McClure MO.
International Investigative Dermatology Meeting, Kyoto
82. HPV associated mucocutaneous disease post HAART/IRD – patient immunophenotype. 2008
Meys R, Asboe D, Gotch FM, Bunker CB.
International Investigative Dermatology Meeting, Kyoto
83. Beta human papillomavirus (beta-HPV) types are common in persistent warts in HAART 2009
treated HIV positive individuals.
Meys R, Purdie KJ, de Koning MN, Quint WG, Cox A, Atkins M, Asboe D, Hawkins DA,
Gotch FM, Harwood CA, Bunker CB.
Society for Investigative Dermatology, Montreal
84. Immunogenetics of HIV-associated HPV Disease after HAART. 2009
Meys R, Fowles F, Little A-M, Marsh SGE, Asboe D, Hawkins DA, Gotch FM, Bunker CB.
Society for Investigative Dermatology, Montreal
85. Quantification of Human Endogenous Retrovirus K (HERV-K) Expression in Primary Melanoma,
Normal Skin and Benign Naevi.
Singh S, Kaye S, Francis ND, Peston, D, Gore ME, McClure MO, Bunker CB. 2009
Society for Investigative Dermatology, Montreal
86. Expression of Human Endogenous Retrovirus K (HERV-K) mRNA and Production of 2009
Putative Viral Particles by Melanoma Cell Lines.
Singh S, Bunker CB, Kaye S, Tristem M, Gore ME, McClure MO.
Society for Investigative Dermatology, Montreal
87. The neurocutaneous environment of warts in HIV infection 2009
69
Meys R, Mantovani C, Asboe D, Hawkinns D, Gotch FM, Terenghi G and Bunker CB.
European Society for Dermatological Research, Budapest
88. Clinical features of Toxic Epidermal Necrolysis (TEN): with CWH TEN management protocol 2010
De Sica-Chapman A & Bunker CB.
4th International Drug Hypersensitivity Meeting, Rome
89. G-CSF enhances wound healing in severe TEN 2010
& should be considered in management of fulminant TEN irrespective of neutropaenia
De Sica-Chapman A & Bunker CB.
4th International Drug Hypersensitivity Meeting, Rome
135. The HPV profile of cutaneous warts in HIV infected patients 2010
Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA,
Quint WG,
Gotch FM, Harwood C, Bunker CB.
Society for Investigative Dermatology, Atlanta
136. The HPV profile of genital warts in HIV infected patients. 2010
Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D,
Hawkins DA, Quint WG,
Gotch FM, Harwood C, Bunker CB.
Society for Investigative Dermatology, Atlanta
137. Penile Carcinoma in-situ and β-HPV types 2010
Krishna SK, Meys R, Purdie KJ, de Koning MN, Bardhan A, Gotch FM, Quint WG,
Harwood C, Bunker CB.
Society for Investigative Dermatology, Atlanta
138. HPV genotype distribution in cutaneous and genital warts is different in HIV infected patients.
de Koning MNC, Meys R, Purdie KJ, Nelson M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,
Bunker CB, Quint WGV.
26th International Papillomavirus Conference, Montreal 2010
139. High risk HPV but no Betapapillomavirus types detected in penis in-situ cancers
de Koning MNC, Meys R, Krishna SK, Purdie KJ, Francis ND, Ryder TA, Walker MM, Harwood,
CA, Bunker CB, Quint WG.
26th International Papillomavirus Conference, Montreal 2010
140. Cutaneous HPV-related immune reconstitution associated disease (IRAD) in HIV: 2011
an underrecognized phenomenon.
Meys R, Weir J, Gotch F, Bunker CB.
American Academy of Dermatology, New Orleans
141. Case report of an unusual skin tumour mimicking a basal cell carcinoma. 2011
Cutaneous lymphadenoma/ adamantinoid trichoblastoma.
Rickaby W, T Maruthappu T, Perret C, Bunker CB & Freeman A.
Pathological Society, Ghent
142. Central nervous system disorder of unknown aetiology as a cuse of neuropathic pruritus. 2011
Chandrakumar A & Bunker C.
British Association of Dermatologists, London
143. HrHPV but no betaPV types detected in penis in-situ cancers. 2011
de Koning MNC, Meys R, Krishna SK, Purdie KJ, Francis ND, Ryder TA, Walker MM, Harwood CA,
Bunker CB & Quint WG.
27th International Papillomavirus Conference and Clinical Workshop, Berlin
144. HPV distribution in warts is different in HIV infected patients. 2011
70
de Koning MNC, Meys R, Purdie KJ, Nelson M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,
Bunker CB & Quint WG..
27th International Papillomavirus Conference and Clinical Workshop, Berlin
145. Non-melanoma skin cancer and pre-cancer in HIV infection: the role of human papillomavirus (HPV). 2011
Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N,
Meys R, Harwood CA& Bunker CB.
3rd HIV Symposium ,Blizard Institute, Barts and The London School of Medicine and Dentistry, London
146. Non-melanoma skin cancer and pre-cancer in HIV infection: the role of human papillomavirus (HPV). 2011
Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N,
Meys R, Harwood CA& Bunker CB.
William Harvey Day, St Bartholomew’s Hospital,
Barts and The London School of Medicine and Dentistry, London
147. Adamantinoid Trichoblastoma: A Rare Clinicopathological Entity Mimicking Basal Cell Carcinoma. 2012
Maruthappu T, Rickaby W, Freeman A, Perrett CM and Bunker CB.
American Academy of Dermatology, San Diego
148. Male Genital Lichen Sclerosus (MGLSc) and Urine. 2012
Shim TN and Bunker CB
American Academy of Dermatology, San Diego
149. HPV is associated with non-melanoma skin cancer in HIV. 2012
Goolamali SI, Mladkova N, Purdie KJ, de Koning MN, Quint WG, Francis N, Morar N,
Meys R, Harwood CA and Bunker CB.
Society for Investigtaive Dermatology, Raleigh
150. Urinary voiding symptomatology (microicontinence) in male genital lichen sclerosus. 2012
Shim TN, Patel N & Bunker CB.
British Association of Dermatologists, Birmingham
151. Human papillomavirus is associated with nonmelanoma skin cancer in human immunodeficiency virus. 2012
Goolamali S, Mladkova N, Purdie K, de Koning M, Quint W, Francis N, Morar N, Meys R,
Harwood CA & Bunker CB.
British Association of Dermatologists, Birmingham
152. Human papillomavirus in non-melanoma skin cancer. 2012
Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint MGV, Francis N, Morar N, Meys R,
Harwood CA & Bunker CB.
European Society for Dermatological Research, Venice
153. HPV in male genital lichen sclerosus, penile carcinoma in situ and penile squamous carcinoma. 2013
Shim T, de Koning M, Muneer A, Minhas S, Francis N, Jameson CF, Dinneen M, Purdie KJ,
Goolamali SI, Harwood CA & Bunker CB.
International Investigative Dermatology, Edinburgh
154. HPV in non-melanoma skin cancer/precancer in HPV. 2013
Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MN, Quint WQ, Francis N,
Morar, N, Meys R, Harwood CA & Bunker CB.
International Investigative Dermatology, Edinburgh
155. Skin cancer in ageing HIV positive patients. 2013
EE Merika, DTA Lim, D Asboe, A Pozniak, M Boffito, CB Bunker and N Morar
British HIV Association, Manchester
156. Skin cancer in ageing HIV positive patients. 2013
EE Merika, DTA Lim, D Asboe, A Pozniak, M Boffito, CB Bunker and N Morar
National HIV Nurses Association (NHIVNA), Birmingham
71
157. Male Genital Dermatoses in HIV. 2013
Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson CF, Francis N,,
Dinneen M & Bunker CB
STI & AIDS World Congress,
International Society for Sexually Transmitted Diseases Research (ISSTDR),
International Union against Sexually Transmitted Infections (IUSTI), Vienna
158. HPV in non-melanoma skin cancer/pre-cancer in HIV. 2013
Goolamali SI, Mladkova N, Purdie KJ, Shim, TN, de Koning MN, Quint WG, Francis N, Morar N,
Meys R, Harwood CA, & Bunker CB.
5th Blizard Institute HIV Symposium, Barts and The London, London
159. Male genital lichen sclerosus and filaggrin. 2014
Shim TN, Brown SJ, Campbell LE, Francis N, Dinneen M, Hawkins D, Muneer, A, Minhas S,
Freeman A, McLean WHI & Bunker CB.
British Association of Dermatologists, Glasgow
160. Cables 1, male genital lichen sclerosus and penile cancer. 2014
Shim TN, Francis N, Peston D, Phan S, Minhas S, Nuneer A, Dinneen M, Freeman A & Bunker CB.
British Association of Dermatologists, Glasgow
161. A case series of pyoderma gangrenosusm after deep inferior epigastric perforator-flap breast reconstruction. 2014
J Simpson, P Harris, G Stamp, S James, C Bunker & L Fearfield.
British Association of Dermatologists, Glasgow
163. Human leucocyte antigen and human papilloma virus in male genital lichen sclerosus, penile precancer 2014
and penile cancer.
Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C,
Muneer A, Minhas S, De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB..
World Congress on Cancer of the Skin, Edinburgh
Scholarship winner and plenary presentation
161. Prevalence of human papillomavirus in male genital lichen sclerosus, penile carcinoma in situ and 2014
penile carcinoma: correlation with p16INK4a status.
Shim TN, de Koning MN, Gollamali SI Meys R, Francis N, Jameson C, Freeman A, Dinneen M, Minhas S,
Muneer A, Purdie KJ, Harwood CA & Bunker CB.
World Congress on Cancer of the Skin, Edinburgh
162. Immunosuppression, human papilloma virus and Merkel cell polyomavirus in male genital lichen sclerosus, 2014
penile precancer and penile cancer.
Shim TN, Goolamali SI, Francis N, Dinneen M, Muneer A, Minhas S, Freeman A, Jameson C, Purdie KJ,
Harwood CA & Bunker CB.
World Congress on Cancer of the Skin, Edinburgh
163. Human papillomavirus (HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. 2014
Goolamali SI, Shim T, Purdie K, Mladkova N, Francis N, Harwood CA & Bunker CB.
European Society for Dermatological Research, Copenhagen
164. A rare case of colocalisation between lichen planus and vitiligo. 2015
Kravvas G, Veitch, D & Bunker CB.
American Academy of Dermatology, San Francisco
165. Dermatological manifestations of syphilis. 2015
Noy M, Bunker CB, Fuller C, Shelley J, Weir J, & Fearfield L.
British Association of Dermatologists, Manchester
166. Immunogenetics of non-melanoma skin cancer/pre-cancer in HIV. 2015
Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch F, Harwood CA & Bunker CB
72
European Society for Dermatological Research, Rotterdam
167. Obesity related lichen sclerosus and bariatrics. 2015
Doiron P & Bunker CB.
European Academy of Dermatology and Venereology, Copenhagen
168. Cutaneous tuberculosis and HIV coinfection: a case series. 2016
Fitzgerald M, Bunker CB, Pozniak A & Morar N.
British Society for Skin Care in Immunocompromised Individuals,
British Association of Dermatologists, Birmingham
169. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. 2016
Goolamali, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F,.Gotch FM, Marsh SGE,
Harwood CA & Bunker CB.
European Academy of Dermatology and Venereology, Vienna
170. The diagnosis and management of male genital lichen sclerosus and penile intraepithelial neoplasia: 2016
Audit of 374 patients
Kravvas G, Shim T, Doiron PR, Freeman A, Muneer A, Dinneen M, Francis N & Bunker CB
European Academy of Dermatology and Venereology, Vienna
171. Human papilloma virus (HPV) in non-melanoma skin cancer/pre-cancer in HIV. 2016
Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MNC, Quint WGV, Francis N, Morar N,
Meys R, Harwood CA & Bunker CB.
British Skin Foundation, Skin Deep: 20 Years of Research, London
172. Human papilloma virus (HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. 2016
Goolamali SI, Shim TN, Purdie KJ, Mladkova N, Francis N, Harwood CA & Bunker CB
British Skin Foundation, Skin Deep: 20 Years of Research, London
173. Immunogenetics of non-melanoma skin cancer /pre-cancer in HIV. 2016
Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE,
Harwood CA & Bunker CB.
British Skin Foundation, Skin Deep: 20 Years of Research, London
174. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. 2016
Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE,
Harwood CA & Bunker CB.
British Skin Foundation, Skin Deep: 20 Years of Research, London
175. The balanopreputial mycobiome in health and disease: male genital lichen sclerosus. 2018
Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker.
British Society for Investigative Dermatology, London
176. The Balanopreputial Microbiome in Male Genital Lichen Sclerosus. 2018
Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker.
International Investigative Dermatology, Orlando
177. Circumcision is not always curative in male genital lichen sclerosus 2018
M Shah, RE Watchorn & CB Bunker
British Association of Dermatologists, Edinburgh
73
CLINICAL CASES PRESENTED AT MEETINGS:
1. Digitate dermatosis, St. John’s Hospital Dermatological Society 1986
2. Erythrokeratoderma variabilis, Royal Society of Medicine 1986
3. True histiocytic lymphoma, Royal Society of Medicine 1986
4. Pseudoporphyria cutanea tarda, St. John’s Hospital Dermatological Society 1986
5. Cock’s peculiar tumour, Royal Society of Medicine 1987
6. Granulomatous cheilitis and Crohn’s disease, St. John’s Hospital Dermatological Society 1988
7. Giant cell arteritis and SLE, British Association of Dermatologists, The Royal Free Hospital, London 1988
8. HTLV-1 associated ATLL: indolent cutaneous prodrome, Royal Society of Medicine 1988
9. Familial localised scleroderma, telangiectasia, and cytogenetic abnormalities, Royal Society of Medicine 1989
10. HTLV-1 associé au lymphome/leucémie de l’adulte: prodrome cutané peu évolutif. 1989
British Association of Dermatologists, Cambridge
11. Cock’s peculiar tumour, European Academy of Dermatology and Venereology, Florence 1989
12. HTLV-1/ATLL: indolent prodrome, European Academy of Dermatology and Venereology, Florence 1989
13. Cock’s peculiar tumour, American Academy of Dermatology, San Francisco 1989
14. Eyelid lesions and Histiocytosis X (Langerhans-cell histiocytosis), Royal Society of Medicine 1990
15. Eyelid lesions and Histiocytosis X (Langerhans-cell histiocytosis), 1990
American Academy of Dermatology, Atlanta
16. Morphoea and mononeuritis multiplex (with Drs Dowd and Goldsmith) 1990
American Academy of Dermatology, Atlanta
17. Wegener’s granulomatosis, Royal Society of Medicine 1990
18. Scleredema of Buschke, Royal Society of Medicine 1991
19. Neuro-Behçets disease, Royal Society of Medicine 1991
20. Erythrokeratoderma variabilis, British Association of Dermatologists, The Royal London Hospital 1991
21. Granulomatous cheilitis (Crohn’s), British Association of Dermatologists, The Royal London Hospital 1991
22. Scleredema of Buschke, British Association of Dermatologists, The Royal London Hospital 1991
23. Irritant contact dermatitis due to water (with Dr P Goldsmith) 1991
British Association of Dermatologists, The Royal London Hospital
24. Paget’s disease of the scrotum (by Dr A Bewley), St. John’s Hospital Dermatological Society 1992
25. Paget’s disease of the scrotum (by Dr A Bewley, with Dr R. Staughton), Royal Society of Medicine 1992
26. Trichorrhexis nodosa (by Dr J Ross), St. John’s Hospital Dermatological Society 1992
74
27. Cholesterol emboli (by Dr J Ross), Royal Society of Medicine 1993
28. Epidermolysis bullosa acquisita (by Dr R Yu), St. John’s Hospital Dermatological Society 1993
29. Synthetic fibre hair transplant (by Dr J Ross), St. John’s Hospital Dermatological Society 1994
30. Venous vascular malformation (by Dr A Farrell), St. John’s Hospital Dermatological Society 1994
31. Cronkite Canada syndrome (by Dr C Gooptu), Royal Society of Medicine 1994
32. Scleredema diabeticorum (by Dr A Farrell), Royal Society of Medicine 1994
33. Merkel cell carcinoma (by Dr C Gooptu), Royal Society of Medicine 1994
34. Acquired Ichthyosis and Leiomyosarcoma (by Dr A Farrell), Royal Society of Medicine 1994
35. Multiple pilomatrixomas, dystrophia myotonica and AIDS (by Dr A Farrell), Royal Society of Medicine 1994
36. Staphylococcal scalded skin syndrome in HIV (by Dr A Farrell), Royal Society of Medicine 1994
37. Pyoderma gangrenosum of the penis (by Dr A Farrell), Royal Society of Medicine 1995
38. Eosinophilic fasciitis (by Dr A Farrell), Royal Society of Medicine 1995
39. Meningococcal septicaemia with extensive skin necrosis, Royal Society of Medicine 1995
40. Pyoderma gangrenosum /Takayashu’s arteritis 1995
(by Dr J Ross, with Dr R Staughton), Royal Society of Medicine
41. Degos Disease (by Dr A Farrell), Royal Society of Medicine 1995
42. A military bite (by Dr A Farrell, with Dr J Cream), Royal Society of Medicine 1995
43. Aquagenic urticaria and HIV (by Dr L Fearfield), Royal Society of Medicine 1996
44. Hansen’s disease presenting as erysipelas, Royal Society of Medicine 1997
(by Dr G Osborne, with Dr P Easterbrook),
45. Familial cutaneous leiomyoma and uterine leiomyoma, Royal Society of Medicine 1997
(by Dr L Fearfield with Dr R Staughton)
46. Angioimmunoblastic lymphadenopathy/dysproteinaemia (by Dr L Fearfield), Royal Society of Medicine 1997
47. Cutaneous CMV in AIDS mimicking nodular prurigo (by Dr E.Mallon), Royal Society of Medicine 1997
48. Ig A pemphigus (by Dr E Mallon, with Dr P Mortimer), Royal Society of Medicine 1998
49. Chronic erosive herpes simplex of the penis in HIV following immune reconstitution in AIDS 1988
(by Dr L Fearfield) Royal Society of Medicine
50. Dermatomyositis associated with carcinoma of the bladder (by Dr E Mallon), Royal Society of Medicine 1997
51. Reticular erythematous mucinosis in HIV, Royal Society of Medicine 1998
(by Dr R Morris-Jones, with Dr R Staughton)
75
52. Phimosis and stridor due to Kaposi’s sarcoma (by Dr R Morris-Jones), Royal Society of Medicine 1998
53. Sinus histiocytosis with massive lymphadenopathy/Rosai-Dorfman Disease, Royal Society of Medicine 1998
(by Dr S.Grabcyznska)
54. Zosteriform metastasis of SCC in HIV (by Dr L Fearfield), Royal Society of Medicine 1999
55. Verrucous lupus erythematosus (by Dr O O’Gorman-Laylor), St. John’s Hospital Dermatological Society 1999
56. Buschke-Lowenstein tumour of the penis (by Dr O O’Gorman-Lalor), Royal Society of Medicine 1999
57. Granulomatous CTCL (by Dr L Fearfield), Royal Society of Medicine 2000
58. Leukaemia cutis- response to UVB (by Dr W Porter). Royal Society of Medicine 2000
59. Reticular erythematous mucinosis (by Dr R Sidwell). St. John’s Dermatological Society 2000
60. Granuloma faciale (by Dr S Dawe, with Dr R Staughton). St. John’s Dermatological Society 2000
61. Anorexia, alcohol, eczema and poliosis (by Dr S Simpson-Dent). Royal Society of Medicine 2000
62. Common variable immunodeficiency (by Dr R. Sidwell ) Royal Society of Medicine 2000
63. Metastatic squamous carcinoma following excessive sunbed exposure (by Dr K Agnew) 2000 Royal Society of Medicine
64. Follicular mucinosis/conglobate acne - A case for diagnosis (by Dr S Dawe) Royal Society of Medicine 2000
65. ?IFAP (ichthyosis follicularis with alopecia and photophobia - A case for diagnosis (by Dr K Agnew) 2001
Royal Society of Medicine
66. Non-venereal sclerosing lymphangitis of the penis (by Dr J Jones). Royal Society of Medicine 2001
67. Case for diagnosis: ? acne in HIV. (by Dr S Hunt with Dr R Staughton). Royal Society of Medicine 2001
68. The cutaneous side effects of cetuximab (by Dr S Hunt). Royal Society of Medicine 2002
69. Epidermodysplasia verruciformis-like eruption with HIV (by Dr S Davison). Royal Society of Medicine 2002
70. Severe acneiform folliculitis and HIV (by Dr S Hunt). Royal Society of Medicine 2002
71. Anogenital in situ /frank carcinoma in monozyotic twins with SLE (by Dr K Agnew) 2002
Royal Society of Medicine
72. Toxic Epidermal Necrolysis treated with Human Iv Ig (by Dr N Lomax with Drs F Vega-Lopez & R Yu) 2002
Royal Society of Medicine
73. Delayed persistent and recurrent cutaneous reactions to jellyfish sting (by Dr P-A Phan). 2002
St. John’s Hospital Dermatological Society
74. Severe multifocal anogenital epithelial neoplasia in HIV (by Dr K Agnew). Royal Society of Medicine 2003
75. Cutaneous CMV immune restoration disease in HIV (by Dr S Riaz). Royal Society of Medicine 2003
76. Divided naevus of the penis (by Dr P-A Phan). Royal Society of Medicine 2003
76
77. Spontaneous regression of extramammary Paget’s disease after excision or underlying inguinal apocrine 2004
carcinoma (by Dr. J. Bowling). Royal Society of Medicine
78. A new cutaneous polyposis syndrome: response to acitretin (by Dr. N. Heaton). Royal Society of Medicine 2004
79. Solitary anogenital xanthogranulomas (by Dr. J. Bowling). Royal Society of Medicine 2004
80. Subcutaneous granuloma annulare of the penis in two adolescents (by Dr. R. Sidwell). 2004
American Academy of Dermatology, Washington DC
81. Dorsal perforation of the prepuce (with Dr H. Malhomme). Royal Society of Medicine 2004
82. Pyoderma gangrenosum of the penis treated with topical tacrolimus (by Dr. A. Lally, with Dr N Turner). 2005
British Association of Dermatologists
83. Necrolytic migratory erythema due to glucagonoma. (by Dr. N. Attard). Royal Society of Medicine 2005
84. Metastatic medulloblastoma. (by Dr. E. Topham). Royal Society of Medicine 2005
85. Cutaneous lupus erythematosus in HIV infection: 2005
minocycline-induced or immune restoration disease (IRD)? (by Dr S Goolamali)
Royal Society of Medicine
86. Herpes simplex scrotal immune reconstitution disease treated with imiquimod (by Dr E. Edmonds) 2005
Royal Society of Medicine.
87. Angiokeratoma circumscriptum of the penis (by Dr. M. Saha). 2005
Royal Society of Medicine.
88. Mycobacterium chelonae after facelift surgery. (by Dr. M. Saha, with Mr. L Ion). 2006
Royal Society of Medicine .
89. Progesterone Dermatitis due to Mirena coil (by Dr. A. Roberts). 2006
St. John’s Hospital Dermatological Society
90. Eccrine poroma (by Dr. S. Henna). St. John ‘s Hospital Dermatological Society. 2006
91. Saxaphone penis (by Dr. M. Saha). St. John’s Hospital Dermatological Society. 2006
92. Cutaneous side effects of herceptin (by Dr. Ophelia Veraitch). 2006
St. John’s Hospital Dermatological Society
93. Acute erosive dermatosis: ? factitious (by Dr. Rubetta Matin, with Dr. J. Cream). 2006
St. John’s Hospital Dermatological Society
94. 3H Syndrome and TEN. (by Dr. A Chapman, with Dr. S. Mayou). Royal Society of Medicine 2006
95. Cock’s Peculiar Tumour. (by Dr. J Jones). Royal Society of Medicine 2006
96. Aneurysmal fibrous histiocytoma of the earlobe. (by Dr. WC Chan) Royal Society of Medicine 2007
97. HTLV-1 associated Adult T cell leukaemia-lymphoma. (by Dr. R Patalay, with Dr. S. Whittaker) 2007
Royal Society of Medicine
98. Penile lymphoedema in association with occult Crohn’s disease (by Dr. M Saha) 2007
Royal Society of Medicine
77
99. Juvenile Hyaline Fibromatosis. (by Dr. R Sidwell, with Prof M Pope) 2007
Royal Society of Medicine
100. Sarcoidosis in HIV Infection. (by Dr A Roberts, with Dr N Morar and Dr. R Staughton) 2007
Royal Society of Medicine
101. Chronic lymphoedema complicated by septic arthritis (by Dr W. C Chan). 2007
Royal Society of Medicine
102. Penile acne, pili incarnarti and dermatitis artefacta (by Dr. Ien Chan). 2007
St. John’s Hospital Dermatological Society
103. Mycobacteria chelonie following surgery for polyostotic fibrous dysplasia (by Dr. Priya Dewan). 2007
St. John’s Dermatological Society
104. Pityriasis rubra pilaris with Murray Williams warts (with Dr. Ien Chan). 2007
St. John’s Hospital Dermatological Society.
105. Extensive Squamous Cell Carcinoma of the Scalp Complicating Radiodermatitis 2007
(by Dr. C. Macedo and with Mr. N. Kirkpatrick)
Royal Society of Medicine
106. Bloom Syndrome. (by Dr. T. Basu with Dr. R. Eeles) 2007
Royal Society of Medicine
107. Angiolymphoid hyperplasia with eosinophilia of the penis. (by Dr. P.Dewan) 2007
Royal Society of Medicine
108. Trichophyton erinacei kerion barbae. (by Dr. Ien Chan) 2007
Royal Society of Medicine
109. Foreign body reaction following silicon implant rhinoplasty. (Dr. P. Dewan with Mr. Niall Kirkpatrick) 2007
Royal Society of Medicine
110. Focal acral mucinosis. (by Dr. S. Zokaie) 2008
St. Johns Hospital Dermatological Society
111. Case for diagnosis-lupus erythematosus. (by Dr. C. Macedo). 2008
St. John’s Hospital Dermatological Society
112. Giant idiopathic leg ulcer (dermatitis artefacta) . (by Dr S. Zokaie) 2008
St. John’s Hospital Dermatological Society
113. Drug associated granuloma annulare. (by Dr. M. Liew) 2008
St. John’s Hospital Dermatological Society
114. Erythrokeratoderma variabilis with onset in an adult. (by Dr. C, Macedo with Dr. R. Staughton) 2008
St. John’s Hospital Dermatological Society
115 Cryptic blistering dermatosis and lipodystrophy (by Dr S. Zokaie) 2008
St. John’s Hospital Dermatological Society
116. Cutaneous and systemic lupus erythematosus. (by Dr. E. Wedgeworth with Dr. Carullia and Dr. I. White) 2008
St. John’s Hospital Dermatological Society
117. Folliculitis decalvans. (by Dr. O. Dadzie) 2008
Royal Society of Medicine
78
118. Lentigo maligna melanoma of the face. (by Dr. C. Macedo) 2008
Masterclass in Advanced Cancer Medicine, Regent’s College, London
119. Spindle cell carcinoma of the scalp post radio exposure. (by Dr. C. Macedo) 2008
Masterclass in Advanced Cancer Medicine, Regent’s College, London
120. Carcinoma en curaisse and erysipeloides. (by Dr. C. Macedo) 2009
Royal Society of Medicine
121. Myotonic dystrophy and basal cell carcinomas. (By Dr. S Goolamali) 2009
Coincidence or true association? British Association of D.ermatologists
122. Cutaneous HPV (IRAD) in HIV. (by Dr. R. Meys) 2009
Royal Society of Medicine
123. Lues maligna and HIV. (by Dr. C. Borysiewicz) 2009
Royal Society of Medicine
124. ?Ethambutol induced epidermolysis bullosa aqisita. (by Dr. A.Tewari) 2010
Royal Society of Medicine
125. Severe acute fulminant bullous ‘exfoliative’ dermatitis due to flucloxacillin. (by Dr. N. Patel) 2010
Royal Society of Medicine
126. Melanoma of the eyelid. (by Dr. C. Macedo) 2010
Masterclass in Malignant Melanoma , London Metropolitan University, London
127. Melanoma in HIV. (by Dr. C. Macedo) 2010
Masterclass in Malignant Melanoma , London Metropolitan University, London
128. Granuloma faciale (by Dr C. Borysiewicz) 2010
St. John’s Hospital Dermatological Society
129. Reticulate hyperpigmentation in HIV: ? emtricitabine. (by Dr. A. Rao) 2010
St. John’s Hospital Dermatological Society
130. Pityriasis lichenoides acuta. (by Dr. T. Basu) 2010
St. John’s Hospital Dermatological Society
131. Sweet’s syndrome, carcinoid and myeloma: a long prodrome 2010
Royal Society of Medicine
132. Pityriasis lichenoides acuta treated with mycophenolate. (by Dr. T. Basu) 2010
Royal Society of Medicine
133. Multiple primary melanomas. (with Dr. L. Fearfield, by Dr A. Rao) 2010
Royal Society of Medicine
134. Unilateral nevoid telangectasia in pregnancy. (by Dr. T. Maruthappa) 2010
St. John’s Hospital Dermatological Society
135. Unilateral neuropathic pruritus. (by Dr. A. Chandrakumar) 2010
St. John’s Hospital Dermatological Society
136. Nekam’s disease. (by Dr. N. Patel) 2011
St. John’s Hospital Dermatological Society
79
137. Case for Diagnosis: ?syringotropic CTCL. (by Dr A. Chandrakumar) 2011
St. John’s Hospital Dermatological Society
138. Punctate palmoplantar keratoderma. (by Dr. C. Borysiewicz) 2011
St. John’s Hospital Dermatological Society
139. Acrodermatitis chronica atrophicans. 2011
St. John’s Hospital Dermatological Society
140. Vertically acquired HIV and epidermodysplasia verruciformis. (with Prof R. Miller, by Dr. R. Meys) 2011
St. John’s Hospital Dermatological Society
141. Adamantinoid trichoblastoma. (by Dr. T. Maruthappu) 2011
Royal Society of Medicine
142. Chronic erosive verrucous HSV in CLL. (by Dr. T. Shim) 2011
Royal Society of Medicine
143. Primary cutaneous amyloidosis of the penis. (with Dr. W. Porter by Dr. E. Merika) 2012
Royal Society of Medicine
144. Penile melanoma in a patient with lichen sclerosus. (by Dr. N. Turnbull) 2012
Royal Society of Medicine
145. Eccrine carcinoma of the scrotum and metastatic extramammary Paget’s disease. 2012
(with Drs. C. Macedo and L. Fearfield by Dr. R. Sinha)
Royal Society of Medicine
146. Case for diagnosis/facial psoriasis. (by Dr. A. Chandrakumar) 2012
St. John’s Hospital Dermatological Society
147. ?Granulomatous rosacea-in HIV and post-blepharoplasty. (with Dr N. Morar by Dr A. Scott) 2012
St. John’s Hospital Dermatological Society
148. X-linked gammaglobulinaemia and a chronic unilateral leg ulcer. (with Dr N. Morar by Dr R. Sinha) 2012
Royal Society of Medicine
149. Chronic erosive and verrucous herpes simplex of the penis in in chronic lymphocytic leukaemia. 2012
(by Dr T.Shim and wit.h Mr A. Muneer)
British Society for Skin Care in Immunocompromised Individuals,
British Association of Dermatologists, Birmingham
150. Giant condyloma of the penis. (by Dr T. Shim, with Mr. S. Minhas) 2012
British Society for Male Genital Dermatology, British Association of Dermatologists, Birmingham
151. Penile amyloid. (by Dr E. Merica and with Drs P. Craig and W. Porter) 2012
British Society for Male Genital Dermatology, British Association of Dermatologists, Birmingham
152. Insterstitial granulomatous drug eruption in HIV. ? raltegravir. (by Dr. A. Scott with Dr. N. Morar) 2012
St. John’s Hospital Dermatological Society
153. Lichen sclerosus associated with perineal urethrostomy. 2013
(by Dr T. Shim, with Prof A Mundy and Ms D. Andrich)
Royal Society of Medicine
154. HTLV1 presenting with dyshidrotic eczema. (by Dr. R. Meys: SpR prize winner) 2013
Royal Society of Medicine
155. Nevoid urticaria pigmentosa. (by Dr. E. Merika with Dr. S. Singh) 2013
80
156. Acantholytic dermatosis localized of the penis. (by Dr. M-C, Wilmot with Drs. C. Perrett and E. Calonje) 2013
British Association of Dermatologists, Liverpool
157. Intense Pulsed Light (IPL) and premature ageing. (by Dr. L. Thomas) 2013
St. John’s Hospital Dermatological Society
158. Generalised essential telangectatsia. (by Dr. L. Thomas) 2013
St. John’s Hospital Dermatological Society
159. Connective tissue disease. (by Dr. N. Rouhani) 2013
St. John’s Hospital Dermatological Society
160. Pyoderma gangrenosum post deep inferior epigastric perforator-flap 2013
breast reconstruction. (by Dr J Simpson with Mr P Harris, Mr S James and Dr L Fearfield)
Royal Society of Medicine
161. Acral blistering ? due to tetrazepam. (by Dr. D. Laheru) 2014
St. John’s Hospital Dermatological Society
162. Acrodermatitis chronica atrophicans. (by Dr. D. Sandhu) 2014
St. John’s Hospital Dermatological Society
163. Folliculotropic mycosis fungoides. (by Dr. D. Sandhu) 2014
St. John’s Hospital Dermatological Society
164. Anetoderma. (by Dr. D. Sandhu) 2014
St. John’s Hospital Dermatological Society
165. Recalcitrant facial actinic dermatitis and severe Bowenoid Papulosis (by Dr. M. Noy with Dr. C. Fuller) 2014
St. John’s Hospital Dermatological Society
166. Nodular prurigo in HIV treated by thalidomide. (by Dr. M. Noy with Dr. N. Morar) 2014
St. John’s Hospital Dermatological Society
167. Penile squamous carcinoma in an elderly cirrcumcised Moslem (by Dr G. Kravvas, with others) 2015
Clinical Cases from around Europe, D3T01.2
European Academy of Dermatology and Venereology, Copenhagen
168. Facial Demodicosis (by Dr. M. Noy) 2015
St. John’s Hospital Dermatological Society
169. Obesity-related male genital lichen sclerosus (by Dr P. Doiron, with Messrs. M. Dinneen and A. Muneer) 2016
Royal Society of Medicine
170. ‘Idiopathic’ cellulitis and oedema of the penis (by Dr T. Shim) 2016
Royal Society of Medicine
171. Primary cutaneous amyloidosis of the penis (by Dr E. Merika) 2016
Royal Society of Medicine
172. An atypical case of penile carcinoma in situ (by Dr M. Noy, with Dr N. Morar and others) 2016
Royal Society of Medicine
173. Two salutary and instructive cases of penile cancer (by Dr G. Kravvas, with others) 2016
Royal Society of Medicine
174. Sebopsoriasis associated with HIV infection (by Dr T. Tull with Dr N. Morar) 2016
Royal Society of Medicine
81
175. Cutaneous tuberculosis and HIV (by Dr M. Fitzgerald, with Dr A. Pozniak) 2016
Royal Society of Medicine
176. Use of anti-TNF therapy for severe psoriasis in HIV (by Dr P. Doiron with Drs N. Morar and A. Pozniak) 2016
Royal Society of Medicine
177. Salutary cases of penis cancer: i) HIV & ii) urethral primary (by Dr P. Doiron, with Dr. H. Menagé) 2016
Royal Society of Medicine
178. Eosinophilic fasciitis (by Dr K. Heelan): Prizewinner 2016
St. John’s Hospital Dermatological Society
179. A white plaque on the glans penis: epidermal nevus (by Dr P. Doiron) 2016
St. John’s Hospital Dermatological Society
180. Lichen nitidus of the breast (with Dr S-M. Ang) 2016
St. John’s Hospital Dermatological Society
181. Destructive acneiform folliculitis in HIV 2016
St. John’s Hospital Dermatological Society
182. Pretibial myxoedema (by Dr R. Ramessur) 2016
St. John’s Hospital Dermatological Society
183. Psoriatic arthritis and vitiligo: adalimumab (by Dr S. Mounsey) 2016
St. John’s Hospital Dermatological Society
184. Sneddon-Wilkinson disease (by Dr S-L Chan) 2017
St. John’s Hospital Dermatological Society
185. Porokeratosis ptychotropica (by Dr E. Ong) 2018
Royal Society of Medicine
186. Multiple eruptive dermatofibromas in HIV (by Dr E. Panou, with Dr W. Bakkour) 2018
187. Haemorrhagic necrosis of the skin (by Dr E. Panagou, with Prof H. Cohen) 2018
188. Male genital lichen sclerosus and sensory neuropathy (by Dr N. Papalexopoulou with Dr M-C. Wilmot) 2018
St. John’s Hospital Dermatological Society
82
INVITED LECTURES:
1. Responding to Patients with Skin Problems 1986
North West Thames RHA Pharmaceutical Course, London
2. Dermatology for Chiropodists 1988
Guy’s Hospital, London
3. Psoriasis and Eczema 1991
Homerton and St Bartholomew’s Hospitals Vocational Training Scheme, London
4. The Mouth, Anus and Male Genitalia 1992
Dermatology for Genitourinary Physicians, Westminster Hospital, London
5. Tropical and Imported Dermatology 1992
Westminster Hospital Dermatology Course for GPs, London
6. Skin at the Deep End 1992
Inaugural Consultant Appointment Lecture, Westminster Medical School Old Student’s Day, London
7. Dermatology
GP Refresher Course, Westminster Hospital 1992
8. Calcitonin Gene-Related Peptide 1992
Dermatopharmacology Symposium, American Academy of Dermatology, San Francisco
9. Psoriasis - Treatment in General Practice 1993
Chelsea & Westminster Hospital Dermatology Course for GPs, London
10. Calcitonin gene-related peptide and Raynaud’s phenomenon 1993
The Skin Investigation Society (THESIS), Bristol
11. Calcitonin Gene-Related Peptide 1993
Dermatopharmacology Symposium, American Academy of Dermatology, Washington DC
12. What to cut out and what to refer. 1993
Westminster Hospital Dermatology Course for GPs, London
13. Psoriasis 1994
Westminster Hospital Dermatology Course for GPs, London
14. Lumps and Bumps. What to cut out. 1994
Chelsea & Westminster Hospital Minor Surgery course, London
15. Calcitonin Gene-Related Peptide 1995
Dermatopharmacology Symposium, American Academy of Dermatology, New Orleans
16. HIV and the Skin 1995
Inauguration of GUM Department, St Albans Hospital, St Albans
17. Indications for Surgery 1994
Chelsea & Westminster Hospital Minor Surgery course, London
18. HIV and the Skin: an Experiment of Nature: Research implications 1995
HIV and the Skin Course, Chelsea and Westminster Hospital, London
19. Penile Dermatoses 1995
83
BPMF Advanced Course in Sexually Transmitted Diseases, Chelsea and Westminster Hospital, London
20. Dermatology and Cancer 1995
Club for the Advancement of Palliative Care, St Bartholomew’s Hospital, London
21. HIV and the Skin 1995
Advanced Course in Sexually Transmitted Diseases, British Postgraduate Medical Federation, London
22. Dermatomyositis 1995
Dermatomyositis and Polymyositis Support Group, Institute of Education, London
23. Nasty Spots and Rashes 1995
Charing Cross Hospital GP Course, Postgraduate Centre, Charing Cross Hospital, London
24. Male Anogenital Skin Disease 1995
St. John’s Dermatology Centre, St Thomas’s Hospital, London
25. Nasty Spots and Rashes 1996
Charing Cross Hospital GP Course, Postgraduate Centre, Charing Cross Hospital, London
26. HIV as an experiment of nature - avenues for Skin research. 1996
HIV and The Skin Study Day, Gleeson Lecture Theatre, Chelsea & Westminster Hospital, London
27. Indications for Surgery - What should be cut out. 1996
Refresher Course for GPs, Postgraduate Medical Centre, Chelsea & Westminster Hospital, London
28. Dermatology 1997
GP Refresher Course, Postgraduate Medical Centre, Charing Cross Hospital, London
29. HIV as an experiment of nature - avenues for Skin research 1997
HIV and The Skin Study Day, HIV/GUM Education Unit, Chelsea & Westminster Hospital, London
30. Raynaud’s Phenomenon. 1997
19th International Charing Cross Symposium, London
31. Penile Dermatoses 1997
Dept. of GU Medicine, Charing Cross Hospital, London
32. HIV and the Skin 1997
Dept. of GU Medicine, Royal South Hants Hospital, Beaulieu, Hants.
33. MRCP Part II clinical examinations for SHOs - Dermatology 1997
Chelsea & Westminster Hospital, London
34. “Sorting the Skin Lumps – Which are safe, which should be removed and which referred” 1997
The Skin in Your Practice ( for General Practitioners), Chelsea & Westminster Hospital, London
35. HIV as an experiment of nature - Avenues for skin research. 1988
HIV and the Skin Course, Chelsea & Westminster Hospital, London
36. Skin Disease in the Elderly 1998
Medicine in Old Age Course, Postgraduate Education Centre, Charing Cross Hospital, London
37. Serious Rashes: Important Lumps 1998
Refresher Course for General Practitioners, Chelsea & Westminster Hospital, London
38. Dermatological Self Assessment 1998
84
GP Refresher Course, Postgraduate Education Centre, Charing Cross Hospital, London
39. HIV and the Skin 1998
Trent Region Specialist Registrar Training Day, Leicester
40. The Diagnosis of Common Skin Complaints in General Practice 1998
Postgraduate Education Centre, Charing Cross Hospital, London
41. Penile Dermatology 1999
MSc in Sexually Transmitted Disease, UCL, London
42. Epidemiology and Prognostic factors in Melanoma - Symposium on Skin Cancers for GPs 1999
Postgraduate Medical Centre, West Middlesex Hospital, London
43. HIV/Penile Dermatology 1999
Department of Dermatology, Amersham Hospital, Amersham
44. Below the Belt. Genital Dermatology (with Dr Sallie Neill) 1999
The Skin and Your Practice - GP Course, Chelsea & Westminster Hospital, London
45. Penile Dermatology 1999
Department of Dermatology, Churchill Hospital, Oxford
46. Expanding Role of the Dermatology Nurse - Consultant View. 1999
British Dermatological Nursing Group, British Association of Dermatologists, Edinburgh
47. Skin Health and Disease 1999
Medical Society, St Paul’s Girls’ School, London
48. Penile Dermatology 2000
Department of Dermatology, Kings College Hospital, London
49. Dermatology for the Urologist, 2000
Section of Urology, Royal Society of Medicine, London
50. Penile Dermatology 2000
Department of Dermatology, Addenbrooke’s Hospital, Cambridge
51. Dermatology of the Penis 2000
Department of Dermatology, NYU, New York
52. Scientific evidence and expert clinical opinion for the investigation and management 2000
of Stage II malignant melanoma. Royal College of Physicians, London
53. Penile Rashes 2000
The Skin in Your Practice - GP Course, Chelsea & Westminster Hospital, London
54. How to sort the lumps and bumps and which to refer 2000
The Skin in Your Practice - GP course, Chelsea & Westminster Hospital, London
55. Clinic visit and hands on diagnosis/Workshop 2000
The Skin in Your Practice - GP course, Chelsea & Westminster Hospital, London
56. Dermatology for the General Physician 2000
Revision Course in General Internal Medicine for SpRs, Charing Cross Hospital, London
57. Penile Skin Lesions 2000
South West Thames Regional Dermatology Meeting, St. George’s Hospital, London
85
58. Male Genital Dermatology 2000
Fifth Annual Aberdeen Dermatology Symposium, Aberdeen Royal Infirmary, Aberdeen
59. Inflammatory Skin Conditions- male 2000
Genital Skin Conditions & The Dermatology of HIV Course, Chelsea & Westminster Hospital, London
60. Prize Rarities - male. 2000
Genital Skin Conditions & The Dermatology of HIV Course, Chelsea & Westminster Hospital, London
61. Genital Dermatoses in Men 2000
Dermatology Day, Royal Pharmaceutical Society, London
62. Seminar in Oncology: Skin Cancer 2000
Royal Marsden Hospital, London
63. Drug eruptions 2001
Royal College of Physicians Teach In -Update in Dermatology, London
64. Penile Pearls 2001
Surgical Sixty Club Meeting, Charing Cross Hospital, London
65. Problems in diagnosis and management of the commoner penile dermatoses. 2001
Joint Meeting of the Section of Dermatology and the MSSVD, RSM, London
66. Dermatology for the General Physician 2001
SpR Revision Course, Charing Cross Hospital, London
67. The Diagnosis of Melanoma 2001
John Thornton Ingram Lecture,
General Internal Medicine for the Physician Course, Royal College of Physicians, London
68. Inflammatory Diseases of the Penis. 2001
European Association of Dermatovenereology – Workshop IV: perigenital dermatoses, Munich
69. Inflammatory dermatoses in the male 2001
HIV, GUM & The Skin Course, Chelsea & Westminster Hospital, London
70. Genital intraepithelial neoplasia in the male 2001
HIV, GUM & The Skin Course, Chelsea & Westminster Hospital, London
71. Prize rarities-male 2001
HIV, GUM & The Skin Course, Chelsea & Westminster Hospital, London
72. Dermatology of the Penis 2002
Pan-Thames Teaching Programme, St. John’s Institute of Dermatology, London
73. Management of Skin problems 2002
GP Refresher course, Charing Cross Hospital, London
74. Penile Dermatology 2002
HIV/GUM Dept., Royal Sussex County Hospital, Brighton
75. Dermatology Emergencies 2002
SpR Revision Course in General Medicine, Charing Cross Hospital, London
76. The normal penis and congenital abnormalities 2002
Genital Skin Conditions and the Dermatology of HIV disease. Chelsea & Westminster Hospital, London
77. Inflammatory skin conditions – male 2002
86
Genital Skin Conditions and the Dermatology of HIV disease. Chelsea & Westminster Hospital, London
78. Penile intraepithelial neoplasia: diagnosis and medical management 2002
Genital Skin Conditions and the Dermatology of HIV disease. Chelsea & Westminster Hospital, London
79. Prize rarities: male 2002
Genital Skin Conditions and the Dermatology of HIV disease. Chelsea & Westminster Hospital, London
80. Update on Penile Cancer: suspicious dermatoses– diagnosis and treatment 2003
British Association of Urological Surgeons, Manchester
81. Male genital dermatology 2003
Department of Dermatology, Hope Hospital, Manchester
82. Male genital dermatology 2003
Medical Society for the Study of Venereal Diseases, Non-consultant career grade conference
Loughborough University
83. Pitfalls in the diagnosis of cancer of the penis 2004
Indian Association of Dermatology, Venereology and Leprosy, Mumbai, India
84. Pitfalls in the diagnosis of cancer of the penis 2004
Chandigarh, India
85. The diagnosis of melanoma 2004
Chandigarh, India
86. Penis pre-cancer 2004
St John’s Hospital Dermatological Society, London
87. Male genital dermatology 2004
Current Issues in Sexual & Reproductive Health, Margaret Pyke Memorial Trust, London
88. The dysfunctional foreskin 2004
Dermatovenereology Focus Session, British Association of Dermatologists, Belfast
89. Penile rashes 2004
Primary Care Dermatology Society Lecture, Birmingham
90. Male genital dermatoses 2004
West Scotland Regional meeting, Glasgow
91. The dysfunctional foreskin 2004
Workshop 21. Male Genital Dermatology, European Association of Dermatovenereology, Florence
92. Lumps and Bumps 2005
GP Vocational Training Scheme, Chelsea & Westminster Hospital
93. Lesions of the penis.
British Association of Urological Surgeons, Section of Oncology Educational Meeting, London, 2005
94. The SAC Perspective, BAD Training Day (Feb) 2005
British Association of Dermatologists, London
95. The SAC Perspective, BAD Training Day (Mar) 2005
British Association of Dermatologists, London
96. Perianal Dermatology 2005
Primary Care Dermatology Society Meeting, Cambridge
87
97. Penile Dermatoses 2005
Registrars Training Day, BAD.
98. ‘Bottoms up’ – male ano-genital dermatology – diagnosis and management 2005
The skin in your practice GP course, Chelsea & Westminster Hospital
97. The Dysfunctional Foreskin 2005
Symposium S16 – Penile Dermatoses, European Association of Dermatovenereology, London
98. Male Genital Dermatology 2005
West Yorkshire Regional Dermatology Meeting, Leeds
99. The Normal penis and Dysfunctional Foreskin 2005
Genital Skin Conditions and the Dermatology of HIV Disease, Chelsea & Westminster Hospital
100. Penile intraepithelial neoplasia 2005
Genital Skin Conditions and the Dermatology of HIV Disease, Chelsea & Westminster Hospital
101. Hidden Secrets, Genital Dermatoses – Penile lesions 2006
Urology Section, Royal Society of Medicine, London
102. Penile Dermatology – an overview 2006
South East Thames GUM/Dermatology Alliance, Maidstone
103. Male Genital Dermatology and Precancerous Dermatoses 2006
British Association of Urological Surgeons, Penis Cancer Teaching Course, Manchester
104. MMC and Training-the Future 2006
Education on Education, British Association of Dermatologists, Manchester
105. Competency Assessments Feedback 2006
British Association of Dermatologists, London
106. Bottoms up – male anogenital dermatology – diagnosis and management 2006
Skin in your Practice, Chelsea & Westminster Hospital
107. Getting Your Hands on a Penis 2006
St John’s Hospital Dermatological Society, Presidential Vignette, London
108. Penile Carcinoma in Situ 2007
Indian Association of Dermatology, Venereology and Leprosy, Dermacom, Chennai, India
109. Non-venereal infections of the the penis 2007
American Academy of Dermatology, Washington, D.C.
110. Male Genital Dermatology 2007
Department of Dermatology, Boston University School of Medicine, Boston
111. Penile carcinoma in situ 2007
Causation and management of penile cancer. Joint Urology/Dermatology Sections, RSM, London
112. The Dysfunctional Foreskin 2007
Special Presidential Lecture, Noah Worcester Dermatological Society, London
113. Male Genital Dermatology 2007
Scottish Dermatology Association, Dunfermline
114. ‘His and Hers’: Genital Dermatology (with Dr S Neill) 2007
88
British Association of Dermatologists, Birmingham
115. HIV and the Skin 2007
Primary Care Dermatology Society, Bristol
116. Male Genital Dermatology Masterclass 2007
Primary Care Dermatology Society, Bristol
117. Deerstalking in Scotland 2007
Presidential Address, West London Medicochirurgical Society, London
118. The Normal Penis and the Dysfunctional Foreskin 2007
Dermatology in Genitourinay & HIV Medicine Course, Chelsea & Westminster Hospital
119. Penile Intraepithelial Neoplasia: diagnosis and management. 2007
Dermatology in Genitourinay & HIV Medicine Course, Chelsea & Westminster Hospital
120. CGRP in Raynaud’s Phenomenon and other Projects. ‘Festschrift’: Professor Pauline M Dowd 2007
Royal Society of Medicine
121 ‘Festschrift’. Dr Richard Staughton 2007
Chelsea & Westminster Hospital
12. The pathogenesis of male genital lichen sclerosus. 2008
Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chandigarh
123. Preancerous Dermatoses of the Penis and penile carcinoma in situ. 2008
BAUS Section of Oncology, Spring Training Meeting, Leicester
124. Penile Dermatoses. 2008
BAD SpR Training Event, Windsor
125. Dermatoses affecting the male genitalia. 2008
Clinical Dermatology Update Programme, Manchester
126 Pathomechanisms: Male Genital Lichen Sclerosus, Malignant Melanoma, and HPV IRAD in HIV. 2008
Dermatology Lunchtime Seminar Series, St. John’s Institute of Dermatology, KCL, London
(with Drs Singh and Meys)
127. Common clinical errors in the management of malignant melanoma. 2008
UK KEY ADVANCES IN CLINICAL PRACTICE SERIES (2008):
Key Advances in the Effective Management of Malignant Melanoma. 2nd National Update, London
128. Masterclass in Advanced Cancer Medicine-Skin Cancers 2008
Panellist and Case presentations (with Dr. C. Macedo)
129. The Normal Penis and the Dysfunctional Foreskin 2008
Dermatology in Genitourinay & HIV Medicine Course, Chelsea & Westminster Hospital
130. Penile Intraepithelial Neoplasia: diagnosis and management. 2008
Dermatology in Genitourinay & HIV Medicine Course, Chelsea & Westminster Hospital
131. Male Genital Dermatoses. 2008
Kuwaiti Dermatology Association, Kuwait
132. Topics in the Diagnosis & Management of Malignant Melanoma 2009
Primary Care Dermatology Society of Ireland, Dublin
133. Perianal Dermatology 2009
89
Primary Care Dermatology Society of Ireland, Dublin
134. Male Genital Dermatology/The Dysfunctional Foreskin 2009
Sexuality and Sexual Health Section, Royal Society of Medicine, London
135. The Dysfunctional Foreskin 2009
Advanced Medical Dermatology Symposium S011, American Academy of Dermatology
San Francisco
136. A Practical Approach to Penile Skin. 2009
Colposcopy and Genital Dermatosis Special Interest Group. British Association for Sexual Health and HIV
London
137. Male Genital Dermatology 2009
Solent Skin Society, Winchester
138. HIV Dermatology: Current Issues 2009
International Society of Dermatology, Prague
139. Male Genital Dermatology 2009
Section of Dermatology, Royal Academy of Medicine in Ireland, Dublin
140. Male Genital Dermatology, 2009
Primary Care Dermatology Society, Scottish Meeting, St. Andrews
141. HIV and Dermatology: Current issues. 2009
HIV and Dermatology Virtual Clinic Meeting (Gilead), St. Stephen’s Club, London
142. Male Genital Dermatology 2009
St John’s Institute of Dermatology, MSc Course, London
143. Perianal Dermatology 2009
St John’s Institute of Dermatology, MSc Course, London
144. HIV Dermatology: Current Issues 2009
Maadi Military Hospital, Cairo
145. Male Genital Dermatology 2010
Maadi Military Hospital, Cairo
146. Male Genital Dermatology 2010
Pan-Thames, GUM/HIV Spr Training Day, Medical Society of London
147. Masterclass in Advanced Cancer Medicine-Skin Cancers 2010
Panellist and Case presentations (with Dr. C. Macedo)
148. HIV Dermatology: Current Issues 2010
St John’s Institute of Dermatology, SpR Training, London
149. HIV Dermatology: Current Issues from London 2010
HIV Symposium SO 17, American Academy of Dermatology, Miami Beach
150. Ethical Issues in Private Practice in Dermatology 2010
British Association of Dermatologists, London
151. Skin at the Deep End 2010
Dowling Oration, Lincoln
152. The Dysfunctional Foreskin 2010
90
American Dermatological Association, New York
153. Impact of ARVT on HIV Dermatology 2010
EADV, Gothenburg
154. Lichen Sclerosus and Carcinoma in Situ of the Genitalia: His and Hers (with Dr Sallie Neill) 2010
EADV, Gothenburg
155. Male Genital Dermatology 2010
Sharm Derma, Sharm El Sheikh, Egypt
156. HIV Dermatology: Current Issues, 2010
Sharm Derma, Sharm El Sheikh, Egypt
157. Male Genital Dermatology and the Impact on Sexual and Urinary Function 2010
European Society for Sexual Medicine, Malaga
158. Melanoma in the 21st Century: Why This Disease is Important for All Physicians 2010
Royal College of Physicians Regional Lecture
South West Regional Update, Taunton
159. HIV and the Skin 2010
British Association of Dermatologists & St John’s Hospital Dermatology Society
Annual UK Consultants Course, London
160. HIV Dermatology in the 21st Century: Neil Smith memorial lecture 2011
St John’s Hospital Dermatological Society
161. Male Genital Dermatology 2011
6th Annual GPSI Meeting, Leeds
162. The Immunocompromised Patient in Dermatology 2011
Primary Care Dermatology Society of Ireland, Galway
163. Dermatological Signs in Internal Malignancy 2011
Primary Care Dermatology Society of Ireland, Galway
164. HIV and the Skin: 2011 2011
Current Issues in Sexual Health 2011: 3rd National Conference, London
165. The Dysfunctional Foreskin and Penis Pre-cancer 2011
UCLH Penile Cancer Day
166. Male Genital Dermatology: from Dyspareunia to Penis Cancer 2011
VII All-Russian Congress “Men’s Health”, Rostov-on-Don
167. Melanoma 2011
GP Seminar, UCLH, London
168. Male Genital Dermatology: The Dysfunctional Foreskin and Penis pre cancer and Cancer 2011
British Association of Urological Surgeons, Liverpool
169. Skin and HIV 2011
BASHH HIV Focus Meeting, RSM, London
170. Genital and Oral Lesions-Whats your Diagnosis? (with Drs Setterfield, Neil and Pelisse 2011
EADV, Lisbon
171. Penile Dermatoses 2011
91
1st BASHH Genital Dermatology Course, London
172. Penile Dermatoses and their Management 2011
British Association of Dermatologists & St John’s Hospital Dermatology Society
Annual UK Consultants Course, London
173. Melanoma: Why This Disease is Important for All Physicians 2011
Eastern Mediterranean Seminar on General Medicine,
Medical Royal Colleges Association, Limassol, Cyprus
174. HIV Dermatology post HAART 2011
Eastern Mediterranean Seminar on General Medicine,
Medical Royal Colleges Association, Limassol, Cyprus
175. Emergency Dermatology 2011
Eastern Mediterranean Seminar on General Medicine,
Medical Royal Colleges Association, Limassol, Cyprus
176. HIV Dermatology in the Era of HAART 2011
ASICON, Lucknow
177. Lichen Sclerosus and Penis Cancer 2011
AIIMS, New Delhi
178. Male Genital Dermatology 2011
Eropean Society for Sexual Medicine, Milan
179. Pathogenesis of Male Genital Lichen Sclerosus 2012
Dermacon 2012, Jaipur
180. Male Genital Dermatology 2012
Ulster Dermatological Society, Craigavon
181. Male Genital Dermatology 2012
European Association of Urology, Paris
182. Male Genital Lichen Sclerosus 2012
Male Gential Dermatology and Oral Dermatology: the fundamentals
University of Hertfordshire, Hatfield
183. What does the Dermatologist expect from the Pathologist in Penile Pathology? 2012
Selected Aspects of Genital Dermatopathology,: 19th Update in Dermatopathology
St Johns’s Institute of Dermatology, London.
184. Male Genital Dermatology: from Dyspareunia to Penis Cancer 2012
Astellas ‘Seven Wonders of the Skin’, London
185. From Dyspareunia to Penis Cancer: Male Genital Dermatology 2012
Hampstead Medical Society, London
186. Male Genital Dermatology 2012
St John’s Institute of Dermatology, MSc Course, London
186. New Healthcare Providers stepping into Dermatology: Reorganisation of the NHS 2012
International League of Dermatological Societies, 1st Dermatology Summit. Berlin
188. Penis Cancer: An Unnecessary Disease 2012
EADV, Verona
92
189. Lichen Sclerosus and Lichen Planus (Male) 2012
Ano-Genital and Mucosal Dermatology Course, St Thomas’ Hospital
190. The Aetiopathogenesis and Medical Management of Male Genital Lichen Sclerosus 2012
British Association of Urological Surgeons, Glasgow
191. Male Genital Dermatology 2012
British Association of Dermatologists, Trainee session, Birmingham
192. The Pathogenesis of Male Genital Lichen Sclerosus 2012
British Association of Dermatologists, Professors & Registrars Forum, Birmingham
193. Presidents Address 2012
British Association of Dermatologists, Birmingham
194. HIV Dermatology Post HAART 2012
International Medical Meeting, Riga
195. The Dysfunctional Foreskin: from Dyspareunia to Penis Cancer 2012
BASHH SAS Conference, Loughborough
196. HIV Dermatology in the 21st Century 2012
SAS Clinical Update Meeting, Manchester
197. HIV and the Skin 2012
BAD SpR Training Event, London
198. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2012
2nd BASHH Genital Dermatology Course, London
199. Male Genital Dermatology 2012
Eropean Society for Sexual Medicine, Amsterdam (in absentia: snow)
200. HIV Dermatology in the Era of HAART 2013
Astellas ‘Seven Wonders of the Skin’, London
201. Male Genital Lichen Sclerosus 2013
St John’s Registrar Teaching, London
202. Penis Pre-Cancer and Carcinoma in Situ 2013
British Association of Dermatologists Non-Melanoma Skin Cancer Update
Royal College of Physicians, London
203. HIV Dermatology post HAART; Current Issues 2013
World Congress of Dermatology Vancouver 2015 Preview
American Academy of Dermatology, Miami Beach
204. Male Genital Lichen Sclerosus 2013
Male Gential Dermatology and Oral Dermatology, University of Hertfordshire, Hatfield
205. Dr Robin Graham-Brown and the BAD/BSF 2013
Festschrift, Midlands Dermatological Society, Leicester
206. HIV Dermatology in the Era of ARVT 2013
Guest Lecture, British Society for Skin Care in Immunocompromised Individuals, Liverpool
207. London EADV Spring Symposium 2015: British Bid 2013
EADV Board, European Academy of Dermatology & Venereology, Istanbul
93
208. Aetiopathogenesis and Management of Male Genital Lichen Sclerosus 2013
European Academy of Dermatology & Venereology, Istanbul
209. Malignant Melanoma Pitfalls 2013
Clinical Dermatology Update Meeting, SAS Doctors, Manchester
210. The Dysfunctional Foreskin-from dyspareunia to penis cancer 2013
Baltic Association of Dermatovenereologists, Kaunas
211. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2013
3rd BASHH Genital Dermatology Course, London
212. HIV Dermatology 2013
Primary Care Dermatology Society, Edinburgh
213. Perianal and Penile Dermatology 2013
Primary Care Dermatology Society, Edinburgh
214. The Aetipathogenesis and Management of Male Genital Lichen Sclerosus 2013
International Congress of Dermatology and Dermacon, New Delhi
215. HIV Dermatology post cART 2014
European Dermatology Forum, Bern
216. Lichen Sclerosus in Men
Male Gential Dermatology and Oral Dermatology, University of Hertfordshire, Hatfield 2014
217. Crisis in Dermatology: Happy Birthday PCDS 2014
Primary Care Dermatology Society, Kenilworth
218. A Different Perspective: Male Genital Lichen Sclerosus 2014
British Society for the Study of Vulval Disease, Glasgow
219. Selected Topics in Male Genital Dermatology 2014
Registrar Training Day, Australasian College of Dermatologists, Melbourne
220. HIV Dermatology 2014
Australasian College of Dermatologists, Melbourne
221. The Aetiopathogenesis of Male Genital Lichen Sclerosus 2014
Genital Dermatology Symposium, Australasian College of Dermatologists, Melbourne
222. Toxic Epidermal Necrolysis 2014
Australasian College of Dermatologists, Melbourne
223. Toxic Epidermal Necrolysis 2014
Baltic Association of Dermatovenereologists, Riga
224. Clinical and Research Agenda, British Association of Dermatologists 2014
UK TREND Launch, London
225. The Aetiopathogenesis of Male Genital Lichen Sclerosus 2014
Dowling Club, Moscow
226. Melanoma and Non-melanoma Skin Cancer in HIV 2014
World Congress on Cancer of the Skin, Edinburgh
227. HIV and Skin Manifestations 2014
European Academy of Dermatology & Venereology, Amsterdam
94
228. Male Genital Lichen Sclerosus 2014
European Academy of Dermatology & Venereology, Amsterdam
229. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2014
BASHH Genital Dermatology Course, London
230. HIV Dermatology in the Era of cARV Therapy 2014
College of Podiatry Annual Conference, Bournemouth
231. Toxic Epidermal Necrolysis 2014
North London Academic Dermatology Meeting, London
232. HIV Dermatology in the Era of cART 2014
Retired Fellows’ Society, Royal Society of Medicne, London
233. Male Genital Lichen Sclerosus-from dyspareunia to penis cancer 2014
Urology Arena, Berne
234. HIV Dermatology in the Era of cART 2015
John Thornton Ingram Lecture, Royal College of Physicians
Medical Dermatology Meeting, (RCP, BAD, BSMD, BSSCII), London
235. HIV Dermatology in the Era of cART
European Academy of Dermatology & Venereology, Valencia 2015
236 When to think of HIV (and how to proceed)
European Academy of Dermatology & Venereology, Valencia 2015
237. Male Genital Lichen Sclerosus-From Dyspareunia to Penis Cancer 2015
Grand Rounds, Dpartment of Dermatology, UCSF, San Francisco
238. Toxic Epidermal Necrolysis. 2015
Residents Seminar, Department of Dermatology, UCSF, San Francisco
238. Male Genital Skin Disease 2015
FO35, AIDS and STIs, American Academy of Dermatology, San Francisco
239. Penile Dermatology for the Urologist 2015
Inaugural European School of Urology Course: Penile Diseases
European Association of Urology, Madrid
240. HIV in Dermatology 2015
Dubai Derma, 15th Dubai World Dermatology and Laser Conference and Exhibition
Dubai
241. Toxic Epidermal Necrolysis 2015
Dubai Derma, 15th Dubai World Dermatology and Laser Conference and Exhibition
Dubai
242. Toxic Epidermal Necrolysis 2015
Teach In. Dermatology for the General Physician, Royal College of Physicians
243. Male Genital Lichen Sclerosus 2015
Male Genital Disease
5th Annual Anogenital and Oral Genital Dermatology Course, St John's Institute of Dermatology
Royal College of Physicians, London
244. Male Genital Lichen Sclerosus 2015
95
‘Best of British’, ILDS Member Society Meeting
World Congress of Dermatology, Vancouver
245. The Many Faces of Skin Manifestations in HIV 2015
SY05, Sexually Transmitted Infections
World Congress of Dermatology, Vancouver
246. HIV Skin Disease in the Era of cART 2015
CO06, Microbiology & Infectious Diseases
World Congress of Dermatology, Vancouver
247. Lichen Sclerosus in Males 2015
SY21, Genito-Anal Disorders
World Congress of Dermatology, Vancouver
248. HPV Infection in HIV Infected Patients 2015
SY25, HPV–New Horizons
World Congress of Dermatology, Vancouver
249. Male Genital Lichen Sclerosus: Aetiopathogenesis & Management 2015
SY70, Men’s Issues
World Congress of Dermatology, Vancouver
250. The Many Faces of Skin Manifestations in HIV 2015
The World Congress Experience (Vancouver), Telelecture, Diegem (Belgium)
251. Male Genital Lichen Sclerosus: Aetiopathogenesis & Management 2015
The World Congress Experience (Vancouver), Telelecture, Diegem (Belgium)
252. HIV & Co-infections: HPV & HSV 2015
D1T5.4 Review and Updates: HIV
European Academy of Dermatology & Venereology, Copenhagen
253. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2015
BASHH Genital Dermatology Course, London
254. Male Genital Lichen Sclerosus - from Dyspareunia to Penis Cancer 2015
Dept. of Dermatology, Edinburgh
255. Topics in Male Genital Dermatology - MGLSc, CIS and IPL 2015
Joint RSM Urology/ BAUS Andrology Teaching Day, Andrology Today, London
256. Toxic Epidermal Necrolysis 2015
UK National DermSoc Day, British Association of Dermatologists, London
257. HIV Dermatology 2015
UK National DermSoc Day, British Association of Dermatologists, London
258. Male Genital Dermatology 2015
UK National DermSoc Day, British Association of Dermatologists, London
259. HIV Dermatology in the Era of cART 2015
North Thames Dermatology/Rheumatology Training Day, UCLH
260. Toxic Epidermal Necrolysis-Guidelines v Lifelines 2015
West Midland Regional Dermatology Meeting, Birmingham
261. HIV Dermatology in the Era of cART 2015
British Association of Dermatologists Training Event, London
96
262. Male Genital Dermatoses 2015
Euroderm Excellence, Nice
263. Selected Topics in Male Genital Dermatology 2016
Dansk Dermatologisk Selskab, Munkebjerg, Veijle
264. Melanoma 2016
Dermatology Workshop for Nuffield Health GPs, King Edward VII Hospital, London
265. Toxic Epidermal Necrolysis 2016
Advanced Medicine Conference, Royal College of Physicians, London
266. Penile Dermatology for the Urologist 2016
European School of Urology Course: Penile Diseases, European Association of Urology, Munich
267. Male Genital Dermatology 2016
Primary Care Dermatology Society of Ireland, Killarney
268 The Diagnosis of Melanoma 2016
Primary Care Dermatology Society of Ireland, Killarney
269. Male Genital Lichen Sclerosus 2016
Male Genital Disease
6th Annual Anogenital and Oral Genital Dermatology Course, St John's Institute of Dermatology
Royal College of Physicians, London
270. HIV Dermatology in the Era of cART (Plenary Lecture) 2016
European Academy of Dermatology & Venereology, Athens
271. Skin at the Deep End 2016
Pierre Deville Memorial lecture, Royal Society of Medicine
272. HIV Dermatology in the Era of cART 2016
BASHH Genital Dermatology PLUS Course, London
273. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2016
BASHH Genital Dermatology Course, London
274. Male Genital Lichen Sclerosus 2016
2nd International Conference of Dermatology & XIIIth SODVELON, Kathmandu
275. Toxic Epidermal Necrolysis 2016
2nd International Conference of Dermatology & XIIIth SODVELON, Kathmandu
276. HIV Dermatology in the Era of cART 2016
2nd International Conference of Dermatology & XIIIth SODVELON, Kathmandu
277. Male Genital Dermatology 2016
Euroderm Excellence, Nice
278. This House believes that UK Dermatology is not ready for Evidence Based Medicine 2016
Opposer to the motion
British Association of Dermatologists & St John’s Hospital Dermatology Society,
Annual UK Consultants Course, London
279. Male Genital Dermatology 2017
Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo
97
280. HIV Dermatology in the Era of cART 2017
Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo
281. Male Genital Lichen Sclerosus 2017
Male Genital Disease
7th Annual Anogenital and Oral Genital Dermatology Course, St John's Institute of Dermatology
Royal College of Physicians, London
282. Bowenoid Papulosis 2017
European Academy of Dermatology & Venereology, Geneva
283. Male Genital Lichen Sclerosus - from Dyspareunia to Penis Cancer 2017
Society for the Study of Sexually Transmitted Diseases in Ireland, Dublin
284. Penile Dermatology for the Urologist 2018
European School of Urology Course: Penile Diseases, European Association of Urology, Copenhagen
285. Male Genital Dermatology 2018
Pan-Thames, Dermatology SpR Training, Guy’s Hospital, London
286. HIV Dermatology 2018
Dowling Club Meeting, Valletta, Malta
287. Male Genital Lichen Sclerosus 2017
Male Genital Disease
8th Annual Anogenital and Oral Genital Dermatology Course, St John's Institute of Dermatology
Royal College of Physicians, London
288. HIV Dermatology in the Era of cART 2018
Primary Care Dermatology Society, London
289. How to Prevent Penis Cancer 2018
British Society for Geriatric Dermatology, British Association of Dermatologists, Edinburgh
Numerous lectures annually to medical students at the several institutions at which I have worked:
e.g. 12 per annum at Imperial College 2005-2010